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ABSTRACT 
This thesis comprises an investigation into the reaction of 
halogenated xenobiotics and anaesthetic agents, with hepatic 
microsomal stearate desaturase. The levels of stearate 
desaturase in the hepatic microsomes were routinely elevated 
by re-feeding the experimental animals a high carbohydrate 
diet. The interaction of the xenobiotics with stearate 
desaturase was assessed by monitoring their effects on the 
redox steady state of hepatic microsomal cytochrome b 5 , in 
the presence and absence of cyanide. Approximately half of 
the xenobiotics examined shifted the redox steady state of 
NADPH reduced ferrocytochrome b 5 towards the ferric form of 
the protein. Those compounds which shifted the redox steady 
state of cytochrome b 5 to a figure of 40% or below were 
examined further by assessing their effect on the re-oxidation 
of NADH reduced microsomal ferrocytochrome b
5
. The pseudo 
first order rate constant for the rate of re-oxidation of 
NADH reduced microsomal ferrocytochrome b
5 
was significantly 
elevated in the presence of bromotrichloromethane, l,2-
dibromo-1,2-dichloroethane, chloroacetaldehyde, halothane, 
enflurane and methoxyflurane. The enhanced re-oxidation of 
microsomal ferrocytochrome b 5 observed in the presence of 
the above compounds was significantly diminished by 0,5 mM 
cyanide. Furthermore, these compounds appeared to stimulate 
the oxidation of microsomal ferrocytochrome b 5 without 
affecting its reduction. 
VII 
The effects of these halogenated xenobiotics on the re-
oxidation of microsomal ferrocytochrome b 5 appeared to 
parallel the dietary induction of stearate desaturase. In 
those rats which had been re-fed a high carbohydrate diet 
to induce stearate desaturase, the effect of the compounds 
on microsomal cytochrome b 5 was enhanced while fasting, 
which is known to drastically reduce stearate desaturase 
activity, eliminated these effects. Similarly, fasting 
together with phenobarbitone pretreatment, which is also 
known to reduce stearate desaturase activity, eliminated 
these effects. Furthermore, the effects of the halogenated 
hydrocarbons on microsomal cytochrome b 5 paralleled the 
dietary induction of the 69-desaturase and not the 66-
desaturase which is known to be differently regulated, thus 
excluding the 66-desaturase from involvement in the observed 
reactions. 
The enhanced rate of re-oxidation of microsomal ferrocyto-
chrome b 5 observed in the presence of bromotrichlorornethane, 
halothane, enflurane and methoxyflurane was not affected by 
the presence of CO, an inhibitor of cytochrome P-450. The 
effect of chloroacetaldehyde and l,2-dibrorno-1,2-dichloro-
ethane however, appeared to be decreased in the presence of 
co. Metyrapone, another cytochrome P-450 inhibitor, was 
without effect on the enhanced rate of re-oxidation of micro-
somal ferrocytochrome b 5 observed in the presence of bromo-
trichloromethane, halothane, enflurane and methoxyflurane. 
VIII 
The equilibrium constant (K ) for the stimulation of the eq 
re-oxidation of microsomal ferrocytochrome b 5 by bromo-
trichloromethane, l,2-dibromo-1,2-dichloroethane, enflurane 
and methoxyflurane has been determined. No K value was eq 
calculable for chloroacetaldehyde inasmuch as the rate 
constant for the re-oxidation of microsomal ferrocytochrome 
b 5 was decreased in the presence of relatively low concentra-
tions (< 10 rru~) of this compound. The first order rate constants 
(kobs) for the re-oxidation of microsomal ferrocytochrome b 5 
in the presence of bromotrichloromethane and l,2-dibromo-1,2-
dichloroethane were found to be similar to the K s 
determined for their binding to cytochrome P-450. 
values 
The K eq 
for enflurane differed from the K and K values for the s m 
interaction of this anaesthetic agent with cytochrome P-450, 
whereas the K for methoxyflurane differed from the Km for eq 
NADPH oxidation by cytochrome P-450, but not from the K s 
for binding to cytochrome P-450 or the K for fluoride ion 
m 
production from this anaesthetic agent by cytochrome P-450. 
The K. values obtained for cyanide inhibition of the en-
1 
hancement of the re-oxidation of microsomal ferrocytochrome 
b 5 by the three halo compounds and the anaesthetic agents 
were within experimental error of the K. value of 0,1 mM 
l 
determined by Oshino et al. (1966) for cyanide inhibition of 
stearate desaturase activity. 
Neither the halo compounds nor the anaesthetic agents had 
any effect on the conversion of stearoyl CoA to oleate by 
IX 
hepatic microsomal stearate desaturase. 
The effect of the anaesthetic agents, enflurane and methoxy-
flurane on the rate constant for the oxidation of purified, 
trypsin-cleaved ferrocytochrome b 5 was examined. Neither 
enflurane nor methoxyflurane had any significant effect on 
the oxidation of ferrocytochrome b
5
• 
Neither bromotrichloromethane, 1,2-dibromo-1,2-dichloroethane 
nor chloroacetaldehyde had any significant effect on the 
activities of either the NADH- or the NADPH-cytochrome c 
reductases. Enflurane and methoxyflurane also appeared to 
significant 
be withoutAeffect on either of these reductases although 
enflurane slightly increased the activity of the NADH-cyto-
chrome c reductase. 
From several lines of evidence, it is concluded that bromo-
trichloromethane, l,2-dibromo-1,2-dichloroethane, enflurane 
and methoxyflurane stimulate hepatic microsomal electron flow 
through cytochrome b 5 by interacting with stearate desaturase: 
the effects of these xenobiotics on the re-oxidation of micro-
somal ferrocytochrome b
5 
paralleled the dietary induction of 
stearate desaturase, the equilibrium constants determined 
for the re-oxidation of ferrocytochrome b
5 
in the presence 
of these xenobiotics differed from the K and K values for s m 
their interaction with cytochrome P-450 and the K. for 
1 
cyanide inhibition of the enhancement of the re-oxidation of 
ferrocytochrome b 5 agreed with that observed for the 
X 
inhibition of stearate desaturase activity. 
In view of these results, the metabolism of these xeno-
biotics by stearate desaturase and their ability to uncouple 
the stearate desaturase enzyme system was assessed. A 
reconstituted system, as described by Shimakata et al. (1972) 
comprising hepatic microsomal stearate desaturase, cytochrome 
b 5 and NADH-cytochrome b 5 reductase was employed to study the 
in vitro metabolism of the anaesthetic agents halothane, 
enflurane and methoxyflurane. Hepatic microsomes treated 
with either iodomethane or potassium thiocyanate to deplete 
cytochrome P-450 levels while maintaining elevated levels of 
stearate desaturase were employed to study the in vitro 
metabolism of the anaesthetic agents. 
Utilizing the reconstituted and microsomal systems, it 
appears that the stearate desaturase enzyme system does not 
metabolize halothane, enflurane or methoxyflurane. No 
fluoride ion or acid-labile fluorine compounds were released 
from the anaesthetic agents. No bromide ions were released 
from halothane. No volatile metabolites from any of the 
anaesthetic agents could be detected by gas liquid chroma-
tography. No non-volatile metabolites of halothane were 
detected using [1- 1 ~c]-halothane. 
The uncoupling of the stearate desaturase enzyme system by 
xenobiotics was assessed by determining the levels of active 
oxygen species in hepatic microsomes. The enhanced electron 
XI 
flow through cytochrome b 5 observed in the presence of the 
halo compounds and anaesthetic agents was correlated with 
the production of hydrogen peroxide. Chloroacetaldehyde 
and bromotrichloromethane produced a transient increase in 
hydrogen peroxide production, while a significant sustained 
increase was observed in the presence of halothane, enflurane 
and methoxyflurane. The anaesthetic agents did not increase 
the production of superoxide anion in hepatic microsomes. 
The increase in hydrogen peroxide in the presence of the 
anaesthetic agents provided evidence that they uncouple the 
stearate desaturase enzyme system as they bind to, but are 
not metabolized by stearate desaturase. 
The effects in vivo of halothane, enflurane, ether and 
chloroform on the stearate desaturase enzyme system, 
cytochrome P-450, S.G.O.T. and histology were examined. A 
comparison was made between halothane and enflurane which 
have been shown to interact with the stearate desaturase 
enzyme system in vitro, and ether and chloroform which do 
not interact. The levels of stearate desaturase were un-
affected by repeated exposures to any of these anaesthetic 
agents. Cytochrome P-450 levels were decreased by halothane 
anaesthesia while ether anaesthesia had an inductive effect 
on the cytochrome. S.G.O.T. levels were significantly 
increased after chloroform anaesthesia only. Hepatotoxicity, 
as assessed histologically and oy raised S.G.O.T. levels 
was not evident following anaesthesia by halothane, enflurane 
or ether. Chloroform however, produced gross centrilobular 
XII 
hepatic necrosis. It is concluded that halothane and 
enflurane are not potentially hepatotoxic. 
A similar study of the effects on hepatotoxicity of these 
anaesthetic agents and methoxyflurane administered under 
hypoxic conditions was undertaken. Anaesthesia under 
hypoxic conditions is known to produce centrilobular hepatic 
necrosis. Anaesthesia with N2o;o2 under hypoxic conditions 
had no detrimental effect on stearate desaturase activity, 
mortality or hepatic histology. Methoxyflurane and enflurane, 
under hypoxic conditions produced negligible hepatotoxicity, 
while chloroform produced gross centrilobular necrosis of the 
hepatocytes, raised S.G.O.T. and high mortality, independantly 
of the levels of stearate desaturase in these animals. 
Anaesthesia with halothane under hypoxic conditions had no 
effect on stearate desaturase activity or cytochrome P-450 
levels. Halothane had a deleterious effect on animals 
exposed under hypoxic conditions, as evidenced by raised 
S.G.O.T. levels, mortality and hepatic histology. This 
effect appeared to be decreased in those animals having 
elevated levels of stearate desaturase. It is therefore 
possible that stearate desaturase could play a protective 
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differs significantly from control value, P < 0,001 
differs significantly from control value, P < 0,01 
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differs significantly from differently treated 
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differs significantly from differently treated 
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probably differs from differently treated samples, 
P < 0,05 
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The last forty years has seen great advances in the field of 
drug metabolism. Drug metabolism is the process whereby 
compounds foreign to the body, known generally as "xeno-
biotics" undergo enzymatic biotransformation, leading to 
the production of metabolites. This observation is 
especially true in the case of the volatile anaesthetic agents 
which were initially assumed to be chemically inert sub-
stances, which exerted their anaesthetic properties without 
being metabolized. The classic work of Haggard (1924) on 
the absorption, distribution and elimination_ of diethyl 
ether provided a basis for this hypothesis. There was one 
exception to this hypothesis, namely trichloroethylene which 
as early as 1939, was shown to be metabolized in vivo 
(Barrett and Johnston, 1939). More recently, hepatic 
necrosis following anaesthesia provided a stimulus for a 
re-examination of the possible in vivo metabolism of anaes-
thetic agents. In the early 1960's, Stier (1964) and Van 
Dyke (Van Dyke et al., 1964a, 1964b, Van Dyke and Chenoweth, 
1965) demonstrated that the volatile anaesthetic agent halo-
thane (cF 3CHBrCl) could be converted in vivo to urinary 
metabolites. It has subsequently been determined that 
virtually all xenobiotics undergo enzymatic biotransformation 
and this has led to a new field in biochemistry, namely the 
study of xenobiotic metabolism and its consequences. 
2 
The metabolism of xenobiotics has been established to 
occur primarily in the liver, while the enzymes of 
other organs and tissues such as the kidney, lungs 
and skin usually play minor roles. The main function of 
drug metabolizing enzymes is to protect the body against 
the deleterious effects of xenobiotics. These enzymes 
function via a 2-step process : the first step being the 
introduction of more polar side chains such as hydroxyl 
groups into the molecule. This process often involves 
hydroxylations, oxidations, reductions and hydrolyses. 
Once the xenobiotics have been hydroxylated, less toxic 
intermediates result which are more polar molecules and 
hence more water soluble than the parent compounds. 
Besides hydroxylation by cytochrome P-450, the first step 
in the metabolism of xenobiotics may be catalyzed by other 
enzymes situated in the endoplasmic reticulum, cytosol 
and mitochondria of liver cells. For example, the oxi-
dation of amines is catalyzed by enzymes such as mito-
chondrial monoamine oxidase, while the oxidation and reduc-
tion of alcohols, aldehydes and ketones is performed by 
cytosolic alcohol and aldehyde dehydrogenases. The hydra-
tion of epoxides is catalyzed by epoxide hydrase, an enzyme 
of the endoplasmic reticulum (Handbook of Experimental 
Pharamcology, 1971). 
Once a xenobiotic has been metabolized by one or more of 
these hepatic enzymes, the second step in its metabolism 
is often conjugation with a small polar molecule such as 
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glucuronic acid (Dutton, 1971) or reduced glutathione 
(Chasseaud, 1976). For glucuronidation to occur, the 
xenobiotic or its metabolite is conjugated with glucuronic 
acid by a heterogenous group of enzymes, the glucuronyl 
transferases (Mulder, 1974). Similarly, compounds are 
conjugated with glutathione by glutathione-S-transferases 
(Chasseaud, 1976). The metabolites resulting from these 
enzymatic reactions may then be excreted in the urine via 
the kidney. 
The major hepatic enzymes involved in the first step of the 
metabolism of xenobiotics are known collectively as cyto-
chrome P-450 although there is abundant evidence that they 
are a group of enzymes rather than a single enzyme (Conney, 
1967; Gillette, 1971). Cytochrome P-450 is a group of b 
type cytochromes containing apoprotein moeities of molecular 
weight, 44 000 to 54 000 daltons. The term cytochrome 
P-450 is derived from the phenomenon that the CO-difference 
spectrum of the ferrocytochrome exhibits an absorption peak 
at 450 nm (Omura and Sato, 1962). 
The presence of this CO-binding pigment in mammalian liver 
microsomes was first reported by Klingenberg (1958) and 
Garfinkel (1958) and evidence for its hemoprotein nature 
was provided by Omura and Sato (1964). Cytochrome P-450 
has been shown to be a terminal oxygen-activating hemo-
protein and is one of a group of enzymes known collectively 
as the mixed function oxidases (Gillette et al., 1972). 
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This term is used to describe any enzyme utilizing one 
oxygen molecule in its reactions, one oxygen atom being 
incorporated into the substrate while the other oxygen 
atom is reduced to water. 
For the cytochrome P-450 mediated hydroxylation reactions, 
NADPH,oxygen and substrate are required, usually in a 1:1:1 
molar stoichiometry. Electrons from NADPH are transferred 
to cytochrome P-450 via a flavoprotein called NADPH-cyto-
chrome c (P-450) reductase (Lu et al., 1976). Cytochrome 
b 5 may also be involved in the transfer of electrons from 
NADH or NADPH to cytochrome P-450 (Hildebrandt and Estabrook, 
1971; Mannering et al., 1974; Archakov et al., 1975), but 
it is not an obligate intermediate electron carrier. 
Cytochrome b 5 , when reduced by NADH can usually only pro-
vide the second electron to cytochrome P-450 (Hildebrandt 
and Estabrook, 1971; Mannering et al., 1974). The path-




Figure 1 : 
substrate hydroxylated subtrate 
~
NADPH-cytochrome c cytochrome P-450 o2 
(P-450) reducta~ / 
NADH-cytochrome b 5 cytochrome b 5 reductase 
Electron transport pathways in hepatic microsomes. 
(Straight arrows indicate electron flow). 
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The overall reaction catalysed by cytochrome P-450 is : 
NADPH + o2 + H+ + SH 
where SH indicates the substrate and SOH the hydroxylated 
substrate. The mechanism whereby cytochrome P-450 hydroxy-
lates substrates is proposed to proceed as follows : (Esta-
brook et al,, 1973; Coon et al., 1975; Dawson et al., 1976; 






















Figure 2 Pathway of cytochrome P-450 catalyzed reactions. 
SH indicates the substrate and SOH indicates the 
hydroxylated substrate. 
Fe++ d F +++ . d" t an e in ica e the oxidation state of the 
heme of cytochrome P-450. 
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While the metabolism of xenobiotics by these enzymes is 
generally advantageous in that it protects the body from 
the deleterious effects of some xenobiotics, it may also 
be detrimental to the body. Particularly, cytochrome P-450 
mediated metabolites, which are usually hydroxylated com-
pounds or derivatives thereof, are not always less toxic 
than the parent compounds. The metabolism of vinyl 
chloride by cytochrome P-450 gives rise to carcinogenic 
metabolites, probably chloroethylene oxide or chloroacetal-
dehyde (Kappus et al., 1975). The metabolism of the anaes~ 
thetic agent fluroxene by cytochrome P-450 not only gives 
rise to metabolites such as 2,2,2-trichloroethanol which are 
hepatotoxic, but also to reactive metabolites which are 
capable of chemically altering the heme of cytochrome P-450 
apparently resulting in "suicide" inhibition of this 
important enzyme (Ivanetich et al., 1975; Ivanetich et al., 
1976). 
Cytochrome P-450 and several of the other drug metabolizing 
enzymes are situated in the endoplasmic reticulum. On 
homogenization of the liver, the endoplasmic reticulum is 
disrupted and segmented. The broken portions of the endo-
plasmic reticulum reseal to form vesicles which may be 
separated from the remaining cell debris by high speed 
centrifugation (Holtzman and Carr, 1972) or column chroma-
tography (Tangen et al., 1973)~ The vesicles isolated from 
the endoplasmic reticulum are known as microsomes. They 
contain all of the enzymes originally present in the intact 
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endoplasmic reticulum and therefore provide a useful tool 
for investigations of drug metabolism. 
The activities of microsomal drug metabolizing enzymes may 
be elevated in the livers of animals by pretreatment with 
various drugs, hormones or carcinogens such as the barbi-
turate phenobarbitone or the carcinogen 3-methylcholanth-
rene (Conney, 1967; Gillette, 1971). The increased enzyma-
tic activity after treatment with these chemicals results 
from an increased level of the enzymes and is known as 
enzyme induction. Enzyme inducing agents provide an 
important tool for investigations of drug metabolism in 
vitro and in vivo. 
Phenobarbitone is one of the most widely used inducing 
agents for cytochrome P-450 and other xenobiotic metaboliz-
ing enzymes. Phenobarbitone causes enhanced proliferation 
of the smooth endoplasmic reticulum of the hepatocytes 
which results in increased production of microsomal protein. 
In addition, phenobarbitone induces the levels of drug meta-
bolizing enzymes such as cytochrome P-450, NADPH-cytochrome 
c reductase and cytochrome b 5 
relative to the levels of 
total microsomal protein (Conney, 1967; Gillette, 1971). 
The type of cytochrome P-450 induced by different chemicals 
differs. For example, the form of cytochrome P-450 elevated 
by phenobarbitone differs from that induced by 3-methyl-
cholanthrene. The form of cytochrome P-450 induced by the 
8 
latter chemical is known as cytochrome P-448 because the 
CO-difference spectrum of the ferrocytochrome has a maxi-
mum absorption at 448 nm as opposed to the 450 nm absorp-
tion maximum found for the forms of cytochrome P-450 
present in microsomes from phenobarbitone and uninduced 
rats (Mannering et al., 1969). The different forms of 
cytochrome P-450 differ in terms of their substrate 
specificity. Advantage has been taken of the different 
chemicals to induce different forms of cytochrome P-450 
and this tool has been used extensively in studies on drug 
metabolism using hepatic microsomes. 
METABOLISM OF ANAESTHETIC AGENTS 
(1) Halothane. 
Halothane, a volatile halogenated hydrocarbon of the 
structure cF
3
CHBrCl, was introduced as an anaesthetic 
agent in 1956 (Bryce-Smith and O'Brien, 1956). It 
was the product of an extensive search for a non-
explosive, non-flammable anaesthetic agent. Halothane 
has since become the most widely used anaesthetic agent 
in medical history due to the relative safety of its 
action, ease of administration, lack of emitic proper-
ties and rapid recovery characteristics. 
The metabolism of halothane has been studied extensively. 
Up to 23% of the administered dose of halothane in vivo 
is excreted as non-volatile urinary metabolites 
9 
(Cascorbi et al., 1970) with the major urinary metabolite 
of halothane in man being trifluoroacetic acid (Stier, 
1964; Van Dyke and Chenoweth, 1965, Rehder et al., 1967; 
Airaksinen et al., 1970; Cascorbi and Blake, 1971). 
It has been proposed, but is disputed that trifluoroacetic 
acid is produced via trifluoroethanol and trifluoroacetal-
dehyde and it is known that trifluoroethanol is toxic 
(Blake et al., 1969; Airaksinen et al., 1970; Cohen, 1971). 
Bromide and chloride ions are other known halothane meta-
bolites (Stier, 1964; Van Dyke et al., 1964b; Van Dyke and 
Chenoweth, 1965; Cohen, 1971). 
Other urinary metabolites include trifluoroacetyl ethanol-
amine (Cohen, 1971), N-trifluoro-2-amino-ethanol and an N-
acetyl-cysteine conjugate, identified as N-acetyl-S-(2-bromo-
2-chloro-1,1-difluoroethyl )-cysteine (Cohen et al., 1975). 
The initial step in the metabolism of halothane has been 
shown to occur in the microsomal fraction of the liver and 
to be mediated by cytochrome P-450 (Van Dyke, 1966; Kara-
shima et al., 1977). 
The metabolism of halothane by cytochrome P-450 was initially 
thought to be oxidative, but recent studies have shown that 
a reductive pathway involving cytochrome P-450 is also 
operative. Oxidative metabolism by cytochrome P-450 con-
verts halothane to trifluoroacetic acid or to compounds 
which may react with phosphotidyl ethanolarnine or gluta-




































































































































































































































































































































































The reductive metabolism of halothane, mediated by 
cytochrome P-450 occurs under hypoxic conditions. This 
pathway gives rise to volatile metabolites, two of 
which have recently been identified as cF 3cH 2cl an
d 
CF 2=CH
C1 (Mukai et al., 1977). These volatile meta-
bolites are thought to be produced via free radical and 
carbanion intermediates in the following manner (Sharp 
et al., 1979) : 
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Two electron reduction of halothane : 
F Br + 
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One electron reduction of halothane : 
F Br + 



































Figure 4 : Proposed pathways for the reductive metabolism of 
halothane by__£Vtochrome P-450. 
13 
The observed hepatotoxicity following halothane anaesthesia 
in clinical practice, together with studies on its meta-
bolism led to the realization that halothane was poten-
tially hepatotoxic. Initially, halothane was not sus-
pected to be the cause of the hepatotoxicity occasionally 
observed after halothane anaesthesia {Virtue and Payne, 
1958). "Unexplained fever after halothane" or "halothane 
hepatitis" as the lesion has come to be called, is an 
extremely rare disorder and much controversy still 
surrounds it (The National Halothane Study, 1966). The 
lesion is characterized by fever occurring 2 to 3 days 
after exposure to halothane and is followed by jaundice 
(The National Halothane Study, 1966), chills and rashes 
{Klatskin and Kimberg, 1969; Klion et al., 1969) and 
anorexia leading to eventual coma {Trey et al., 1968; Peters 
et al., 1969). When examined microscopically, the livers 
of patients with halothane hepatitis reveal marked centri-
lobular necrosis, consistent with severe, chronic conges-
tion (Burnap et al., 1958). Increases in serum enzymes 
also occur (Peters et al., 1969). Halothane hepatitis 
occurs more frequently in patients who undergo multiple 
exposures to halothane {The National Halothane Study, 
1966; Klatskin, 1968; Trey et al., 1968), who are obese or 
aged (Peters et al., 1969) or have malignant disease 
(Simpson et al., 1971; Trowel et al., 1975). A simi-
larity between halothane hepatitis and viral hepatitis 
has further complicated the understanding of halothane 
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hepatitis (The National Halothane Study, 1966; Klion 
et al., 1969). It has been suggested that a hyper-
sensitive immune response to halothane or its meta-
bolites may be the cause of the observed hepatitis 
(Belfrage, 1966; Klatskin and Kimberg, 1969). 
Despite the controversy surrounding halothane, it is 
generally regarded as a safe anaesthetic agent; un-
explained fever and hepatic necrosis have been observed 
to occur after exposure to other anaesthetic agents as 
well (Trey et al., 1968; Simpson et al., 1971). The 
unsatisfactory situation regarding halothane prevailing 
at present, coupled with the accumulating evidence that 
halothane is hepatotoxic, was a fundamental reason for 
the investigations of halothane reported in this thesis. 
To date, research into metabolism and hepatotoxicity 
of halothane has been confined mainly to the interac-
tion of halothane with hepatic microsomal cytochrome 
P-450. Inasmuch as both the oxidative and reductive 
metabolic pathways of halothane already elucidated 
do not provide an explanation of the conditions of 
halothane hepatitis, the interaction of halothane with 
other microsomal enzymes becomes relevant. In this 
regard, the interaction of halothane with hepatic 
microsomal stearate desaturase was investigated. 
(2) Enflurane. 
Enflurane (CClFHCF 2ocF 2H) is a relative
ly new volatile 
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anaesthetic agent. It was first synthesised in 1963 
and was introduced into clinical practice in 1966 
(Dobkin et al., 1968). It is believed to be superior to 
many other currently used anaesthetic agents because of 
the virtual absence of toxic effects following enflurane 
anaesthesia ("Ethrane", 1972, Harrison et al., 1976). 
In contrast to halothane, only about 2% of the admini-
stered dose of enflurane is detected in urine as fluoride 
ion and non-volatile organo-fluorine metabolites (Chase 
et al., 1971; Maduska, 1974; Cousins et al., 1976; Mazze 
et al., 1977; Corall et al., 1977), while 98% of the 
enflurane is excreted unchanged via the lungs. One mole 
of inorganic fluoride is proposed to be produced per 
mole of enflurane metabolised (Cousins et al., 1976). 
The first step in the metabolism of enflurane appears 
to be mediated partly by cytochrome P-450. Enflurane 
is known to bind to the substrate binding site of cyto-
chrome P-450 with the production of a type I difference 
spectrum ( ;\ 386 nm; ;\ . 419 nm) . max min 
(Ivanetich et al., --
1979). Evidence for the participation of cytochrome 
P-450 in the metabolism of enflurane is provided by the 
ability of enflurane to enhance the CO-inhibitable 
NADPH consumption by hepatic microsomes. The K for m 
the oxidation of NADPH in the presence of enflurane 
has been determined to be approximately 2 x 10-~M 
(Harrison et al., 1976; Ivanetich et al., 1979). It 
has been demonstrated that the metabolism of enflurane by 
16 
cytochrome P-450 gives rise to fluoride ion, but no 
acid-labile fluorine compounds could be detected 
(Ivanetich et al., 1979). Furthermore, enflurane is 
metabolized primarily by the form of cytochrome P-450 
induced by phenobarbitone (Ivanetich et al., 1979). 
The metabolism of enflurane has been proposed to occur 
via three pathways. These pathways are however, 
extremely tenuous and have been proposed in analogy to 
the pathways for the metabolism of methoxyflurane, 
inasmuch as the only metabolite of enflurane which has 
been identified is fluoride ion. The ratio of fluoride 
to inorganic fluoride detected in the urine of humans 
anaesthetised with enflurane suggested that dehalogena-
tion of the beta carbon of the ethyl moeity of the 
enflurane molecule could occur (Chase et al., 1971; 
Cousins et al., 1976). 
Cytochrome P-450 is proposed to catalyze the first step 
in each of the three pathways suggested for the meta-
bolism of enflurane (Figure 5). The initial step in 
two of the pathways involves dehalogenation (Kuzava, 
1973; Loew et al., 1974) while the third pathway in-
volves 0-dealkylation (Cousins and Mazze, 1974). It 
has been proposed that one pathway for the metabolism 
of enflurane proceeds via an initial dehalogenation and 
subsequent 0-dealkylation to produce oxalic acid (Loew 
et al., 1974) (Figure 5, pathway 1). Enflurane has 
also been proposed to be metabolized by dehalogenation 
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to l,l,2-trifluoro-2-hydroxyethyl difluoromethyl ether 
and subsequently by o-dealkylation to difluoromethoxy-
difluoroacetic acid and finally to oxalic acid 
(Cousins and Mazze, 1974) (Figure 5, pathway 2). The 
third pathway involves o-dealkylation of enflurane to 
2-chloro-l,l,2-trifluoroethanol and subsequently to 
chlorofluoroacetic acid and finally to oxalic acid 
(Cousins and Mazze, 1974) (Figure 5, pathway 3). 
Although many substrates of cytochrome P-450 are in-
ducing agents for this enzyme, enflurane does not 
appear to be one : exposure to enflurane at anaesthetic 
or subanaesthetic doses has been reported to be with-
out effect on the levels or activities of several 






















































































































































































































































































































































































Enflurane has not been implicated as an hepatotoxic 
or nephrotoxic drug ("Ethrane", 1972; Harrison et al., 
1976), although it has been observed that exposure to 
enflurane can cause cell degeneration and necrosis 
(Van der Reis et al., 1974; Stevens et al., 1977). 
Renal dysfunction, similar to that produced by the 
anaesthetic agent methoxyflurane, has been rarely 
attributed to enflurane (Barr et al., 1974). Minimal, 
but reversible, changes in hepatic enzyme levels occur 






) was introduced into clinical 
practice as a volatile anaesthetic agent in 1961 (Black 
and Clarke, 1971). It is non-flammable and is a good 
muscle relaxant, besides possessing excellent analgesic 
properties at low concentrations. About half of the 
methoxyflurane administered is exhaled unaltered in man 
and about 10% is converted to co 2 which is also exhaled 
(Holaday et al., 1970). High levels of serum inorganic 
fluoride are also produced after exposure to methoxy-
flurane (Holaday et al., 1970; Taves et al., 1970; Fry 
et al., 1973; Brodeur et al., 1976). The urinary meta-
bolites of methoxyflurane in man are inorganic fluoride, 
dichloroacetic acid and methoxydifluoroacetic acid which 
is the major urinary metabolite (Holaday et al., 1970; 
Yoshimura et al., 1976) (Figure 6). The ultimate meta-
bolic product of methoxyflurane metabolism is proposed 
20 
to be oxalic acid (Lee Son et al., 1972) which may be --
produced via methoxydifluoroacetic acid and difluoro-
hydroxyacetic acid (Mazze et al., 1971) (Figure 6). 
21 
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Pathway 1 Pathway 2 
Figure 6 : Proposed pathways for the metabolism of 
methoxyflurane. 
The first step in each of the pathways is pro-
posed to be catalyzed by cytochrome P-450. 
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The metabolism of methoxyflurane is known to be 
mediated by cytochrome P-450. Methoxyflurane, like 
enflurane, binds to cytochrome P-450 with the produc-
tion of a type I difference spectrum (Ivanetich et al., 
1979). Methoxyflurane binds to the type of cytochrome 
P-450 induced by phenobarbitone and to at least one 
other form of this cytochrome, although not to the form 
of cytochrome P-450 induced by 3-methylcholanthrene 
(Ivanetich et al., 1979). Methoxyflurane has been 
found to stimulate the CO-inhibitable NADPH consumption 
by hepatic microsomes, and a K of 1 - 2 x 10- 4 M has m 
been determined for this process (Ivanetich et al., 1979). 
The metabolism of methoxyflurane by cytochrome P-450 
gives rise to fluoride ion and to acid-labile fluorine 
compounds. The production of both fluoride ion and 
acid-labile fluorine compounds (i.e. methoxydifluoro-
acetic acid) from methoxyflurane in hepatic microsomes 
gave rise to biphasic kinetic data plots from which two 
sets of K and V values could be calculated m max 
(Ivanetich et al., 1979). 
The metabolites of methoxyflurane are known to produce 
nephrotoxicity rather than hepatotoxicity and the 
degree of nephrotoxicity can be increased by pheno-
barbitone pretreatment (Lee Son et al., 1972; Brodeur 
et al., 1976). The urinary metabolite, oxalic acid, 
is also known to be a renal toxin (Lee Son et al., 1972; 
Hayler and Herman, 1973) while fluoride ions are also 
23 
responsible for nephrotoxicity {Mazze et al., 1971). 
The accumulated evidence against methoxyflurane has 
led to its being withdrawn from clinical use recently. 
STEAR.i;.TE DESATUR]I.SE ENZYME SYSTEM 
Although hepatic microsomes contain some of the major 
enzymes involved in the metabolism of xenobiotics, they also 
contain a number of other enzymes which function primarily 
or exclusively in the metabolism of endogenous physiological 
compounds. An important member of this latter group of 
enzymes is stearate desaturase. 
This enzyme system was identified by Bernhard et al. in 1959 
and its components have since been isolated using detergent 
solubilization {Gurr and Robinson, 1970; Shimakata et al., --
1972; Strittmatter et al., 1974; Safford et al., 1975). 
The isolated terminal oxidase consists of one polypeptide 
chain of 456 amino acid residues and has a molecular weight 
of 53 000 daltons. From amino acid analysis, it was deter-
mined that 62% of the amino acid residues are non-polar. 
Further, one equivalent of non-heme iron is associated with 
the desaturase enzyme {Strittmatter et al., 1974). 
Studies on the chemical modification of the desaturase 
enzyme indicate that several argenine and tyrosine residues 
may be directly involved in its action. The tyrosines may 
also participate in iron co-ordination, while the argenine 
residues are involved in ionic interactions {Enoch and 
24 
Strittmatter, 1978). Inasmuch as one of the major 
characteristics of stearate desaturase is its inhibition 
by cyanide, the terminal oxidase is also known as the 
"cyanide sensitive factor" or C.S.F. (Oshino et al., 1966). 
The main physiological function of stearate desaturase is 
the desaturation of CoA esters of fatty acids, converting 
them to 69-mono unsaturated fatty acids which are sub-
sequently incorporated into biological membranes and are 
important in maintaining membrane fluidity. Stearate 
desaturase inserts a double bond between carbon atoms 9 
and 10 of the long chain saturated fatty acid, stearic 
acid, converting it to the unsaturated fatty acid oleic 
acid (Holloway et al., 1963; Brett et al., 1971; De Gomez 
Dumm and Brenner, 1975). The enzyme shows a high degree 
of specificity for fatty acids with chain lengths of 
16 - 18 carbon atoms (Paulsrud et al., 1970; Brett et al., -- --
1971). 
For enzymatic activity, stearate desaturase requires several 
components such as molecular oxygen and reduced pyridine 
nucleotides which serve as electron donors (Gellhorn and 
Benjamin, 1964; Oshino et al., 1966). NADH is the pre-
ferential electron donor (Jones et al., 1969; Joshi et al., -- --
1977), but NADPH can also supply electrons. The purified 
enzyme has a lipid requirement (Holloway and Katz, 1972) 
in particular for phospholipids, triglycerides and fatty 
acids (Jones et al., 1969). Several proteins are known to 
be involved in the stearate desaturase enzyme system. 
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and the cyanide sensitive factor itself. 
It has recently been shown that several other protein 
factors enhance desaturase activity. A soluble protein 
with molecular weight of 24 000 has been shown to stimu-
late stearate desaturase activity in vitro (Jeffcoat et 
al., 1976). A second factor required for desaturase 
activity has been isolated and found to be unstable to 
heat and tryptic digestion. This factor was concluded to 
be a specific protein and to be loosely bound to the micro-
somal membrane as it could be extracted with buffers of low 
ionic strength (Catala et al., 1975). Another heat sensi-
tive protein factor which has a stimulatory effect on 
stearate desaturase has been identified as catalase (Baker 
et al., 1976). Catalase appears to exert its stimulatory 
effect by preventing inactivation of stearate desaturase 
activity by hydrogen peroxide. A protein having a regula-
tory role in the desaturase reaction has recently been 
isolated from the cytosolic fraction of rat liver (Jones 
and Gaylor, 1979). 
The overall reaction for the conversion of stearic acid to 
oleate is as follows : stearic acid is first converted 
to stearoyl CoA. Subsequently the stearoyl CoA is converted 
-
by the stearate desaturase enzyme system to oleate (Marsh 
and James, 1962; Masaro, 1968) : 
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ATP, Mg2+ 
Step 1 stearic acid+ CoA stearoyl CoA 
microsomes 
Step 2 : (a) stearoyl CoA + enzyme stearoyl-









(d) oleyl-enzyme + CoA oleyl-CoA + enzyme 
* proposed intermediate, not proved. 
The mechanism whereby a double bond is inserted between 
carbon atoms 9 and 10 of the 18 carbon chain by stearate 
desaturase is an intricate one : to insert the double 
bond, the two hydrogens must be in the cis configuration 
(Morris, 1970) and the substrate must be closely enfolded 
between c5 - c15 and less closely enfolded at c314116 and 
11· The substrate must then fit into a cleft in stearate 
0 0 
desaturase which is 26 A long by 4 A wide, and to allow 
this, there must be a substantial conformational change in 
the enzyme substrate complex (Brett et al., 1971). It has 
been suggested that the methylene chain of stearoyl CoA 
assumes an "eclipsed" or gauche conformation at carbon atoms 
9 and 10 of the enzyme substrate complex (Enoch et al., 
1976). This could lead to rotation of the 9-10 carbon-
carbon bond, bringing the 2 hydrogens together on the same 
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side of the chain in an eclipsed conformation. This allows 
a simultaneous, concerted removal of the 2 hydrogens by 
cis-elimination, this being the rate limiting step of the 
desaturase reaction (Morris, 1970; Brett et al., 1971; 
Enoch et al., 1976). There is no precedent for this reac-
tion in model systems as the insertion of a double bond in 
a specific site along a carbon chain is unique. 
A variety of compounds have been shown to enhance or 
decrease the activity of stearate desaturase. The enzyme 
is under dietary regulation: fasting alone diminishes 
desaturase activity (Inkpen et al., 1969; Lee and Sprecher, 
1971; Oshino and Sato, 1972), while fasting followed by 
re-feeding a high carbohydrate diet induces stearate desatu-
rase (Elovson, 1965; Inkpen et al., 1969; Oshino et al., 
1971; Oshino and Sato, 1972) as does a fat-free diet 
(Holloway and Holloway, 1975; Holloway and Holloway, 1977; 
Jeffcoat and James, 1977). A variety of compounds stimulate 
desaturase activity by adaptive enzyme formation, including 
glucose (Donaldson, 1973), insulin (Gellhorn and Benjamin, 
1964; Inkpen et al., 1969) and glycerol-3-phosphate (Raju 
and Reiser, 1972). Saturated fatty acids, fructose and 
glycerol also induce enzyme activity via increased protein 
synthesis (Mercuri et al., 1974; Jeffcoat and James, 1977). 
During induction of stearate desaturase increased enzymatic 
activity is due to an increase in the levels of the terminal 
oxidase of stearate desaturase, i.e. the cyanide sensitive 
factor (Oshino and Sato, 1972). 
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The best known inhibitor of stearate desaturase is cyanide 
(Oshino et al., 1966; Oshino et al., 1971) which, at 
concentrations of 0,5 mM, can cause full inhibition of the 
desaturase reaction in vitro (Joshi et al., 1977). Stearoyl 
CoA, at concentrations greater than 10 - 12 µM can cause 
substrate inhibition (Enoch et al., 1976; Jeffcoat et al., 
1976; Joshi et al., 1977), while oleic acid can cause end-
product inhibition. Linoleic acid, lysolecithin, deoxy-
cholate and palmityl-DL-carnitine are also inhibitory 
(Uchiyama et al., 1967; Pande and Mead, 1968; Pande and 
Mead, 1970; Jeffcoat and James, 1978). Sterculate, a Cl9 
fatty acid, has been found to inhibit stearate desaturase 
and equally effective inhibitors are cyclopropene fatty 
acids (Allen et al., 1967; Fogerty et al., 1972), which 
exert their inhibition by irreversible binding of the 
enzyme sulfhydryl group to the cyclopropene group (Raju 
and Reiser, 1967). 
Stearate desaturase activity is decreased by compounds 
which are known to induce cytochrome P-450 in vivo such as 
the barbiturate phenobarbitone and the carcinogen 3-methyl-
cholanthrene (Oshino and Sato, 1971; Montgomery and 
Holtzman, 1975). It is not known by what mechanism these 
drugs decrease the activity of stearate desaturase. 
Reduced enzymatic activity is observed following administra-
tion of ethionine (Lyman et al., 1970) cycloheximide and 
actinomycin (Oshino and Sato, 1972). Neoplastic tissue and 
tissue from copper deficient animals also have reduced 
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levels of stearate desaturase (Rao and Abrahams, 1975; 
Mercurio and De Tomas, 1978; Wahle and Davies, 1975). 
Stearate desaturase appears to be identical to 4-methyl 
sterol oxidase (Gaylor and Mason, 1968; Siegfried and 
Gaylor, 1976). The 4-methyl sterol oxidase catalyzes the 
oxidation of the 4a-methyl group of sterols during the 
biosynthesis of cholesterol from lanosterol, resulting in 
the formation of a carboxylic acid (Gaylor et al., 1975). 
It is also suggested that the steroidal 4a-carboxylic acid 
is formed by methyl sterol oxidase from an hydroxymethyl inter-
mediate, similar to the hydroxylated intermediate proposed 
for the action of stearate desaturase. 
The properties of stearate desaturase and 4-methyl sterol 
oxidase are the same. Both enzymes require oxygen and 
reduced pyridine nucleotides (Gaylor and Maion, 1968; 
Siegfried and Gaylor, 1976). Both enzymes are inhibited 
by cyanide. Furthermore, fasting lowers the activity of 
both enzymes, while neither is inhibited by the inhibitors 
of cytochrome P-450, viz. CO and ethyl isocyanide (Oshino 
et al., 1966; Gaylor and Mason, 1968). 
Microsomal electron transfer pathway~. 
Cytochrome b 5 plays a central role in hepatic microsomal 
electron transfer. It passes electrons from NADH and NADPH 
to stearate desaturase, cytochrome P-450 and oxygen (as 



















































































































































































































































































Cytochrome b 5 is an amphipathic molecule, whose hydro-
phobic portion attaches it to the microsomal membrane. 
This segment comprises amino acid residues near the amino 
terminal part of the molecule, while the hydrophilic end 
is exposed to the environment and is the enzymatically 
active part of the molecule (Spatz and Strittmatter, 1971; 
Rogers and Strittmatter, 1975). Cytochrome b 5 has been 
sequenced (Ozols and Gerard, 1977) and contains a peptide 
chain of 141 amino acid residues per molecule of heme 
(Spatz and Strittmatter, 1971) with a molecular weight of 
25 000 (Ito and Sato, 1968). 
Proof that cytochrome b 5 is involved in the transfer of 
electrons to stearate desaturase comes from several sources. 
Cytochrome b 5 can accept electrons from NADH, which is the 
preferential electron donor for stearate desaturase, and 
from NADPH, which primarily provides electrons for cyto-
chrome P-450 mediated reactions. Antisera prepared against 
the hydrophilic part of cytochrome b 5 were found to inhibit 
the desaturase reaction, confirming the involvement of this 
section of cytochrome b 5 in transferring electrons from 
NADH and NADPH to stearate desaturase (Oshino and Omura, 
1973). Reconstitution experiments revealed that the absence 
of cytochrome b 5 leads to complete loss of desaturase 
activity and restitution of activity was dependent on the 
amount of cytochrome b 5 added, providing further evidence 
for its involvement (Shimakata et al., 1972). 
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Electrons from NADPH are donated to cytochrome b 5 via 
NADPH-cytochrome c (P-450) reductase in hepatic micro-
somes (Prough and Siler Masters, 1974; Enoch and 
Strittmatter, 1979). The NADPH-cytochrome c reductase is 
not as effective as the NADH-cytochrome b 5 reductase in 
reducing cytochrome b 5 and therefore in the presence of 
NADPH,cytochrome b 5 is not fully reduced. NADPH-cyto-
chrome c reductase is a membrane-bound protein and reduces 
cytochrome b 5 directly. This reductase is capable of 
reducing cytochrome c indirectly, via cytochrome b 5 , with 
electron transfer between ferrocytochrome b 5 and ferri-
cytochrome c being rapid. The participation of NADPH-
cytochrome c reductase in the desaturation of fatty acids 
has been demonstrated in vitro by Oshino (Oshino et al., 
1966; Oshino et al., 1971.) 
The reduction of cytochrome b 5 by NADH is mediated via 
NADH-cytochrome b 5 reductase (Okuda et al., 1972; Rogers 
and Strittmatter, 1975). This reductase is an amphipathic 
molecule, whose ability to bind to the microsomal membrane 
is conferred by the hydrophobic segment of the molecule 
(Rogers and Strittmatter, 1975). The hydrophilic, cata-
lytically active portion is therefore exposed to the cyto-
plasm {Spatz and Strittmatter, 1973). The reductase has a 
molecular weight of 200 000 and consists of six subunits 
each of molecular weight of 35 000 daltons. The hydro-
phobic portion of the peptide is responsible for the poly-
merization (Spatz and Strittmatter, 1972). The catalytically 
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active reductase is a more compact molecule than the 
inactive formandthe flavin portion is in a more non-
polar environment (Strittmatter, 1971). 
It is believed that cytochrome b 5 and NADH-cytochrome b 5 
reductase undergo translational diffusion in the plane of 
the microsomal membrane (Rogers and Strittmatter, 1974a; 
1974b). Interactions between the lipid bilayer of the 
membrane and the hydrophobic portions of cytochrome b 5 and 
NADH-cytochrome b 5 reductase are essential for, and exert 
control over, the overall rate of reduction of cytochrome 
b 5 by NADH. The amphipathic nature of these proteins is 
responsible for the lipid dependence of this interaction 
(Rogers and Strittmatter, 1973). 
The mechanism of reduction of cytochrome b 5 by NADH-cyto-
chrome b 5 reductase has been extensively investigated: 
it is proposed that cytochrome b 5 interacts with NADH-
cytochrome b 5 reductase via complementary charge pair 
interactions involving the cytochrome b5 side chain 
carboxyls of glutamine 47, 48 and 52, the single exposed 
heme propionate and a 5th, as yet unidentified, side 
chain carboxyl group (Dailey and Strittmatter, 1979). 
Once cytochrome b 5 has been reduced by NADH, and the NADH 
is exhausted, cytochrome b 5 autoxidizes via first order 
kinetics. The autoxidation of cytochrome b 5 involves the 
transfer of electrons from ferrocytochrome b 5 directly to 




(Boveris et al., 1972; Berman et al., 
1976). It has been shown that the re-oxidation of cyto-
chrome b 5 is enhanced in the presence of a substrate for 
stearate desaturase. Furthermore, it has been demon-
strated by Oshino et al., (1971) that this enhanced re-
oxidation of cytochrome b
5 
is directly proportional to the 
activity of stearate desaturase. This phenomenon is 
therefore the basis for a simple assay of stearate desatu-
rase activity, as opposed to the more involved assay 
utilizing 14 C-stearoyl CoA. 
Stearate desaturase and xenobiotics. 
Stearate desaturase is generally not thought to interact 
with xenobiotics, and there have been very few reports of 
such interactions. It was first demonstrated by Oshino and 
Sato (1971) that p-cresol, together with several other 
phenolic compounds, enhanced the re-oxidation of NADH 
reduced cytochrome b 5 analagous to the enhancement seen in 
the presence of stearoyl CoA (Oshino et al., 1971). This 
stimulated rate of re-oxidation of cytochrome b 5 was 
inhibited by cyanide, suggesting involvement of stearate 
desaturase. Confirmation of the involvement of cytochrome 
b 5 in this reaction occurred when the rate of p-cresol 
stimulation of the re-oxidation of cytochrome b
5 
was 
inhibited by antibodies to cytochrome b
5 
(Oshino and Omura, 
1973). 
The first report on the interaction of an anaesthetic agent 
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with stearate desaturase was that of Berman et al., (1975). 
Halothane was found to accelerate microsomal electron trans-
fer by interacting with the C.S.F. of stearate desaturase. 
Halothane accelerated stoichiometric consumption of NADPH and 
oxygen and increased the rate of re-oxidation of NADH reduced 
cytochrome b
5
. It was confirmed that the observed effects of 
halothane on microsomal electron transfer were not due to 
interaction with cytochrome P-450 (Berman et al., 1975). 
General aims. 
This thesis covers a detailed investigation of the following 
(1) The interaction of xenobiotics, in particular the vola-
tile anaesthetic agents halothane, enflurane and methoxy-
flurane and three selected halogenated xenobiotics, 
bromotrichloromethane, l,2-dibromo-1,2-dichloroethane and 
chloroacetaldehyde with hepatic microsomal stearate 
desaturase was investigated. It was initially attempted 
to establish whether the xenobiotics might interact with 
stearate desaturase by monitoring their abilities to 
stimulate microsomal electron transfer via cytochrome b 5 , 
namely their effects on the NADPH redox steady state of 
cytochrome b 5 and on the re-oxidation of NADH reduced 
hepatic microsomal ferrocytochrome b 5 , inasmuch as all 
xenobiotics known to interact with stearate desaturase 
enhance the re-oxidation of cytochrome b
5
. 
(2) It was attempted to establish whether the bound xeno-
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biotics were metabolized by stearate desaturase or 
whether xenobiotics uncoupled the stearate desaturase 
enzyme system. A reconstituted system comprising 
NADH-cytochrome b 5 reductase, cytochrome b 5 and C.S.F. 
was employed, as well as hepatic microsomes having 
elevated levels of stearate desaturase activity, but 
artificially reduced levels of cytochrome P-450 to 
assess the metabolism of the anaesthetic agents. 
(3) The ability of the levels of stearate desaturase to 
have an effect on the capacities of the anaesthetic 
agents to exert an hepatotoxic effect on the liver was 




(1) Pretreatment of animals. 
Sodium phenobarbitone was supplied by Maybaker, Port 
Elizabeth, E.P., South Africa. The vitamin mixture 
used for the dietary induction of stearate desaturase 
was constituted from vitamins received as a gift from 
Roche (Pty) Ltd., Isando, Transvaal, South Africa. 
Dextrin was supplied by Merck Chemicals, Darmstadt, 
Germany and by Sigma Chemicals. Choline chloride and 
cellulose were obtained from B.D.H. Chemicals Ltd., 
Poole, England. Casein was purchased from Merck 
Chemicals, Darmstadt, Germany. 
(2) Anaesthetic agents. 
Halothane (fluothane) was obtained from Halocarbon 
Laboratories Inc., Hackensack, N.J., U.S.A. Enflurane 
(ethrane) and methoxyflurane (penthrane) were supplied 
by Abbott Laboratories, Aeroton, Transvaal, South 
Africa. Diethyl ether was obtained from the Natal Cane 
By-Products Ltd., Merebank, Natal, South Africa. 
Chloroform was purchased from Maybaker Ltd., Dagenham, 
England. 
(3) Assays on hepatic rnicrosornes. 
NADH, NADPH, NADP and cytochrome c (horse heart) and 
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glucose-6-phosphate dehydrogenase were obtained from 
Miles Laboratories, Cape Town, South Africa. Stearoyl 
CoA and [1- 14 C]-stearoyl CoA were supplied by Sigma 
Chemicals, Poole, England and New England Nuclear, 
Boston, Mass., U.S.A. Potassium cyanide and sodium 
dithionite were obtained from B.D.H. Chemicals Ltd., 
Poole, England. Glucose-6-phosphate was obtained from 
Koch-Light Laboratories Ltd., Colnbrook, Bucks., England. 
(4) Xenobiotics. 
The xenobiotics used in the survey were obtained as 
follows : Allylbromide, l-bromo-2-chloroethane, chloro-
acetaldehyde, 1,2-dibrorno-l,l-dichloroethane, ethyl 
vinyl ether and 1,1,2-trichloroethane were from Fluka 
Chemicals, Buchs, Switzerland. Allyl chloride, bromo-
ethane, carbon tetrachloride, diethyl ether, iodoform, 
chloromethyl methyl ether, 1,2-dichloroethane, brornoform, 
2,2,2-trichloroethanol, trifluoroacetic acid and 2,2,2-
trifluoroethanol were from Merck Chemicals, Darmstadt, 
Germany. Bromotrichloromethane and l,l,l-trichloro-2,3-
epoxypropane were obtained from Aldrich Chemical Com-
pany, Milwaukee, Wisconsin, U.S.A. Chloroform, divinyl 
ether and ethyl iodide were purchased from Maybaker Ltd., 
Port Elizabeth, E.P., South Africa. 1-chloropropane and 
1,2,3-trichloropropane were supplied by Eastman Organic 
Chemicals, Rochester, New York, U.S.A. Dibromomethane, 
1,2-dibromopropane, dichloromethane, diiodomethane, 
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iodomethane, 1,1,2,2-tetrabromomethane, 1,1,1- and 
1,1,2-trichloroethane and trichloroethylene were from 
B.D.H. Chemicals Ltd., Poole, England. l,2-dibromo-
1,2-dichloroethane, 1-fluorobutane, perfluorohexane, 
tetrabromomethane, tetraiodomethane and 2,2,2-trifluoro-
acetaldehyde hydrate were from ICN Pharmaceuticals Inc., 
Plainview, New York, U.S.A. Fluroxene was from Ohio 
Medical Products, Madison, Wisconsin, U.S.A. l,2,2-tri-
chloro-1,1,2-trifluoroethane (freon 113) was a gift from 
Anglo American Co., Cape Town, South Africa. Cylinders 
of vinyl chloride and other compressed gases were from 
Afrox Ltd., Cape Town, South Africa. 2,2,2-trifluoro-
ethyl ethyl ether was synthesized as described earlier 
(Ivanetich et al., 1975). 
Trypsin-cleaved cytochrome b 5 was purified from rat 
liver microsomes by the method of Omura and Takesue (1970). 
(5) Inhibitors. 
SKF 525A(2-diethylaminoethyl-2,2-diphenyl valerate) was 
a gift from Smith Kline and French Laboratories, Isando, 
Transvaal, South Africa. Metyrapone (2-methyl-1,2-
bis-[3-pyridyl]-1-propanone) was a gift from Ciba-Geigy 
Ltd., Basle, Switzerland. 
(6) Isolation of hepatic microsomal stearate desaturase. 
Sodium deoxycholate and Triton X-100 were obtained from 
B.D.H. Chemicals Ltd., Poole, England. Reduced glutathione 
was obtained from Sigma Chemicals, Poole, England. 
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(7) Treatment of hepatic microsomes. 
Dioxane, iodomethane, iso-butanol and sodium iodide 
were purchased from B.D.H. Chemicals, Ltd., Poole, 
England. Potassium thiocyanate was obtained from 
Merck Chemicals, Darmstadt, Germany. 
{8) Gas liquid chromatography. 
Di-iso-decylphthalate was supplied by Applied Science 
Laboratories Inc. Chromosorb P (acid-washed) and WHP 
Chromosorb/SE 30 were supplied by Johns-Manville, 
Denver, Colorado, U.S.A. Chromosorb 102 was purchased 
from Chemlab (Pty) Ltd., Cape Town, South Africa. 
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B. METHODS 
(1) Treatment of animals. 
Male Long-Evans rats weighing 250 - 300 g were used. 
Rats were fed routinely on a laboratory diet of Epol 
Laboratory Chow [protein (min. 20%); fat (2,5%); 
fibre (max. 6%); calcium (l,4%) and phosphorus (0,7%)] 
manufactured by Epol Ltd., Goodwood, Cape Town, South 
Africa. This diet is referred to throughout as the 
normal diet. 
Hepatic microsomal stearate desaturase was routinely 
induced by feeding rats a high carbohydrate semi-
purified diet of the following composition: Dextrin 
126 g; sucrose 30 g; cellulose 4 g; casein 30 g; NaCl 
4 g; KCl 2 g; vitamin mixture 6 g and choline chloride 
0,2 g. The vitamin mixture comprised the following: 
vitamin A, 2,5 g (325 000 I.U./g); vitamin D, 2,0 g 
(200 000 I.U./g); vitamin B2 (Riboflavin), 0,5 g; niacin, 
7,5 g; pantothenic acid, 1 g; made up to a total of 500 g 
with dextrin. This diet is referred to throughout as the 
high carbohydrate diet. Rats were fed this diet for two 
days, fasted on the third day and re-fed the diet for two 
days (Oshino et al. 1971). The rats were sacrificed and 
experiments performed on the sixth day, unless otherwise 
indicated. 
Where indicated, animals were treated with sodium pheno-
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barbitone(80 mg/kg/day) by intraperitoneal injection 
for three days and were fasted overnight prior to 
sacrifice, in order to elevate the levels of hepatic 
microsomal cytochrome P-450. 
(2) Isolation o~ hepatic microsomes. 
Rats were sacrificed by cervical dislocation, the livers 
of three rats were excised and pooled and hepatic micro-
somes were isolated by differential ultracentrifugation 
as described by Holtzman and Carr {1972). The microsomal 
pellet was resuspended at a protein concentration of 1,5 
mg protein/ml 0,02 M Tris-HCl, pH 7,4, unless indicated 
otherwise. The microsomes were in all cases used within 
four hours of preparation. 
(3) Determination of protein. 
The protein concentration of the hepatic microsomes was 
determined by the method of Lowry et al. (1951) as 
modified by Chaykin (1966), using bovine serum albumin 
as standard. A modified procedure described by Petersen 
(1977) was used to determine the protein concentration 
of purified stearate desaturase. 
(4) Determination of hepatic microsomal cytochrome P-450. 
Cytochrome P-450 concentrations were determined from 
measurements of the difference spectrum of CO-ferro-
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cytochrome P-450 versus ferrocytochrome P-450, accord-
ing to the method of Omura and Sato (1964). An extinc-
tion coefficient of 91 mM- 1 cm- 1 for the difference in 
absorbance between 450 nm and 490 nm was utilized (Omura 
and Sato, 1964). 
(5) Redox steady state of microsomal cytochrome b 5 in the 
presence of NADPH. 
The redox steady state of NADPH reduced hepatic micro-
somal cytochrome b 5 was determined from the change in 
absorbance between 424 nm and 409 nm by the method of 
Oshino et al. (1971). The results are expressed as 
the percentage reduction of hepatic microsomal cyto-
chrome b 5 in the presence of NADPH relative to dithionite 
reduced cytochrome b 5 . The xenobiotics, when present, 
were added to 3 ml of microsomal suspension (1,5 mg 
protein/ml) and vortex mixed for 30 seconds prior to 
the addition of NADPH (0,15 mM). 
(6) Re-oxidation of NADH reduced microsomal cytochrome ~
5
. 
The pseudo first order re-oxidation of microsomal ferro-
cytochrome b 5 was monitored spectrally at 409 nm and 424 
nm by the method of Oshino et al. (1971). The xeno-
biotics, when present, were added to 3 ml of hepatic 
microsomes (1,5 mg protein/ml) and vortex mixed for 30 
seconds. The reaction was initiated by the addition of 
NADH (1-5 µM). 
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For the determination of the effects of selected xeno-
biotics on kb, the rate constant for the re-oxida-o s 
tion of NADH reduced hepatic microsomal cytochrome b 5 , 
reaction mixtures were prepared as described above. 
For the determination of the K. values for cyanide 
l 
inhibition of the stimulation of the re-oxidation of 
microsomal cytochrome b 5 by xenobiotics, reaction mix-
tures were prepared as described above, except that 
cyanide was added to the microsomal suspension before 
the xenobiotic. 
(7) NADH- and NADPH-cytochrome c reductase assay~. 
The method of Omura and Takesue (1970) was used to 
determine the activities of hepatic microsomal NADH-
cytochrome c reductase and NADPH-cytochrome c reduc-
tase. The xenobiotics, when present, were suspended 
in 2,10 ml 0,1 M Tris-HCl, pH 7,4, by vortex mixing 
for 30 seconds prior to the addition of ferricytochrome 
c, (0,45 mg/ml) NAD(P)H (0,084 mg/ml) and hepatic 
microsomes (1,5 mg protein/ml). The increase in 
absorbance of ferrocytochrome cat 550 nm was moni-
(8) Binding to cytochrome P-450. 
Three ml of microsomal suspension (2 mg protein/ml) 
prepared from fasted or phenobarbital induced rats 
was added to each of two cuvettes. Spectra were 
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recorded before and after the addition of increasing 
amounts of xenobiotic to the sample cuvette. The 
xenobiotic was, where necessary, dispersed in the 
microsomal suspension by vortex mixing for 30 seconds. 
Absorbance difference spectra were recorded between 
360 nm and 450 nm. 
(9) Oxidation of purified trypsin-cleaved ferrocytochrome b 5 . 
Purified trypsin-cleaved cytochrome b 5 was reduced by 
a modification of the method of Smith (1955) : Purified 
ferricytochrome b 5 was bubbled with N2 for 20 min and 
5% Palladium on asbestos (2% w/v, final concentration) 
was added to the cytochrome solution. The suspension 
was then bubbled with H2 for 1 to 2 hours to convert 
ferricytochrome b 5 to the ferrous form. Aliquots of 
ferrocytochrome b 5 were then removed from the reducing 
suspension, filtered through an 8µ millipore filter, 
and 30 µl of the resultant solution (ca. 25 µM ferro-
cytochrome b 5 ) was added to 1,25 ml of air equilibrated 
0,1 M Tris-HCl, pH 7,4, in the presence or absence of 
the anaesthetic agents. The oxidation of purified 
trypsin-cleaved ferrocytochrome b 5 was monitored 
spectrally at 424 nm. 
(10) Determination of stearate desaturase activity. 
The activity of stearate desaturase was assayed via 
the conversion of [1- 14 c]-stearoyl CoA to [1- 14 c]-oleate 
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essentially by the method of Oshino et al. {1966). 
Incubation mixtures contained hepatic microsomes 
{1,0 mg protein), NADH (1 mM) and [1- 14 c]-stearoyl 
CoA (40 ITL~, 12 µCi) in 0,5 ml 0,1 M Tris-HCl, pH 7,25. 
Incubations were at 37°c for 4 minutes at 60 cycles 
per minute. 
To determine the activity of purified stearate 
desaturase, one unit of purified NADH-cytochrome b 5 
reductase, 0,5 nmoles cytochrome b 5 and 0,07 mg of 
purified C.S.F. protein were incubated with [1- 14 c] 
-stearoyl CoA (40 mM, 12 µCi) in 1 ml 0,30 M Tris-
HCl, pH 7,0 (Shimakata et al., 1972). The reaction 
was initiated by the addition of NADH (1 mM). Incu-
bations were at 37°c for 20 minutes, with shaking at 
60 cycles per minute. On completion of the incuba-
tion period, 2 mg each of carrier oleate and stearate 
were added to the reaction mixture. The fatty acids 




0H by the method of 
McIntosh et al. (1977), and the methyl esters were 
separated by argentation thin layer chromatography on 
silica gel plates (25 cm x 25 cm x 0,25 mm) (Merck 
Chemicals) according to Berman et al. (1975). 
Scrapings from the thin layer chromatograms were 
assayed for radioactivity in 7 ml Instafluor scin-
tillation cocktail (Packard) using a Beckman model LS 
8100 liquid scintillation counter. The results of the 
assay were expressed as the percentage of 
radioactivity in oleate 
radioactivity in oleate + stearate 
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(11) Isolation of hepatic microsomal stearate desaturase, 
£,Ytochrome b 5 and NADH-cytochrome b 5 reductase. 
Hepatic microsomal stearate desaturase, cytochrome b 5 
and NADH-cytochrome b 5 reductase were solubilized with 
the use of detergents essentially as described by 
Shirnakata et al. (1972) 
Hepatic microsomes were isolated from a group of 15 
rats which had been re-fed a high carbohydrate diet,by 
differential centrifugation (Holtzman and Carr, 1972). 
The freshly isolated hepatic microsomes were suspended 
at a protein concentration of 10 mg/ml 0,1 M Tris-HCl, 
pH 8,0 containing sodium deoxycholate (1%), Triton 
X-100 (1%), reduced glutathione (2 mM) and EDTA (5 rru~). 
After stirring for 30 minutes, the suspension was 
centrifuged at 105 000 g, for 120 minutes. The super-
natant was subjected to ammonium sulphate fractionation 
as described by Mihara and Sato (1972). The red 
pellicle collected between 25 - 45% saturation was then 
dissolved in a small volume of 20 mM Tris-HCl, pH 8,0, 
containing reduced glutathione (2 mM) and dialysed for 
two hours against two litres of the same buffer. The 
dialysed solution (5 ml) was diluted 5-fold with 20 mM 
Tris-HCl, pH 8,0, containing Triton X-100, (0,5%) 
reduced glutathione (2 mM), EDTA (2 mM) and KCl (5 mM). 
The solution was then chromatographed on a DEAE-
Sephadex A-50 column (2 x 15 cm) which had been equi-
librated with the same buffer. Elution was achieved 
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by the stepwise increases in the final KCl concentra-
tion of the buffer from 5 mM to 55, 105, 205 and 305 
TIL~. Fractions of 10 ml were collected. The flow rate 
was 1 ml/minute. The fractions containing stearate 
desaturase, cytochrome b 5 and NADH-cytochrome b5 reduc-
tase were concentrated to approximately 15 ml each using a 
Diaflo ultrafiltration apparatus fitted with a PMlO 
membrane. The resulting protein solutions were stored 
at -20°c until use, in all cases within 3 months of 
preparation. 
(12) Determination of purified detergent solubilized cyto-
chrome ~ 5 . 
The concentration of purified detergent solubilized 
cytochrome b 5 was determined by the method of Shimakata 
et al. (1972) from the intensity of the Soret band of 
ferrocytochrome b 5 in the presence of sodium dithionite 
(E424nm = 117 mM-1cm-1). 
(13) Determination of the activity of detergent solubilized 
NADH-ferricyanide reductase. 
The activity of detergent solubilized NA..DH-ferricyanide 
reductase was determined by the method of Mihara and 
Sato (1972). The reaction mixture contained 200 µl of 
enzyme and K3 FeCN 6 (1 mM) in a final volume of 1,5 ml, 
0,1 M potassium phosphate, pH 7,5. The reaction was init-
iated by the addition of NADH (0,2 ITu~) and the decrease in 
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absorbance at 420 nm was monitored. (E = 1,02 420nm 
mM- 1 cm- 1 ). One unit of activity corresponds to 1 
µmole of ferricyanide reduced per minute. 
(14) Xenobiotic concentration. 
The concentration at which each xenobiotic was routinely 
utilized, was the highest concentration which would not 
disrupt the microsomal suspension (assessed visually) 
or convert hepatic microsomal cytochrome P-450 to cyto-
chrome P-420 (assessed spectrally). Suspensions of 
hepatic microsomes (1,5 mg protein/ml) were divided 
equally between two 1-cm path length cuvettes. The 
xenobiotic was introduced below the surface of the 
microsomal suspension in the sample cuvette with a 
Hamilton µL syringe. The cuvette was then stoppered 
and vortex mixed for 30 seconds to disperse the added 
xenobiotic. 
(15) Reconstitution of detergent solubilized stearate desatu-
rase enzyme system. 
The reconstitution of stearate desaturase activity was 
achieved essentially as described by Shimakata et al. 
(1972). The reconstituted system contained 0,06 - 0,07 
mg purified stearate desaturase protein, one unit of 
purified detergent solubilized NADH-cytochrome b
5 
reduc-
tase and 0,5 nmoles of purified detergent solubilized 
cytochrome b 5 in a total volume of 1 ml 0,30 M Tris-HCl, 
pH 7,0. 
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(16) Systems for assessing the possible metabolism of anaes-
thetic agents by stearate desaturase. 
(a) The reconstituted system for the determination of 
metabolites of anaesthetic agents. 
The reconstituted system was as described above (see 
section 15 of Methods). The anaesthetic agents, where 
necessary, were added to the incubation mixture and 
vortex mixed for 30 seconds prior to the addition of 
the NADH. The reaction was started by the addition of 
NADH (0,6 rr~). the reaction was allowed to proceed at 
37°c for 20 minutes. At that time, a further 0,6 mM 
NADH was added and the incubation was allowed to proceed 
at 37°c for a further 20 minutes. The reaction was 
terminated by plunging the tubes into ice. The 
incubates were immediately assayed for possible meta-
bolites of the anaesthetic agents. 
(b) Hepatic microsomal incubation system for the 
determination of metabolites of anaesthetic agents. 
The anaesthetic agents were dispersed in 3 ml hepatic 
microsomes (1,5 mg protein/ml) by vortex mixing for 
30 seconds. The reaction was initiated by the addition 
of NADH (0,3 m.~) and the reaction mixture was incubated 
at 37°c with shaking at 60 cycles per minute. At that 
time, a further 0,3 mM NADH was added, and the reaction 
0 was allowed to proceed at 37 C for an additional 20 
minutes. The reaction wa~ terminated by plunging the 
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tubes into ice. The incubates were immediately assayed 
for possible metabolites of the anaesthetic agents. 
(17) Assays for metabolites of anaesthetic agents from the 
stearate desaturase enzyme system. 
(a) Determination of fluoride ion and acid-labile 
fluorine comoounds. 
Fluoride activities in millivolts were measured with 
an Orion solid state fluoride electrode (model 96-09) 
in combination with a single junction reference elec-
trode (Orion 09-01-00) connected to a Radiometer model 
22 pH meter. Reaction mixtures containing the recon-
stituted detergent solubilized stearate desaturase 
enzyme system or hepatic microsomes were terminated by 
the addition of 1 ml of 0,2 M sodium acetate, pH 4,9, 
to 1 ml of reaction mixtures containing the reconstituted 
enzyme system, or 0,1 ml of 3M sodium acetate, pH 4,9 
to 3 ml of the reaction mixtures containing hepatic 
microsomes. The samples were allowed to equilibrate 
to room temperature and were then analyzed for fluoride 
ion using the fluoride electrode. Known concentrations 
of sodium fluoride in 0,1 M sodium acetate, pH 4,9, 
were used to establish a standard curve each day. For 
the determination of acid-labile fluoride compounds, 
the incubation mixtures were brought to pH 1,5 by the 
addition of 10 µl of concentrated H
2
so4 . The fluoride 
standards were similarly treated and both samples and 
standards were incubated at room temperature for 90 -95 
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hours. The pH was returned to pH 5,0 by the addition 
of 55 - 60 µl of NaOH (6,0 M) and total fluoride was 
measured using the fluoride electrode. 
(b) Deter8ination of bromide ion. 
Bromide ion was determined essentially as described by 
Goodwin (1971) with minor modifications. The protein 
of the reconstituted stearate desaturase enzyme system 
and the hepatic microsomes was precipitated by the 
addition of 750 µland 10 µl of sodium tungstate (10%) 
respectively, and 200 µland 20 µl of H2so 4 (2 M} 
respectively. After centrifugation, the supernatant 
was used directly without filtering. Phosphate buffer 
(2,6 M} and sodium hypochlorite were added to the super-
natant and the solution was heated at 100°c for 15 
minutes. On cooling, 50% sodium formate was added to 
the samples, and the resulting solution was heated at 
100°c for 10 minutes. After cooling, an equal volume 
of the rosaniline/molybdate mixture was added and the 
samples were mixed and allowed to stand for three 
minutes at room temperature after which tert-butanol 
and H2so4 (7 M) were added with mixing. The absorbance 
of the samples at 570 nm was measured using a 4 cm 
path-length cuvette. 
(c) Determination of volatile metabolites by_gas liquid 
chromatography. 
A Packard 428 gas liquid chromatograph equipped with a 
Ni 63 electron capture detector (connected to a Pye-
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Unicam DP 88 computing integrator) was used for the 
quantitative determination of volatile metabolites of 
the anaesthetic agents. The columns used were as follows 
(a) 1 m x 3 mm glass column of WHP Chromosorb/SE 30 
(80 - 100 mesh). Column, detector and injector 
temperatures were 160, 170 and 190°c respectively. 
The gas flow was 40 ml N2 per minute. 
(b) 3 m x 3 ~m glass column of 10% di-iso-decylphtha-
late on Chromosorb P (acid-washed) (60 - 80 mesh). 
Column, detector and injector temperatures were 
120, 200 and 160°c respectively. The gas flow was 
SO ml N2 per minute. 
(c) 2 m x 2,2 mm nickel column of Chromosorb 102 (80 -
100 mesh). The column, detector and injector 
temperatures were 150, 210 and 150°c respectively. 
The gas flow was 50 ml N2 per minute. 
Samples were extracted into 2 ml ether and a few crys-
tals of anhydrous sodium sulphate were added. 1 - 5 µl 
of the dried ether extracts were injected onto the 
columns. 
(d) Determination of non-volatile metabolites. 
Halothane in petroleum ether (10 µl, 0,1 mci[1- 14 c]-
halothane) was added to 3 ml hepatic microsomes (1,5 mg 
protein/ml) and vortex mixed for 30 seconds. The 
reaction was initiated with NADH (0,4 mM) and allowed to 
. 0 
proceed at 37 C for 20 minutes with shaking at 60 cycles • • 
per minute. The r~action ~as terminated by plunging the 
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tubes into ice. Hydrophobic compounds were extracted 
with 4 x 3 ml volumes of ether, and the ether phases 
were combined. The combined ether phases and the 
residual microsomal suspension were assayed separately 
for radioactivity in Instagel scintillation cocktail 
(Packard) using a Beckman model LS 8100 liquid scin-
tillation counter. 
(18) Determination of heme. 
The heme content of hepatic microsomes was determined by 
the alkali pyridine hemochrome method described by Omura 
and Takesue (1970). The absorbance difference between 
557 nm and 575 nm was measured,and an extinction coeffi-
cient of 34,7 mM- 1 cm- 1 was utilized for this difference. 
(19) 0-Demethylation of p-nitroanisole. 
The 0-demethylation of p-nitroanisole by hepatic micro-
somes was determined by a modification of the method of 
Netter and Seidel (1964). 1,5 ml of hepatic microsomes 
(1,5 mg protein/ml) and 1,5 ml p-nitroanisole (1 mM) were 
added to the reference and sample cuvettes. The cuvettes 
were equilibrated to 25°c, and the reaction was initiated 
by the addition of 30 µl of an NADPH generating system, 
~ADPH (0,4 mr,'1), glucose-6-phosphate, (7,5 rru~), glucose-6-
phosphate dehydrogenase (0,5 U/ml), MgC1 2 (5 mM) nico-
tinamide (1 m.~) and EDTA (0,2 inM)] to the sample cuvette. . ~ 
The absorbance cha.nge at 420 nm was monitored -at 25°c 
' 
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for 3 to 4 minutes, and initial reaction rates were 
calculated. The extinction coefficient for Q-nitro-
-1 -1 ( phenol at 420 nm, pH 7,4, is 7,3 rnM cm , Netter 
and Seidel, 1964). 
(20) 3,4-Benzpyrene hydroxylation. 
The rate of hydroxylation of 3,4-benzpyrene to 3-
hydroxybenzpyrene was determined spectrophotometrically 
by the method of Prough et al. (1976). 2,5 ml of hepa-
tic microsomes (1,5 mg protein/ml) containing 3,4-benz-
pyrene (80 µM) in both reference and sample cuvettes 
were equilibrated to 2s 0 c. NADH (200 µM) was added to 
both reference and sample cuvettes. The reaction was 
initiated by the addition of NADPH (100 µM) to the 
sample cuvette. The absorbance was monitored at 428 
nm and 454 nm. An extinction coefficient of 13 200 
rnM- 1 cm- 1 was utilized for this difference (Prough et 
al., 1976). 
(21) Treatment of hepatic microsomes. 
Chemicals used in the treatment of hepatic microsomes 
were chosen on the basis of earlier reports that they 
degrade cytochrome P-450 in vitro ( Imai and Sato, 1967; 
Ichikawa et al., 1968). 
(a) 1,4-Dioxane 
To eliminate the presence of peroxides, 1,4-dioxane was 
refluxed with metallic sodium for 24 hours and subse-
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quently redistilled. The fraction distilling between 
101,5 and 102°c was utilized. Hepatic microsomes {1,5 
mg protein/ml) from rats re-fed a high carbohydrate 
diet were incubated with 1,4-dioxane (1,0 Mor 2,0 M) 
at 30°c for Oto 90 minutes. 
(b) Sodium iodide, iso-butanol and potassium thiocyanate. 
After the 10 000 g centrifugation step in the isolation 
of hepatic microsomes from rats re-fed a high carbo-
hydrate diet, the post-mitochondrial supernatant was 
treated with either sodium iodide (2 M), iso-butanol 
10% (v/v) or 20% (v/v) or potassium thiocyanate (1 M). 
After standing at room temperature for 10 minutes, the 
procedure for the isolation of the hepatic microsomes 
was continued as described earlier. 
(c) Iodomethane. 
Iodomethane (0,27 M) was added to the post-mitochondrial 
supernatant of livers from rats re-fed a high carbohy-
drate diet, and the resulting suspension was vortex 
mixed for 1 minute. The solution was allowed to stand 
for 10 minutes on ice and was then bubbled with nitrogen 
for 10 minutes to drive off residual iodomethane. On 
completion of the microsomal isolation, the microsomes 
were bubbled with a mixture of co: o
2 
at a flow rate of 
80: 20 (v/v) for two minutes to inhibit any cytochrome 
P-450 activity remaining in the microsomes. 
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(22) Determination of hydrogen peroxide. 
Hydrogen peroxide was determined according to the 
method of Hildebrandt et al. (1973). Aliquots (1,5 ml) 
of incubation mixtures were treated with 1,5 ml 5% 
trichloroacetic acid and the resulting suspension was 
centrifuged to precipitate protein. Ferroammoniurn 
sulphate (\0 mM) and potassium thiocyanate (0,13 M) were 
added to the supernatant. The absorbance of the ferric 
thiocyanate complex was monitored at 480 nm in a Gilford 
single beam spectrophotometer. 
(23) Determination of superoxide anion. 
Superoxide anion was determined by a combination of the 
methods of Bartoli et al. (1977) and Misra & Fridorich 
(1972) by monitoring the formation of adrenochrome. The 
reaction mixture contained 3 ml of hepatic rnicrosomes 
(0,5 or 1,5 mg protein/ml), EDTA (0,2 mM) and adrenaline 
(0,6 mM). The anaesthetic agents were dispersed in the 
microsomal suspension by vortex mixing for 30 seconds 
prior to the addition of adrenaline. The reaction was 
initiated by the addition of either NADH (1 mM) or NADPH 
(0,6 mM), and adrenochrome formation was monitored at 
475 nm (E 475nm = 4020M-
1 cm- 1 ) at 37°c. 
(24) Administration of anaesthetic agents. 
Groups of ten rats were fed on either a normal diet or 
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the high carbohydrate diet for five days and were 
then anaesthetised from standard vaporizers with 1 
MAC anaesthetic agent (Eger, 1974), for three hours 
on days 6, 9 and 12 of their respective diets. The 
rats were sacrificed on day 13 of the programme, 24 
hours after the last administration of the anaesthetic 
agent, or at an equivalent time for controls. Alter-
natively, groups of 5 or 10 rats were fed on either 
the normal diet or the high carbohydrate diet for five 
days and, in addition, were in some cases pretreated 
with phenobarbitone (80 mg/kg) for three days. The 
rats were anaesthetised from standard vaporizers with 
1 MAC anaesthetic agent for two hours, under hypoxic 
conditions (14% o
2
, 700 ml/min, using N
2
o, 4,3 1/min 
as the carrier gas). 
The anaesthetic chambers in which the rats were anaes-
thetised were two rectangular perspex boxes (60 cm x 
30 cm x 30 cm) with a fenestrated floor 6 cm from the 
base. The area between the base and the floor was 
filled with anaesthetic soda lime. The anaesthetic 
gas was introduced into each chamber via a port below 
the floor in one corner and exhausted via a port on the 
top corner diagonally opposite from the inlet port. 
Where appropriate, a single gas mixture line with a T-
junction splitting the gas flow to each chamber was 
used to ensure that the same anaesthetic gas mixture 
would be introduced into each anaesthetic chamber. 
59 
(25) Determination of serum glutamic oxaloacetic trans-
aminase (S.G.O.T.). 
Blood was obtained from the aorta of rats immediately 
following sacrifice. The blood was centrifuged at 
3 000 rpm for five minutes to obtain the serum. The 
S.G.O.T. levels were determined spectrally at 340 nm 
by the method of Henry et al. (1960). 
(26) Determination of hepatic reduced glutathione. 
Liver glutathione levels were determined fluorimetrically 
by the method of Cohn and Lyle (1966). The liver was 
homogenized in EDTA (30 µM). Protein was removed by 
precipitation with metaphosphoric acid and subsequent 
centrifugation at 10 000 rpm for fifteen minutes. The 
supernatant was treated with 0-phthalaldehyde. The 
fluorescence of the GSH-O-phthalaldehyde complex was 
monitored at 426 nm, using an excitation wavelength of 365nm 
in a Perkin-Elmer model 203 fluorimeter. 
(27) Hepatic histology. 
Livers were excised from rats immediately after sacrifice 
and were placed in 10% formalin containing NaH2Po4 
(0,26 M) and Na 2HP0 4 (0,46 M). The livers were then 
sectioned by dicing finely, stained with haematoxylin 
and eosin and examined by conventional light microscopy. 
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(28) Spectronhotometry. 
Spectrophotometry was performed on a Unicam SP 1800 
recording spectrophotometer unless otherwise indicated. 
For turbid suspensions, the cell holder adjacent to the 
photomultiplier was used, and the cuvettes were 
positioned so that the light path passed through their 
frosted faces in order to obtain more uniform light 
scattering. Spectral measurements were performed in 
0 thermostatically controlled compartments at 25 C, 
unless indicated otherwise. 
(29) Calculations and statistical analyses. 
The observed first order rate constants (kb) for the 
0 S 
re-oxidation of NADH reduced hepatic microsomal ferro-
cytochrome b 5 were calculated from the slope of plots 
of ln (At - Aa) versus time, where At and Aa are the 
absorbance changes between 409 nm and 424 nm at time t 
and at infinity, respectively. The first order rate 
constants (kb) for the oxidation of purified trypsin-o s 
cleaved cytochrome b 5 were calculated from plots of ln 
(A424 a - A424 t) versus time. In all cases, the ab-
sorbance at infinite time was determined after approxi-
mately ten half-lives. 
Spectral binding constants (K) for the interaction of s 
xenobiotics with hepatic microsomal cytochrome P-450 
were calculated from Hanes and Eadie-Hofstee plots. 
The values of K , the equilibrium constant for the eq 
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effect of xenobiotics on the re-oxidation of ferro-
cytochrome b 5 and Ki' the equilibrium constant for 
cyanide inhibition of the effects of the xenobiotics 
on the re-oxidation of ferrocytochrome b 5 , were cal-
culated from plots of kb versus the concentration of 
0 S 
xenobiotic or cyanide, respectively. Transformations 
of this plot, such as those described by Lineweaver 
and Burke or Eadie and Hofstee, could not be employed, 
as the kb had a finite background value at substrate 
0 S 
concentrations equal to zero. This background rate 
represents the autoxidation of ferrocytochrome b 5 which 
is unaffected by KCN and xenobiotics. 
All determinations, unless indicated otherwise, were in 
duplicate or triplicate on two or three separate prepa-
rations of hepatic microsomes or on two or three 
separate assay systems. + Values reported are means -
standard deviations. Statistical analyses were per-
formed on a Tektronix 31 progammable calculator. After 
testing for equal variances, Student's t test for 
unpaired data was utilized to assess statistical 
significance, unless indicated otherwise. Two-tailed 
P values are reported, with P < 0,001 representing a 
highly significant difference, P < 0,01 a significant 




(1) The Interaction of Xenobiotics with Hepatic Microsomal 
Stearate Desaturase. 
(a) A survev of the interaction of xenobiotics with 
hepatic microsomal stearate desaturase. 
i) The effect of xenobiotics on the redox steady state 
of hepatic microsomal cytochrome ~5 . 
The effects of various xenobiotics, in particular 
halogenated hydrocarbons on the redox steady state of 
NADPH reduced hepatic microsomal cytochrome b 5 in 
microsomes from rats with elevated levels of stearate 
desaturase, are shown in Table 1. The effect of KCN 
(at a concentration equivalent to five times its K. 
l 
for stearate desaturase) on the redox steady state of 
cytochrome b 5 in the presence of xenobiotics is also 
shown in Table 1. That the hepatic microsomes utilized 
contained appreciable stearate desaturase activity is 
confirmed by the ability of stearoyl CoA to significantly 
decrease the redox steady state of cytochrome b 5 (Oshino 
etal., 1971) (Table 1). 
Inasmuch as the purpose of this survey was to investigate 
whether xenobiotics could interact with stearate desatu-
rase, each xenobiotic was used at the maximum concentra-
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tion which would not disrupt the microsomal suspension 
or convert cytochrome P-450 to cytochrome P-420. 
Virtually all of the halogenated alkanes investigated 
significantly shifted the redox status of cytochrome 
b 5 towards ferricytochrome b 5 . The haloalkanes which 
were poly-halogenated and contained one or more types 
of halo atoms, e.g. F, Cl, Br or I appeared to be the most 
effective. In general, the haloethanes were more effect-
ive than, or at least as effective as the halomethanes, 
when compounds containing the same absolute number of 
halo atoms or of the same ratio of halo atoms per carbon 
atom were compared. The chlorinated ethanes, viz. 1,1,2-
trichloroethane and l,l,2,2-tetrachloroethane, were more 
effective than the chlorinated methane chloroform, at 
shifting the redox status of cytochrome b 5 towards the 
ferric form while other halogenated ethanes such as 
1,1,1-trichloroethane decreased the redox status of cyto-
chrome b 5 to the same extent as chloroform. 
Compounds with multiple halo atoms proved to be more 
effective than singly substituted compounds in shifting 
the redox steady state of cytochrome hs towards ferri-
cytochrome b 5 . For instance, 1,2,3-trichloropropane, 
l,l,1-trichloro-2,3-epoxypropane, bromotrichloromethane, 
and methoxyflurane shifted the redox status of cytochrome 
b 5 towards the oxidized form to a greater extent than did 
chloropr0pane, dichloromethane and chloromethyl methyl 
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ether. However, no clear order of reactivity was evident 
for the different halogen substituents. 
However, some comparisons do emerge: 
Chloroacetaldehyde, fluroxene, ethyl vinyl ether, di-
vinyl ether and 2,2,2-trifluoroethyl ether shifted the 
redox state of cytochrome b 5 towards the oxidized form 
of the protein, while comparable concentrations of ace-
taldehyde, trifluoroeacetaldehyde hydrate, 2,2,2-trifluoro-
ethanol, diethyl ether, trifluoroacetic acid and some 
vinyl and allyl halides did not affect the redox state of 
cytochrome 25 . 
The most striking effect on the NADPH steady state of 
cytochrome Q5 occurred in the presence of bromotrichloro-
methane, l,l,2,2-tetrachloroethane, 1,2,3-trichloro-
l, 1,2-trifluoroethane, 1,2-dibromo-l,l~dichloroethane, 
l,2-dibromo-1,2-dichloroethane, l,l,l-trichloro-2,3-
epoxypropane and chloroacetaldehyde and the anaesthetic 
agents halothane, enflurane, methoxyflurane and ethyl 
vinyl ether. 
As shown in Table I, the ability of the haloalkanes to 
shift the redox steady state of cytochrome Q5 towards 
the oxidized form of the protein was diminished in the 
presence of cyanide. This effect was however, com-
parable to the magnitude of the effect of cyanide on 
the redox steady state of microsomal cytochrome QS in 
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the absence of added xenobiotics. 
ii) The effect of xenobiotics on the re-oxidation of 
NADH reduced hepatic microsomal ferrocytochrome b 5 . 
The effects of those compounds which decreased the 
redox status of cytochrome b 5 to 40% or below, were 
further investigated for possible interaction with 
stearate desaturase by assessing their effects on the 
pseudo first order rate constants (kb) for the re-o s 
oxidation of NADH reduced hepatic microsomal ferrocyto-
chrome h5 . Hepatic microsomal cytochrome b 5 was reduced 
with a slight excess of NADH and the first order re-
oxidation of ferrocytochrome b 5 which occurs on exhaus-
tion of the NADH, was monitored. For all studies of the 
re-oxidation of hepatic microsomal ferrocytochrome b 5 , 
unless otherwise indicated, hepatic microsomes were from 
rats in which the levels of stearate desaturase were 
elevated by re-feeding the rats a high carbohydrate diet 
(Oshino et al., 1971). That the level of stearate 
desaturase in these microsomal preparations was elevated 
was demonstrated by the ability of stearoyl CoA to 
increase the rate constant for the re-oxidation of micro-
somal ferrocytochrome b 5 (Table 2) (Oshino et al., 1971). 
Compounds which increased the rate constant for the 
re-oxidation of cytochrome b 5 in a cyanide inhibitable 
manner included diiodomethane, bromotrichloromethane, 
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1,1,2-trichloroethane, l,2-dibromo-1,2-dichloroethane 
and probably chloroacetaldehyde (Table 2). The rate 
constant for the re-oxidation of cytochrome hs was also 
enhanced by l-bromo-2-chloroethane, 1,2-dibromo-l,l-
dichloroethane, l,2,3-trichloropropane, l, l,l-trichloro-
2,3-epoxypropane and ethyl vinyl ether, but the effects 
of these compounds on the re-oxidation of microsomal 
ferrocytoch=om£ hs were not significantly inhibited by 
cyanide. 
The anaesthetic agents halothane, enflurane and methoxy-
flurane stimulated the re-oxidation of microsomal cyto-
chrome hs and their effects are inhibited by cyanide 
(Table 2). This confirms an earlier report by Berman 
et al., (1975) that halothane stimulates the re-oxida-
tion of hepatic microsomal ferrocytochrome b 5 and that 
this effect is inhibited by cyanide. 
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TABLE 1. THE EFFECT OF XENOBIOTICS ON THE REDOX STEADY 
STATE OF HEPATIC MICROSOMAL CYTOCHROME b
5
___!N 

















1,2-Dichloroethane (42 ,0) 
1,1,1-Trichloroethane (7 ,2) 
l,l,2-Trichloroethane (8 ,0) 
% Reduction 
- KCN 
59,1 + 5,0 -
+ * 44,6 - 6,8 
+ 58,2 - 2,1 
47,8 ~ 4,0t 
45,5 ~ 3,7t 
49,5 :!:: 4,8=1 
50,2 :!:: 2,4:f 
45,6 + 10,6 -
+ * 40,5 - 3 , 4 
+ * 31,4 - 4 ,5 
48,7 + 7 ,8 -
+ * 31,2 - 0 ,9 
+ * 44 ,l l - 4,0 
+ * 45 ,7 - 1 ,7 
+ * 37 ,6 - 5 ,4 
+ * l,l,2,2-Tetrachloroethane(8,0) 34 ,4 - 6 ,4 
of cytochrome b 5 
+ 0,5 mM KCN 
70,2 + 5, 0~ -
68,2 ~ 1,3<fl 
56,6 ~ 0,1 11 
+ 50,9 - 3,0 
+ 50,4 2,2 
5 7, 5 ~ 3,811 
+ 51,5 - 7,7 
+ 51,5 - 7,7 
+ 49,3 - 4,0 
49 ,9 :!:: 3 ,9~ 
44,7 + 5,5'11 
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TABLE 1 (Cont.) 
Additions % Reduction of cytochrome h5 
(mM) 
B t ' ( • A (\) rornome nane ~~,v, 
l,l,2,2-Tetrabrosomethane 
( 2 I 5) 






+ * 41,9 - 3,3 
52,1 + l, 5 -
+ * 26,9 - 5,5 
+ * 32,3 - 4,0 
40,5 + 8,1 1 -
+ * l,2-Dibromo-1,1-dichloroethane 28,7 - 5,1 
( 0 , 6) 
+ * l,2-Dibromo-1,2-dichloroethane 34,6 - 9,0 









Diethyl ether (32,4) 
2,2,2-Trifluoroethyl ether 
(28 ,4) 
+ 51,6 - 2,0 
+ * 39,9 - 0,7 
+ 51,2 - 3,5 
+ 52,4 - 1,1 
+ 59,9 - 5,5 
+ 53,6 2,9 
+ * 44,5 - 2,3 
+ 0,5 mM KCN 
+ 49,7 1,0 
51,5 :!: 7,7LI 
+ 54,9 0,0 
48,9 := 4,3H 
32,0 := 5,1'it 
47,l 2: 3,fD 
64,6 := 3,7'R 
48,2 2: 0,69 
61,1:: 1,3rl 
6 2 J 8 :: 2 / 5<:A 
76,1 ~ 5,oll 
53,10 ~ 2,511 
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TABLE 1 (Cont.) 




Methoxyflurane (0, 6) 
Chloromethyl methyl ether 
( 0, 4) 
Unsaturated Compounds 
Allyl chloride (40,5) 
Allyl bromide ( 3, 9) 
Vinyl chloride (13, 0) 
Trichloroethylene ( 7, 4) 
Vinyl ether ( 2 2, 0) 
Ethyl vinyl ether (35, 0) 
Miscellaneous Compounds 
Trifluoroacetic acid (200, 0) 
2,2,2-Trifluoroacetaldehyde 
hydrate (37, 0) 
2,2,2-Trifluoroethanol (69, 0) 
Chloroacetaldehyde (52, 0) 
Chlorobenzene (3, 3) 
2,2,2-Trichloroethanol (6, 9) 




45,7 ~ 4,0t 
27, ~9 ~ 4,8t 
39, 1 ~ 1,7t 
6 4, 7 ~ 3, 9 
+ 51,5 - 7,0 
49, 5 + - 6, 2 
68,4 + - 5, 1 
51, 1 + 4, 5 -
+ 46, 3 - 2, 9 
+ * 35, 7 - 3, 6 
+ 79, 0 - 2,0 
+ 54, 4 - 3, 1 
53, 1 + 5, 3 -
+ * 25, 8 - 6, 1 
+ * 40, 5 - 4, 4 
+ * 46, 5 - 1, 4 
56, 7 + 4, 4 -
+ * 35,3 - 2,8 
+ 0,5 mM KCN 
7 2, 6 + 5, 4 ll 
+ 49,4 - 2, 5 
52,6 + 1,8 -
70,9 + - 0,6 
56, 2 + 0, 6 -
+ 46, 4 - 9, 7 
+ 35,0 - 10, 8 
84, 1 ~ 1, 311 
63, 7 ~ 2, 5ll 
66, 4 ~ 1, 3ll 
33, 3 ~ 1, 8 
+ 6 2~ 49, 2 , 
61, 1 ~ 3, s=fl 
60, 9 ~ 5, 7 
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TABLE 1 (Cont.) 
* Differs significantly from "no additions", P < 0,001 
t Differs significantly from "no additions", P < 0,01 
cl Probably differs significantly from "no additions", 
P < 0,05 
9 Differs significantly from compound minus cyanide, 
P < 0,001 
<fl Differs significantly from compound minus cyanide, 
P < 0,01 
!!Probably differs from compound minus cyanide, P < 0,05 
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TABLE 2. THE EFFECT OF XENOBIOTICS ON TEE RE-OXIDATION OF 
NADH REDUCED HEPATIC MICROSOMAL FERROCYTOCHROME b 5 . 
Additions 
( nu"-1) 
Re-oxidation of ferrocytochrome ~ 5 
10 2 k b (sec- 1 ) 
0 S 
None 






+ 1,35 - 0,35 
+ * 4,19 - 1,49 
l, 60 ~ 0, 11~ 
+ 1,41 - 0,15 
4,38 2: 0,85t 
Halogenated Ethanes and Propanes 
1,1,2-Trichloroethane (8,0) 
l,l,2,2-Tetrachloroethane 
( 8 t O) 
1,2,2-Trichloro-l,l,2-tri-
fluoroethane (14,1) 
1,75 ~ 0,02t 
+ 1,10 - 0,33 
0 ,68 :'.: 0 ,09t 
l-Bromo-2-chloroethane (12, 1) 1,79 ~ 0,20t 
1,2-Dibromo-l,l-dichloro- 1 ,74 ~ 0,38~ 
ethane (0,6) 
l,2-Dibromo-1,2-dichloro-
ethane (0, 6) 
1,2,3-Trichloropropane (3,2) 
Halothane (18,0) 
1 ,61 ~ 0 ,15~ 
1 , 71 ~ 0 ,52# 
2,62 ~ 0,44t 
+ 0 ,5 mM KCN 
+ 1,21 - 0,28 
2,93 2: 0,7611 
+ 1,40 - 0,26 
3,oo:'.:0,191 
1,44 ~ o,osft 
+ 1,11 - 0,14 
0,75 :!: 0,05 
+ 1,83 - 0,20 
+ 1,48 - 0,24 
1,10:: o,2off 
+ 1 ,66 - 0,38 
1,87 + 0,4~ 
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Ethyl vinyl ether (35,0) 
Enflurane (14,0) 
Methoxyflurane (0, 6) 
* 
Differs significantly from 
t 
Differs significantly from 
f; 
Probably differs from "no 
<fl Differs significantly from 
Re-oxidation of ferrocytochrome h
5 
10 2 k b (sec- 1 ) 
0 S 
-KCN 
+ * 1,96 - 0,30 
2,20 ~ 0,20* 
2,25 ~ 0,06t 
3,70 + 0,96T 
3,00 ~ 0,43t 
"no additions", 
"no additions", 





+ 0,5 rnM KCN 
+ 2,03 - 0,42 
1, 81 ~ 0, 2 0 [l 
2, 32 2: 0, 87 
2, 54 ~ o, 82'fl 
2, 55 + 0, 121ft 
0,001 
0,01 
cyanide, p < 0,01 
II Probably differs from compound minus cyanide, P < 0, 05 
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(b) The interaction of three xenobiotics with hepatic 
microsomal enzymes. 
The ability of bromotrichloromethane, l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde to increase the 
re-oxidation of microsomal ferrocytochrome b 5 in a 
cyanide sensitive manner, suggests that these xenobiotics 
may stimulate microsomal electron transfer by inter-
acting with hepatic microsomal stearate desaturase. 
Therefore, a detailed investigation on the interaction 
of these halogenated compounds with hepatic microsomal 
stearate desaturase and with other microsomal enzymes, 
such as cytochrome P-450 and several electron transfer 
proteins was undertaken. In these investigations, advan-
tage was taken of the ability of fasting to reduce the 
levels and activity of stearate desaturase and of the 
induction of cytochrome P-450 by phenobarbitone as well 
as of the effects of known inhibitors of cytochrome P-450. 
Hepatic microsomes from fasted rats were used to assess 
the ability of xenobiotics to affect the re-oxidation of 
cytochrome b 5 , in the absence of stearate desaturase 
activity. The inability of stearoyl CoA to signifi-
cantly increase the rate constant for the re-oxidation 
of cytochrome b 5 in these microsomes confirms that the 
stearate desaturase activities in these preparations is 
not measurable, although the levels of cytochrome P-450 
were unaffected by fasting (Table 3). 
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The enhancement by bromotrichloromethane and l,2-di-
bromo-1,2-dichloroethane, but not by chloroacetalde-
hyde, of the rate constant for the re-oxidation of 
microsomal ferrocytochrome b 5 was diminished by fasting 
(Tables 2 and 3). The cyanide sensitivity of the en-
hancement of the re-oxidation of microsomal cytochrome 
b 5 by bromotrichloromethane and l,2-dibromo-1,2-dichloro-
methane was eliminated by fasting (Tables 2 and 3). 
CO and metyrapone, which are effective inhibitors of 
cytochrome P-450 (Roots and Hildebrandt, 1973; De Bruin, 
1976) were utilized to assess the involvement of cyto-
chrome P-450 in the abilities of xenobiotics to enhance 
the re-oxidation of microsomal ferrocytochrome b 5 . As 
shown in Table 4, neither inhibitor significantly affected 
the re-oxidation of microsomal ferrocytochrome b 5 in the 
absence of xenobiotics or stearoyl CoA, nor do they 
affect the enhancement of the re-oxidation of microsomal 
ferrocytochrome b 5 in the presence of stearoyl CoA and 
bromotrichloromethane. CO and metyrapone did however 
significantly decrease the effects of l,2-dibromo-1,2-
dichloroethane and CO diminished the effect of chloroace-
taldehyde, on the re-oxidation of microsomal ferro-
cytochrome hs· 
The effects of bromotrichloromethane, l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde on the NADPH- and 
NADH-cytochrome c reductases and on stearate desaturase 
are shown in Table 5. None of these halo compounds 
75 
had a significant effect on either the NADPH- or the 
NADH-cytochrome c reductase, or the stearate desaturase 
mediated conversion of stearoyl CoA to oleate. 
The effects of variable concentrations of bromotrichloro-
methane, l,2-dibromo-1,2-dichloroethane and chloroace-
taldehyde on the rate constants for the re-oxidation of 
microsomal ferrocytochrome b 5 are shown in Table 6 and 
Figure 8. The equilibrium constants K , for the effects eq 
of these xenobiotics on cytochrome b 5 , were calculated 
from these data to be 2,2: 0,3 mM for bromotrichloro-
methane and 0,46 ~ 0,1 mM for 1,2-dibromo-l, 2-dichloro-
ethane. It was not possible to calculate a K value eq 
for chloroacetaldehyde because the rate constant for 
the re-oxidation of cytochrome b 5 was substantially 
decreased in the presence of ca. 10 mM chloroacetalde-
hyde. From Figure 8, however, the concentration of 
chloroacetaldehyde at which half maximal stimulation of 
the re-oxidation of cytochrome b 5 was obtained, was 
estimated to be greater than 35 m.~. 
Both bromotrichloromethane and l,2-dibromo-1,2-dichloro-
ethane bound to cytochrome P-450 with the production of 
a type 1 difference spectrum (Amax 387 nm, Amin 421 nm). 
The Ks values for the binding of these compounds to 
cytochrome P-450 in hepatic microsomes from phenobarbi-
tone pretreated rats were calculated from Figure 9 to 
+ + be 1,7 - 0,3 mM for bromotrichloromethane and 0,29 -
76 
0,09 mM for l,2-dibromo-1,2-dichloroethane. The Ks 
for the binding of chloroacetaldehyde to cytochrome 
P-450 in hepatic microsomes from phenobarbitone pre-
treated rats was reported by Ivanetich et al., (1978) 
to be 30 rrii'1. The K values for the binding of bromo-s 
trichloromethane, l,2-dibromo-1,2-dichloroethane and 
chloroacetaldehyde to cytochrome P-450 in hepatic 
microsomes from uninduced, fasted rats were calculated 
+ + from Figure 10 to be 2,20 - 0,30 mM, 0,15 - 0,05 mM 
+ and 31,0 - 8,0 mM, respectively. 
The effects of variable amounts of KCN on the rate 
constants for the re-oxidation of microsomal ferro-
cytochrome Q
5 
in the presence of fixed amounts of 
bromotrichloromethane, 1,2-dibromo-l,2-dichloroethane 
and chloroacetaldehyde are shown in Table 7 and Figure 
11. From these data, the K. values for KCN were calcu-
1 
lated to be 0,12 ~ 0,03; 0,07 ~ 0,02 and 0,10 ~ 0,02 
!Tu~ for the inhibition of the stimulation of microsomal 
electron transfer by KCN in the presence of bromotri-
chloromethane, l,2-dibromo-1,2-dichloroethane and 
chloroacetaldehyde, respectively. 
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TABLE 3. THE EFFECT OF SELECTED XENOBIOTICS AND KCN ON 
THE RATE CONSTANTS FOR THE RE-OXIDATION OF NADH 
REDUCED FERROCYTOCHROME b
5 
IN HEPATIC MICROSOMES 









Stearoyl CoA (0,012) 
Stearoyl CoA (0,012) + KCN (0,5) 
Bromotrichloromethane (3,4) 
Bromotrichloromethane ( 3, 4) + KCN ( 0, 5) 
l,2-Dibromo-1,2-dichloroethane (0,6) 
1,2-Dibromo-l,2-dichloroethane (0,6) + 
KCN ( 0, 5) 
Chloroacetaldehyde (52,0) 
Chloroacetaldehyde ( 5 2, 0) + KCN ( 0, 5) 
Cytochrome P-450 
(nmol/mg microsomal protein) 
* 
1,31 ~ 0,26 
+ 1,12 - 0,46 
1,73 + 0,21 -
1,46 + 0,38 -
+ 2,63 - 0,34 
+ 2,36 - 0,53 
1,27 + 0,07 -
* 
* 
0,95 + 0,06i -
2,52 ~ 0,16* 
+ * 2,67 - 0,23 
+ 1,06 - 0,14 
Differs significantly from "no additions", P < 0,01 
-:/- Probably differs from "no additions", P < 0, 05 
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TABLE 4. THE EFFECTS OF CO AND METYRAPONE ON THE RATE 
CONSTANTS FOR THE RE-OXIDATION OF MICROSOMAL 
FERROCYTOCHROME b
5 
IN THE PRESENCE AND ABSENCE 
OF SELECTED XENOBIOTICS. 
Additions 
(m.1'1) 
Re-oxidation of ferrocytochrome b 5 
10 2 k b (sec- 1 ) 
0 S 
None 
CO:o2 .(80:20 v/v) 
Metyrapone (2,3 m.M) 
Stearoyl CoA (0,012 mM) 
Stearoyl CoA (0,012 mM) + C0:0
2 
(80:20 v/v) 
Bromotrichloromethane (3,4 mM) 
Bromotrichloromethane (3,4 nu~) + 
C0:0 2 (80:20 v/v) 
Bromotrichloromethane (3,4 mM) + 




( 0, 6 mM) + CO: 0 2 ( 8 0 : 2 0 V / V) 
l,2-Dibromo-1,2-dichloroethane 
(0,6 mM) + metyrapone (2,3 mM) 
Chloroacetaldehyde (52,0 mM) 
Chloroacetaldehyde (52,0 mM) + 
C0:02 (80:20 v/v) 
+ 1,31 - 0,17 
l, 20 :!: 0, 24 
+ l, 16 - 0, 10 
4,01 + 0,37t 
4,07 :!: 0,38t 
2,40 :!: 0,22t 
+ 2,10 - 0,42 
l,90 2: 0,37 
l,62 :!: 0,14t 
1,06 :!: o,17'JI 
0, 90 :!: 0, 12'R 
2,50 :!: 0,21t 
l, 90 + 0 I 1lll 
t Differs significantly from "no additions", P < 0,01 
~ Differs significantly from same compound minus inhibitor, 


















































































































































































































































































































































































































































TABLE 6. DETERMINATION OF kb FOR THE STIMULATION OF 
0 S 
THE RE-OXIDATION OF FERROCYTOCHROME ~
5 
IN THE 
PRESENCE OF SELECTED XENOBIOTICS. 
Additions 
( m.1\1) 
Re-oxidation of ferrocytochromeQ5 






















+ l, 32 - o, 05 
+ 1,57 - 0,29 
+ 1,90 - 0,23 
+ 2,48 - 0,42 
+ 2,79 - 0,68 
2,90 2: 0,82i 
l, 49 + 0,14 -
l, 57 + 0,05 -
L 63 + 0,0 -
+ * l, 72 - 0,01 
+ 1,42 - 0,06 
+ 2,58 - 0,16 
+ 2,88 - 0,36 
+ * 3,78 - 0,01 
Differs significantly from "no additions", P < 0,001 
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(c) The interaction of three anaesthetic agents with 
hepatic microsomal enzymes. 
The possibility that the anaesthetic agents halothane, 
enflurane and methoxyflurane enhanced the re-oxidation 
of microsomal ferrocytochrome b 5 by interacting with 
stearate desaturase, was investigated. In addition, 
the ability of these anaesthetic agents to interact 
with other microsomal enzymes such as cytochrome P-450 
and the electron transfer proteins, cytochrome b 5 and 
the NADH- and NADPH-cytochrome c reductases, was assessed. 
The effects of two inhibitors of cytochrome P-450, namely 
metyrapone and CO on the re-oxidation of microsomal 
ferrocytochrorne b 5 in the presence and absence of 
stearoyl CoA and the anaesthetic agents are presented 
in Tables 8 and 9. Neither of these inhibitors affected 
the rate of re-oxidation of cytochrome b 5 observed in 
the presence of NADH alone, suggesting that they do not 
affect the background rate of re-oxidation of cytochrome 
b 5 . The inability of CO and metyrapone to affect the 
enhancement of the re-oxidation of ferrocytochrome b 5 
observed in the presence of stearoyl CoA or the anaes-
thetic agents (Tables 8 and 9), confirms that these 
inhibitors of cytochrome P-450 do not affect the activity 
of stearate desaturase. 
The effects of enflurane and methoxyflurane on the NADPH-
88 
and NADH-cytochrome £ reductase activities are presented 
in Table 10. Neither enflurane nor methoxyflurane had 
a statistically significant effect on the NADPH-cyto-
chrome £ reductase. However, enflurane was found to 
significantly enhance the activity of NADH-cytochrome £ 
reductase (P < 0,01) while methoxyflurane did not. 
Neither enflurane nor methoxyflurane had a significant 
effect on rate constants for the autoxidation of 
purified trypsin-cleaved ferrocytochrome b 5 (Table 10). 
The rate constants for the re-oxidation of NADH-reduced 
ferrocytochrome b 5 in microsomes from fed, fasted or 
fasted, phenobarbitone treated rats are reported in 
Table 11 and these data are summarized in Table 12. 
Stearoyl CoA and enflurane increased k in microsomes 
obs 
from fed rats, but not significantly in microsomes from 
fasted rats or fasted rats pretreated with phenobarbi-
tone. Cyanide inhibited the ability of stearoyl CoA 
to enhance the re-oxidation of microsomal ferrocyto-
chrome b 5 in microsomes from rats fed a normal diet, 
but not in microsomes from fasted or fasted, pheno-
barbitone treated rats. Cyanide had no significant 
effect on the re-oxidation of ferrocytochrome b 5 in 
the presence of enflurane or methoxyflurane in hepatic 
microsomes from fed, fasted or phenobarbitone treated 
rats. The activity of stearate desaturase [as assessed 
by the enhancement of the re-oxidation of hepatic 
microsomal ferrocytochrome QS by stearoyl CoA (Oshino 
89 
et al., 1971)]and the ability of enflurane and rnethoxy-
flurane to stimulate the cyanide sensitive re-oxidation 
of NADH-reduced microsomal ferrocytochrome b 5 decreased 
in the following order: rats fed a high carbohydrate 
diet> fed a normal diet> fasted rats= fasted, 
phenobarbitone treated rats (Table 12). 
The effects of increasing concentrations of enflurane and 
methoxyflurane on the rate constants for the re-oxidation 
of NADH-reduced microsomal ferrocytochrome b
5 
are pre-
sented in Table 13 and Figure 12. These data were uti-
lized to calculate K , the eauilibrium constants for the eq ~ 
stimulation of microsomal electron transfer by these anaes-
thetic agents. The K values are presented in Table 14 eq 
together with several equilibrium constants for the 
interaction of these anaesthetic agents with hepatic micro-
somal cytochrome P-450. Specifically, the Ks values for 
the binding of the anaesthetic agents to hepatic micro-
somal cytochrome P-450 and the K values for NADPH oxida-m 
tion by hepatic microsomal cytochrome P-450 and the pro-
duction of fluoride by cytochrome P-450 in the presence 
of enflurane and methoxyflurane, are presented in Table 
·14. The value of K for the re-oxidation of cyto-eq 
chrome b 5 in the presence of enflurane differed from 
the K for the binding of enflurane to cytochrome s 
P-450 and the Km for NADPH oxidation by cytochrome 
P-450 in the presence of enflurane. 
90 
for the re-oxidation of microsomal cytochrome b 5 in 
the presence of methoxyflurane differed (P < 0,01) 
from the K for the stimulation of NADPH oxidatio~ by 
m 
methoxyflurane and from the high K for fluoride 
m 
production fro~ methoxyflurane by hepatic microsomal 
cytochrome P-450. The K for methoxyflurane did not eq 
differ significantly from the K for binding of methoxy-s 
flurane to cytochrome P-450 or the low Km for the pro-
duction of fluoride ion from methoxyflurane by cyto-
chrome P-450 (P > 0,1). 
The effects of increasing concentrations of cyanide on 
the stimulation of the rate constants for the re-oxida-
tion of NADH-reduced microsomal ferrocytochrome b 5 by 
fixed concentrations of enflurane and methoxyflurane 
are shown in Table 15 and Figure 13. Increasing con-
centrations of cyanide resulted in greater extents of 
inhibition of the enhanced re-oxidation of cytochrome 
b 5 observed in the presence of the anaesthetic agents. 
From these data, the K. values for cyanide inhibition 
l 
+ were determined to be 0,08 - 0,01 mM for enflurane and 
+ 0,11 - 0,02 mM for methoxyflurane. These constants 
compare well with the K. of 0, 14 mI'-1 determined for the 
l 
cyanide inhibition of the stimulation of re-oxidation 
of hepatic microsomal ferrocytochrome b
5 
by halothane, 
reported by Berman et al., (1975), and with the K. of 
l 
0,1 mM for cyanide inhibition of the conversion of 
stearoyl CoA to oleate by stearate desaturase reported 
by Oshino et al., (1966). 
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Neither halothane, enflurane nor methoxyflurane had 
any effect on the stearate desaturase mediated con-
version of stearoyl CoA to oleate (P > 0,1) (Table 16). 
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TABLE 8. THE EFFECT OF METYRAPONE ON THE ENHANCEMENT OF 
THE RATE CONSTANTS FOR THE RE-OXIDATION OF NADH 
REDUCED HEPATIC MICROSOMAL FERROCYTOCHROME b 5 BY 
STEt\RO-':i:"L CoA AND A.NAESTHETIC AGENTS. 
Additions 
(m.M) 
First order rate constant for the 
oxidation of ferrocytochrome h5 
10 2 k b (sec- 1 ) 
0 S 
None 
T\1etyrapone ( 2, 3) 
Stearoyl CoA (0,012) 
Stearoyl CoA (0,012) +metyrapone (2,3) 
Halothane (18,0) 
Halothane (18,0) + metyrapone (2,3) 
Enflurane (14,0) 
Enflurane (14,0) + metyrapone (2,3) 
+ 1,09 - 0,22 
+ 1,17 - 0,18 
+ t 4,19 - 0,59 
4,15:: 0,33t 
+ t 1,68 - 0,15 
2,03 + 0,48t 
2,23:: 0,36t 
2,13:: 0,49t 
Methoxyflurane (1,0) 1,78:: 0, 18t 
Methoxyflurane (1,0) + metyrapone (2,3) 1,70 ~ 0,12t 
t Differs significantly from "no additions" entry, P < 0,01 
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TABLE 9. THE EFFECT OF CO ON THE ENHANCEMENT OF THE RATE 
CONSTANTS FOR THE RE-OXIDATION OF NADH REDUCED 
HEPATIC MICROSOMAL FERROCYTOCHROME b
5 
BY STEAROYL 
CoA AND ANAESTHETIC AGENTS. 
Additions First order rate constant for the 
oxidation of ferrocytochrome Q5 






Stearoyl CoA (0,012 mM) 
Stearoyl CoA (0,012 mM) + CO:o
2 (80:20; v/v) 
Halothane (18,0 mM) 
Halothane (18,0mM) +CO:o
2 (80:20; v/v) 




Methoxyflurane (1,0 mM) 
Methoxyflurane (1,0 mM) + C0:0 2 (80:20; v/v) 
0,97 ~ 0, 15 
+ 1,04 - 0,22 
3,26 ~ l,05t 
3,31 :_: 0,38t 
1,35 ~ 0,28~ 
+ 1,10 - 0,30 
1, 49 :_: o, 08t 
1,62 ~ 0,20t 
l,69:.: 0,3lt 
1,56 ~ 0,42t 
T 
Differs significantly from "no additions" entry, P < 0,01 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 13. THE EFFECT OF VARIABLE CONCENTRATIONS OF ENFLURANE 
AND METHOXYFLURANE ON THE RATE CONSTANTS FOR THE 
RE-OXIDATION OF NADH REDUCED HEPATIC MICROSOMAL 






Enflurane (l, 93) 
Enflurane (2,74) 
None 
Methoxyflurane (0, 29) 
Methoxyflurane (0, 57) 
Methoxyflurane (0, 86) 





























































































































































































































































































































































































































































































































































































































































































TABLE 15. THE EFFECT OF INCREASING CONCENTRATIONS OF KCN ON 
THE RATE CONSTANT FOR THE RE-OXIDATION OF NADH 
REDUCED HEPATIC MICROSOMAL FERROCYTOCHROME b
5 
IN 
THE PRESENCE OF ENFLURANE A..ND METHOXYFLURANE. 
KCN Other additions to Re-oxidation of ferrocytochrome 12.5 
(mM) hepatic microsomes 10 2 k (sec- 1 ) obs 
( nu'1) 
0,0 Enflurane ( l, 4) 2 / 11 + 0,0 -
0,06 Enflurane ( 1, 4) 1, 87 + 0 I 15 -
0 I 12 Enflurane ( l, 4) 1, 4 7 + 0,25 -
0, 25 Enflurane ( l, 4) 1, 31 + 0,05 -
0,50 Enflurane ( l, 4) 1, 36 + 0,06 -
0,0 Methoxyflurane ( 0 I 6) 1, 86 + 0,0 -
0,06 Methoxyflurane ( 0 I 6) 1, 62 + 0,0 -
0,12 Methoxyflurane ( 0 / 6) 1, 40 + 0,24 -
0,25 Methoxyflurane ( 0, 6) 1, 23 + 0 IO 4 -
































































































































































































































TABLE 16. THE EFFECT OF ANAESTHETIC AGENTS ON THE 
CONVERSION OF STEAROYL CoA TO OLEATE BY 








(oleate + stearate) 
+ 0,34 - 0,16 
+ 0,38 - 0,14 
+ 0,36 - 0,12 
+ 0,35 - 0,16 
104 
(2) Metabolism of anaesthetic agents by hepatic microsomal 
_stearate desaturase and uncoupling of the stearate 
desaturase enzyme system by xenobiotics. 
(a) Isolation of hepatic microsomal stearate desaturase, 
NADH-cytochrome ~ 5 reductase and cytochrome e5-12.Y 
detergent solubilization. 
The three enzymes of the stearate desaturase enzyme system, 
viz. cytochrome b 5 , NADH-cytochrome b 5 
reductase and the 
stearate desaturase enzyme (C.S.F.) were isolated from 
the hepatic microsomes of rats re-fed a high carbohy-
drate diet,by the method of Shimakata et al., (1972). 
A typical elution profile of these proteins from the 
DEAE-Sephadex A-50 column used in the final purification 
step of this method is shown in Figure 14. Fractions 15 
to 24 were pooled to obtain NADH-cytochrome b 5 reductase 
and fractions 26 to 35 were pooled to obtain cytochrome 
b 5 . It was not possible to assay stearate desaturase 
activity in fractions eluted from the column because 
the activity of the enzyme in each of the 10 ml frac-
tions was insufficient to be detected. On pooling frac-
tions 1-12, where activity has been reported to occur by 
Shimakata et al., (1972) and concentrating by approxi-
mately 10 fold, stearate desaturase activity could be 
assayed in the presence of added purified detergent 
solubilized NADH-cytochrome b 5 reductase and cytochromee5 . 
105 
The ability of the in vitro reconstituted stearate 
desaturase enzyme system and hepatic microsomes to 
convert stearoyl CoA to oleate is shown in Table 17. 
A comparison of the abilities of the reconstituted 
stearate desaturase enzyme system and hepatic micro-
somes to convert stearoyl CoA to oleate, indicates that 
the reconstituted system was functional, although less 
efficient than the microsomal system. The amount of 
C.S.F. protein employed in the reconstituted system was 
less than that used by Shimakata et al., although the 
amounts of cytochrome b 5 and NADH-cytochrome hs reduc-
tase were in excess. Neither halothane, enflurane nor 
methoxyflurane appreciably affected the conversion of 
stearoyl CoA to oleate in the reconstituted stearate 
desaturase enzyme system (Table 17). 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(b) Metabolism of three anaesthetic agents by the re-
constituted ;:;tear ate desaturase __ enzy]Jle_systern. 
The metabolism of the anaesthetic agents halothane, en-
flurane and methoxyflurane by stearate desaturase was 
assessed utilizing the reconstituted stearate desatur-
rase enzyme system of Shimakata et al., (1972) which 
comprises the electron transfer proteins NADH-cytochrome 
b 5 reductase, cytochrome hs and the terminal oxidase 
* stearate desaturase. The possible metabolites of halo-
thane, enflurane and methoxyflurane which were assayed 
include fluoride and bromide ions, acid-labile fluorine 
containing compounds and volatile halogenated derivatives. 
Inasmuch as fluoride ions have been shown to be meta-
bolites of enflurane, methoxyflurane and halothane, the 
production of fluoride ions and acid-labile fluorine 
compounds was assessed. A standard curve for the pro-
duction of fluoride ion and acid-labile fluorine con-
taining compounds, is shown in Figure 15. Acid-labile 
fluorine compounds were assayed by the difference between 
fluoride ion concentrations before and after treatment of 
the reaction mixtures with H2so 4 (see Methods). The 
amounts of fluoride ion and of acid-labile fluorine 
compounds produced from either 9 mM halothane, 
7 mM enflurane or 3 mM methoxyflurane in the presence 
of the reconstituted stearate desaturaseenzyme system 
* The cytochrome P-450 content of the reconstituted 
system was less than 0,02 nmoles/mg protein. 
109 
were in all cases less than 1 µM. 
Since bromide ions are known metabolites of halothane, 
the production of bromide ions was assessed. The 
standard curve for bromide ion is given in Figure 16. 
The release of bromide ions from halothane by the re-
constituted stearate desaturase enzyme system was 
determined to be< 9 µM. 
Inasmuch as halothane has been reported to give rise to 
volatile metabolites, and enflurane and methoxyflurane 
have been proposed to be converted to volatile meta-
bolites, the production of volatile metabolites from 
these anaesthetic agents by the reconstituted stearate 
desaturase enzyme system, was assessed. No volatile 
intermediates have been detected for enflurane or 
methoxyflurane although several of the proposed inter-
mediates of enflurane and methoxyflurane metabolism, 
such as the halo alcohols, could be volatile (see 
Figures 5 and 6). 
Gas liquid chromatography was employed to assess the 
ability of the reconstituted stearate desaturase enzyme 
system to convert the anaesthetic agents to volatile 
metabolites. Two of the columns, viz. WHP' Chromosorb/ 
SE 30 and Chromosorb P were used to detect compounds 
less volatile than the parent compounds, while the 
third column, Chromosorb 102 was used for the detection 
110 
of metabolites of halothane that are more volatile than 
the parent compound. Utilizing these three columns 
(see Methods for experimental details), the only com-
pounds which were detected in incubation mixtures con-
taining the anaesthetic agents, NADH and the reconstituted 
stearate desaturase enzyme system, were the anaesthetic 
agents themselves, as judged by their retention times. 
In the case of WHP Chromosorb/SE 30 column, the solvent 
ether, halothane, enflurane and methoxyflurane had 
retention times of ca. 13, 30, 25 and 20 seconds, 
respectively. In the case of enflurane, zero time 
incubations as well as incubations lacking NADH or 
containing KCN, were performed. Only enflurane could 
be detected. Using the Chromosorb P column, the solvent 
ether, halothane, enflurane and methoxyflurane had 
retention times of ca. 60, 120, 82 and 322 seconds, 
respectively. Incubation mixtures containing the anaes-
thetic agents as well as from zero time incubations and 
those containing KCN or lacking NADH, produced only an 
ether peak at 53 seconds and a peak having a comparable 
retention time to that of the anaesthetic agent in 
question. The Chromosorb 102 column was utilized to 
assess the metabolism of halothane only. Injections from 
incubation mixtures of the reconstituted system had only 
one peak at 505 seconds, which corresponds exactly to the 
retention time of halothane. Therefore, no volatile 
metabolites appeared to be produced from the interaction 
of the anaesthetic agents with the reconstituted stearate 








































































































































































(c) The effect of chemical and physical treatment on the 
levels of hepatic microsomal enzymes and heme. 
Hepatic microsomes isolated from rats with elevated 
levels of stearate desaturase were treated by either 
physical or chemical means in an attempt to selectively 
decrease the levels and activity of cytochrome P-450 in 
these microsomes, without affecting the activity of 
stearate desaturase. The activity of stearate desatu-
rase was assessed via two methods viz. the re-oxidation 
of hepatic microsomal ferrocytochrome b 5 and by the con-
version of [1- 14 C]-stearoyl CoA to [1- 14 C]-oleate. The 
increase ink b in the presence of stearoyl CoA versus 
0 S 
its absence was taken as a measure of the stearate desatu-
rase activity of the microsomes. 
The effect of storage. 
0 The effect of storing hepatic microsomes at 4 Con cyto-
chrome P-450 levels and stearate desaturase activity is 
reported in Table 18. After one week at 4°c, the levels 
of cytochrome P-450 were significantly lowered compared 
to the levels in freshly prepared microsomes. The 
stearate desaturase activity was completely eliminated 
by storage. After two weeks storage at 4°c, the cyto-
chrome P-450 levels were further depressed and there was 
no stearate desaturase activity in these microsornes. 
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The choice of chemicals. 
The following chemicals (viz. dioxane, sodium iodide, 
iso-butanol, potassium thiocyanate) were chosen on the 
basis of reports that they can decrease the content and 
activity of hepatic microsomal cytochrome P-450 in 
vitro, (Imai and Sato, 1967; Ichikawa et al., 1968). 
The chemicals were added to the purified hepatic micro-
somes at various stages during their preparation, in an 
attempt to selectively decrease cytochrome P-450 levels 
while not affecting the activity of stearate desaturase. 
The effect of dioxane. 
The effect of the addition of 1 Mand 2 M dioxane to 
hepatic microsomes for up to 90 min at 30°c on the 
activity of microsomal stearate desaturase and the levels 
of cytochrome P-450 was assessed. The activity of 
stearate desaturase in the hepatic microsomes was found 
to decrease with time in the presence of dioxane. A 
greater decrease in stearate desaturase activity was 
observed in the presence of the higher concentration of 
dioxane (Table 19). The levels of cytochrome P-450 in 
the hepatic microsomes were also reduced significantly 
in the presence of dioxane, but cytochrome o5 levels 
remained constant until 90 minutes of incubation when 
the cytochrome b 5 content appeared to be significantly 
lowered (Table 20). There is also a significant decrease 
115 
with time in the heme content of these microsomes. 
The observed decrease in cytochromes P-450 and hs 
appeared to be due to the degradation of the heme 
component of these proteins. Although the cytochrome 
P-450 levels were significantly lowered by dioxane 
treatment, stearate desaturase activity was also de-
creased. These microsomes could therefore not be used 
to assay the metabolism of anaesthetic agents by 
stearate desaturase as an essential criterion in the 
treatment of the microsomes was to maintain stearate 
desaturase activity. 
The effect of sodium iodide and iso-butanol. 
Sodium iodide and iso-butanol were added to the post 
mitochondrial supernatant during the isolation of 
hepatic microsomes from rats re-fed a high carbohy-
drate diet. Sodium iodide did not affect stearate 
desaturase activity, but did convert cytochrome P-450 
to cytochrome P-420 (Tables 21 and 22). This observa-
tion was not pursued however, because sodium iodide 
was found to solubilize the microsomes. 
Iso-butanol (10% v/v) had no significant effect on the 
activity of hepatic microsomal stearate desaturase or 
the content of cytochrome b 5 or heme. The cytochrome 
P-450 levels were significantly lowered by iso-butanol, 
although there was still 35% remaining. Iso-butanol 
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(20% v/v) did not affect the cytochrome b 5 or heme 
content of the microsomes, but did lower the cytochrome 
P-450 levels and correspondingly decreased the cyto-
chrome P-450 mediated demethylation of Q-nitroanisole 
(Table 22). Stearate desaturase activity in the 
presence of 20% v/v iso-butanol could not be 
assayed indirectly, namely via the re-oxidation of 
hepatic microsomal ferrocytochrome b 5 in the presence 
of stearoyl CoA (Table 21). However, when the activity 
of stearate desaturase was assessed directly, viz. via 
the conversion of stearoyl CoA to oleate, the activity 
of this enzyme system was decreased by only 50% (Table 
21). This discrepancy in the effect of chemicals on the 
activity of the stearate desaturase enzyme system, when 
assayed by two methods, is not consistent with the 
results of Oshino (Oshino et al., 1971), who reported 
comparable activities when stearate desaturase was 
assayed via the re-oxidation of cytochrome b 5 and via 
the conversion of stearate to oleate. However, this 
discrepancy appears to be due to an effect of 20% iso-
butanol on the ability of cytochrome b 5 to transfer 
electrons to microsomal proteins such as stearate 
desaturase, since there is no measurable microsomal 
electron transfer in the absence of stearoyl CoA 
(Table 21) . 
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The effect of iodomethane. 
Stearate desaturase activity, as determined by the 
re-oxidation of NADH reduced microsomal ferrocyto-
chrome b 5 in the presence of stearoyl CoA, appeared 
to be eliminated by iodomethane treatment, although, 
as shown in Table 23, the conversion of stearoyl CoA 
to oleate was only decreased by 50%. Iodomethane 
appeared to enhance electron transfer through cyto-
chrome b 5 in the absence of stearoyl CoA (Table 23). 
This enhanced background rate of electron flow through 
cytochrome b 5 is comparable to that observed with 
microsomes not treated with iodomethane, in the presence 
of stearoyl CoA (Table 2). Under these circumstances, 
the re-oxidation of cytochrome hs is not a reliable 
method of assessing stearate desaturase activity as no 
enhanced rate of re-oxidation of ferrocytochrome b 5 can 
be observed if the background rate is already stimulated 
to levels comparable to that seen in the presence of 
stearoyl CoA. The conversion of stearoyl CoA to oleate 
indicated that although the activity of the stearate 
desaturase enzyme system is decreased, the enzyme system 
is still active. In fact, the conversion of stearoyl 
CoA to oleate in iodomethane treated microsomes, is two 
to four times greater than that obtained with the 
reconstituted detergent solubilized stearate desaturase 
enzyme system (Tables 17 and 23). 
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Iodornethane significantly lowered cytochrome P-450 
levels and this appears to be due to degradation of 
the heme moeity of this enzyme as the loss of heme 
parallels the decrease in cytochrome P-450 in these 
microsomes (Table 24). The low cytochrome P-450 con-
tent is confirmed by the correspondingly decreased 
activity of Q-nitroanisole demethylase and benzpyrene 
hydroxylase. Cytochrome b 5 levels were not decreased 
by iodomethane treatment, but appeared to be enhanced. 
The effect of ootassium thiocyanate. 
Potassium thiocyanate does not significantly decrease 
stearate desaturase activity when assessed via the 
re-oxidation of cytochrome Q5 . The activity is signi-
ficantly lowered when assessed via the conversion of 
stearoyl CoA to oleate (Table 23). The activity of 
stearate desaturase in the potassium thiocyanate 
treated microsomes is 65 - 70% of that observed in 
untreated microsornes, regardless of which assay method 
is used. 
Cytochrome P-450 levels were significantly reduced by 
potassium thiocyanate, due in part to the degradation 
of the heme moiety of the cytochrome (Table 25). The 
conversion of cytochrome P-450 to cytochrome P-420 is 
confirmed by the low rate observed for the demethylation 
of p-nitroanisole (Table 25). Cytochrome b 5 levels 
119 
appear to be slightly elevated, a phenomenon of no 
known explanation, which has been reported to occur 
in the presence of certain compounds (Wade et al., 
1972; Ivanetich et al., 1978). 
The treatment of microsomes with either 0,27 M iodo-
methane or 1 M potassium thiocyanate appeared to be 
most successful in selectively decreasing cytochrome 
P-450 levels while not significantly affecting stearate 
desaturase activity. These microsomes, treated with 
iodomethane or potassium thiocyanate were therefore 
used to assess the ability of stearate desaturase to 
metabolize the anaesthetic agents halothane, enflurane 
and methoxyflurane as their metabolism by cytochrome 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 24. THE EFFECT OF IODOMETHANE ON HEPATIC MICROSOMAL 






Additions to microsomes 
0,27 M Iodomethane 
+ * (nmoles/mg microsomal 
protein) 



















0,04 0,019 + * 0,02 
72 














% decrease : 
130 
TABLE 24 (Cont.) 







0,27 M Iodomethane 
+ 1,04 - 0,17 
0 
0,83 + * 0,18 
46 
Differs significantly from untreated microsomes, P < 0,001 
-r 


































































































































































































































































































































































































































































































(d) Metabolism of three anaesthetic agents by stearate 
desaturase in hepatic microsomes,with negligible levels 
of cytochrome P-450. 
The metabolism of the anaesthetic agents halothane, 
enflurane and methoxyflurane by stearate desaturase 
was assessed in hepatic microsomes previously treated 
with either iodomethane or potassium thiocyanate to 
reduce cytochrome P-450 levels. In these preparations, 
the metabolism of the anaesthetic agents by stearate 
desaturase could be monitored in the absence of cyto-
chrome P-450 dependent metabolism of these anaesthetic 
agents. 
A standard curve for the production of fluoride ion and 
acid-labile fluorine containing compounds is given in 
Figure 17. It can be seen in Table 26 that less than 
1 µM fluoride ion and acid-labile fluorine containing 
compounds was released from halothane, enflurane and 
methoxyflurane by stearate desaturase in hepatic micro-
somes with elevated levels of this enzyme. Neither the 
iodomethane treated microsomes nor the potassium thio-
cyanate treated microsomes produced any detectable 
fluoride ion or acid-labile fluorine containing compounds 
(< 1 µM) on incubation with halothane, enflurane or 
methoxyflurane. 
The standard curve for bromide production is given in 
133 
Figure 18. The release of bromide ions from 18 mM 
halothane by stearate desaturase was determined to be 
< 9 µMin hepatic microsomes from rats re-fed a high 
carbohydrate diet as well as in hepatic microsomes 
treated with iodomethane or potassium thiocyanate. 
To detect volatile metabolites of the anaesthetic agents, 
a WHP Chromosorb/SE 30 colurnn was utililized (see 
Methods). The retention times of halothane, enflurane 
and methoxyflurane were determined to be ca. 25, 19 and 
25 seconds, respectively. Hepatic microsomes from rats 
re-fed a high carbohydrate diet and treated with either 
iodomethane or potassium thiocyanate were utilized. 
Injections from zero time or forty minute incubations 
containing either of the anaesthetic agents produced 
peaks having comparable retention times to the anaes-
thetic agents alone. It appeared therefore that no 
volatile metabolites are produced by stearate desaturase 
from the anaesthetic agents as no peaks corresponding to 
any metabolites were observed. 
The results of the production of non-volatile meta-
bolites of halothane by stearate desaturase are reported 
in Table 27. No non-volatile metabolites could be de-
tected from the stearate desaturase mediated metabolism 
of halothane by assessing metabolism in hepatic micro-
somes from rats re-fed a high carbohydrate diet and 





































































































































TABLE 26. RELEASE OF FLUORIDE ION AND ACID-LABILE FLUORINE 














Halothane (18, 0) 
Enflurane (14,0) 
Methoxyflurane ( 0 I 6) 
Halothane (18,0) 
Enflurane (14,0) 
Methoxyflurane ( 0 / 6) 
Halo thane (18, 0) 
Enflurane (14,0) 




-233 + 16 -
-233 + 12 -
-230 + 11 -
-229 + 19 -
+ -235 - 25 
-240 + 24 -
-240 + 26 -
+ -244 - 30 
-246 + 30 -
-210 :!: 19 
+ -217 15 
Methoxyflurane (0,6) -218 ~ 15 
Halothane (18,0) -234 + 6 -
+ Enflurane (14, 0) -240 - 4 


























( 1 M) 
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TABLE 26 (Cont.) 
Additions to 
rnicrosornes (rnM) 
Halothane (18, 0) 
Enflurane (14,0) 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(e) The production of active oxygen species in hepatic 
microsomes. 
The anaesthetic agents halothane, enflurane and methoxy-
flurane and the xenobiotics bromotrichloromethane, l,2-
dibromo-1,2-dichloroethane and chloroacetaldehyde 
stimulate microsomal electron transfer through cyto-
chrome b_ apparently due to their interaction with -~ 
stearate desaturase (sections lb and le). Neither 
halothane, enflurane nor methoxyflurane are metabolized 
by stearate desaturase (sections 2b and 2d). The 
enhanced microsomal electron flow observed and the lack 
of metabolism of the anaesthetic agents suggested that 
the anaesthetic agents might uncouple the stearate 
desaturase system. The electrons which are transferred 
by cytochrome ~S would then be incorporated into 
various active oxygen species and an increased produc-
tion of these species would be observed in a system 
uncoupled by these xenobiotics. 
In iodomethane treated microsomes, the production of 
hydrogen peroxide is increased with time in the presence 
of NADH. The xenobiotics themselves have no effect on 
hydrogen peroxide production. Relative to the increase 
of hydrogen peroxide observed in the presence of NADH, 
the production of hydrogen peroxide was significantly 
increased after 1 minute in the presence of NADH plus 
chloroacetaldehyde or bromotrichloromethane. 1,2-
141 
Dibromo-1,2-dichloroethane plus NADH did not produce ele-
vated levels of hydrogen peroxide (Table 28; Figure 19). 
The production of hydrogen peroxide on incubation of the 
anaesthetic agents with differently pretreated micro-
somes is reported in Tables 29, 30 and 31. In the 
absence of NADH, very low levels of hydrogen peroxide 
are produced in the presence of the anaesthetic agents. 
However, in the presence of both NADH and the anaes-
thetic agents, there is a statistically significant 
increase in the production of hydrogen peroxide with 
time (Tables 29, 30 and 31 and Figures 20, 21 and 22). This 
elevation of hydrogen peroxide levels was observed in 
microsomes from high carbohydrate fed rats pretreated 
or not with iodomethane or potassium thiocyanate, to 
decrease cytochrome P-450 levels. 
The effect of the anaesthetic agents halothane, enflurane 
and methoxyflurane on the production of superoxide anion 
is reported in Table 32. Using NADPH as an electron 
donor, only halothane had a significant effect on the 
production of superoxide anion. At a higher protein 
concentration, none of the anaesthetic agents produced 
any superoxide anion. Using NADH as an electron donor, 
no superoxide anion could be detected in the presence of 
any of the anaesthetic agents with either the low or 
high concentrations of hepatic microsomes (Table 32). 
The oxidation of epinephrine to adrenochrome occurs in 
142 
the presence of superoxide anion as evidenced by the 
generation of superoxide anion and formation of 
adrenochrome by the xanthine/xanthine oxidase system. 
(The incubation system comprised adrenaline (0,6 mM), 
xanthine (300 uM) and xanthine oxidase (0,25 µg/ml) 
+ and generated 0,0012 - 0,0002 moles adrenochrome per 
minute). 
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TABLE 28. THE EFFECT OF HALOGENATED COMPOUNDS ON HYDROGEN 
PEROXIDE PRODUCTION IN IODOMETHANE PRETREATED 









(51, 6) + NADH ( l, 0) 
l,2-Dibromo-1,2-di-
chloroethane ( 0 t 6) 
l,2-Dibromo-1,2-di-
chloroethane ( 0 I 6) 


























































methane ( 3 / 4) 
Bromotrichloro-
methane ( 3, 4) + 
NADH ( l, 0) 
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0,51 + 0,93 -
0,36 + 0,72 -
0,48 + 0,48 -
7,62 + 2,94'~ -
+ 13, 89 - 4,92 
13,98 + 3,42 -
t Differs significantly from NADH alone, P < 0,01 
i Probably differs from NADH alone, P < 0,05 
FIGURE 19 
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The effect of xenobiotics on the production of 
hydrogen peroxide. The production of hydrogen 
peroxide by hepatic microsomes from rats fed a 
high carbohydrate diet, with the isolated hepatic 
microsomes being pretreated with iodomethane. 
Additions to incubations as follows : NADH (•), 
chloroacetaldehyde (A) and chloroacetaldehyde + 
NADH (a) (Figure A); NADH (e), l,2-dibromo-1,2-
dichloroethane (A) and l,2-dibromo-1,2-dichloro-
ethane + NADH (m) (Figure B); NADH (e), bromo-
trichloromethane (A) and bromotrichloromethane 
+ NADH (•) (Figure C). 
\,() 
""' r-1 











































































TABLE 29. THE EFFECT OF ANAESTHETIC AGENTS ON HYDROGEN 
PEROXIDE PRODUCTION IN MICROSOMES FROM RATS 
FED A HIGH CARBOHYDRATE DIET. 






























1, 59 + 0,90 -
1, 56 + l, 44 -
2,94 + 1, 68 -




+ 2,10 - 2,94 
+ 2,73 - 1, 56 
2,70 + L 92 -
6,18 + 2,lOt -
6,78 + 2,52t -
0,81 + 1, 14 -
0,66 + L 02 -
0,99 + 1, 14 -
0,60 + 0,78 -
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Enflurane (14,0) + 
NADH ( l, 0) 
Methoxyflurane (0, 6) 
Methoxyflurane ( 0, 6) 



















2,94 + 2,25 -
* 4,80 + l, 50 -
8,31 + 3,99t -
+ * 7,29 - 2,52 
3,72 + l, 83 -
3,00 + 2,28 -
1, 38 + 1, 50 -
0,81 + 0,15 -
2,34 + l, 26 -
* + 5,43 - l, 86 
+ 5,43 - l, 26t 
3, 18 + 1, 47 t -
Differs significantly from NADH alone, P < 0,001 
t Differs significantly from NADH alone, P < 0,01 
FIGURE 20 
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The effects of anaesthetic agents on the produc-
tion of hydrogen peroxide. The production of 
b_ydrogen peroxide in microsomes from rats fed a 
high carbohydrate diet. Additions to incubations 
as follows : NADH (e), halothane (A) and halothane 
+ NADH (R) (Figure A); NADH (e}, enflurane (i) and 
en~lurane + NADH (a) (Figure B): NADH Ce), 
methoxyflurane (i) and rnethoxyflurane + NADH 






























































































TABLE 30. THE EFFECT OF ANAESTHETIC AGENTS ON HYDROGEN 
PEROXIDE PRODUCTIO~ IN MICROSOMES FROM RATS 
FED A HIGH CARBOHYDRATE DIET.PRETREATED WITH 
IODOMETHANE. 
Additions to Time Hydrogen peroxide 
microsomes (min) produced 
( rnivl) (µM) 
------------
NADH ( 1, 0) 1 3, 12 + 1,14 -
5 5,70 + 1, 98 -
15 9,57 + 0,66 -
20 10,32 + 2,34 -
Halothane (18,0) 1 + 2,19 - 2,55 
5 l, 23 + 1, 65 -
15 + 1, 95 - l, 32 
20 + 2,52 - 1, 83 
Halothane (18,0) + 1 4,80 + 0,93;6 -
NADH ( l, 0) 
5 7,68 + 0,96 -
15 10,41 + 1, 35 -
20 9,99 + 2,43 -
·----· ------ -
Enflurane (14,0) 1 3,09 + 1, 11 -
5 4,80 + 2,79 -
15 6,30 + 2,91 -
20 7,47 + 2,52 -
154 
TABLE 30 (Cont.) 
Additions to 
microso::-ies 
( r:i;Ji ) 
------------------
Enflurane (14,0) + 
NP.DH (1 , 0 ) 
Methoxyflurane ( 0, 6) 
Methoxyflurane ( 0, 6) 
+ NADH ( 1, 0) 
* Differs significantly 
t Differs significantly 





























+ * 14,40 - 2,94 
17,01 ~ 3,66t 
16,65 ~ 2,94t 
1, 98 + l, 59 -
5,76 + 2,55 -
4,98 + L 71 -
3,51 + 1, 08 -
8,07 + 2,34t -
+ 13,32 - 3,96t 
+ 16,23 - 4,86 






The effects of anaesthetic agents on the produc-
tion of hydrQgen peroxide. ~he production of 
hydrogen peroxide in microsornes from rats fed a 
high carbohydrate diet and with the isolated 
hepatic rnicrosomes being pretreated with iodo-
methane. Additions to incubations as follows 
NADH (•), halothane (!), and halothane + NADH 
(•) (Fiaure A); NADH (e), enflurane_JJ.) and 
enflurane + NADH (•) (Figure B); NADH (•), 
























































































TABLE 31. THE EFFECT OF A~AESTHETIC AGENTS ON HYDROGEN 
PEROXIDE PRODUCTION TN MICROSOMES FROM RATS 
FED A HIGH CARBOHYDRATE DIET, PRETREATED WITH 
POTASSIUM THIOCYANATE. 

















Halothane (18,0) + 













2,52 + 0,51 -
3,30 + 2, 10 -
5,82 + 3,00 -
+ 9,00 - 2,88 
l, 86 + 2,22 -
0,63 + 0,75 -
+ 0,81 - 0,75 
4,41 + 6,15 -
7,71 =!:: 3,63i 
11,22 + 0,24t 
+ 7,59 3,30 
+ 12,42 - 2,70 
+ 1, 32 - l, 80 
0,39 + 0,81 -
l, 23 + l, 44 -
2,61 + l, 80 -
159 




Enflurane (14,0) + 
NADH ( l, 0) 
Methoxyflurane (0,6) 
Methoxyflurane (0,6) 



















8,13 ~ 3,18i 
6,48 2: 3,30 
+ 11,55 - 4,11 
+ 0,39 - 0,84 
+ 0,57 - 0,93 
+ 0,12 - 0,24 
+ 0,24 - 0,30 
8,46 ~ 2,85t 
+ 7,92 - 4,35 
11, O 1 :: 3 , 12! 
+ 13,56 - 3,36 
t Differs significantly from NADH alone, P < 0,01 
i Probably differs from NADH alone, P < 0,05 
FIGURE 22 
160 
The effects of anaesthetic agents on the nroduc-
tion of hydrogen peroxide. The production of 
hydrogen peroxide in microsomes from rats fed a 
high carbohydrate diet and with the isolated 
hepatic microsomes being pretreated with 
ootassium thiocyanate. Additions to incubations 
as follows : NADH (•), halothane (4), and halo-
thane + NADH (a) (Figure A); NADH (•), enflurane 
J..!l and enflurane + NADH (a) (Figure B); NADH 
J_!tj_, methoxyflurane (!) and methoxyflurane + 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































(3) Experiments in vivo. 
(a) The effects of anaesthetic agents in vivo. 
The effect of repeated anaesthesia of differently pre-
treated rats on the stearate desaturase enzyme system 
and cytochrome P-450 levels was assessed in hepatic 
microsomes. The effects of this treatment on toxicity 
was assessed by monitoring S.G.O.T. levels in blood 
from animals exposed to repeated anaesthesia and by 
examining their livers by conventional light microscopy. 
Advantage was taken of dietary pretreatment, to alter 
the levels of hepatic microsomal stearate desaturase 
and phenobarbitone pretreatment, to increase the levels 
and activity of hepatic microsomal cytochrome P-450. 
The effect of dietary pretreatment on the activity of 
the stearate desaturase enzyme system. 
The activity of stearate desaturase was assessed via 
the re-oxidation of hepatic microsomal cytochrome b 5 . 
The difference ink b in the presence minus absence 
0 S 
of stearoyl CoA was taken as a measure of the activity 
of stearate desaturase. Stearate desaturase activity 
remained elevated 5, 8 and 11 days after the commence-
ment of the high carbohydrate diet (Table 33), as 
evidenced by the increased rate of re-oxidation of 
ferrocytochrome b 5 . Stearate desaturase activity was 
significantly lower in hepatic microsomes from rats fed 
166 
a normal diet when compared to the activity of the 
enzyme in hepatic microsomes from rats fed the high 
carbohydrate diet for 5 days (Table 34). The activity 
of stearate desaturase was negligible in hepatic 
microsomes from fasted or phenobarbitone treated rats 
(Table 34). 
The effect of reoeated anaesthesia on the hepatic micro-
somal stearqte desaturase enzyme system. 
Stearate desaturase activity, in hepatic microsomes 
from rats fed a high carbohydrate diet, was unaffected 
by repeated exposure to halothane, enflurane or chloro-
form when compared to stearate desaturase activity in 
unanaesthetized rats fed a high carbohydrate diet. The 
activity of stearate desaturase was decreased following 
exposure to ether however (Table 35). Similarly, 
stearate desaturase activity in hepatic microsomes from 
rats fed a normal diet, or fasted and pretreated with 
phenobarbitcne, was unaffected by repeated exposure to 
halothane, ether or chloroform (Table 36 and 37) when 
compared to similarly pretreated unanaesthetized animals. 
The effect of repeated anaesthesia on hepatic microsomal 
~ytochrome P-450, S.G.O.T. and hepatic histology. 
The levels of hepatic microsomal cytochrome P-450 were 
unaffected in hepatic microsomes from rats fed a high 
167 
carbohydrate diet in the absence of anaesthesia (Table 
38). Repeated exposure to halothane resulted in 
decreased levels of cytochrome P-450 in hepatic micro-
somes from rats fed a high carbohydrate diet, while 
ether elevated the levels of cytochrome P-450 (Table 
38). This is consistent with the known ability of 
diethyl ether to induce cytochrome P-450 (Brown and 
Sagalyn, 1974; Ross and Cardell, 1978). Repeated 
exposure of rats on the high carbohydrate diet to 
enflurane was without effect on cytochrome P-450 levels 
(Table 38). 
The levels of cytochro~e P-450 were slightly lowered 
in microsomes from rats fed a normal diet after 
repeated exposure to enflurane and decreased to a 
greater extent by chloroform, while the levels of 
cytochrome P-450 in these microsomes were unaffected 
by repeated exposure to halothane or ether (Table 39). 
Cytochrome P-450 levels in hepatic microsomes from 
~sted rats pretreated with phenobarbitone were 
significantly lowered following repeated exposure to 
halothane and ether and were slightly, but significantly 
elevated following exposure to enflurane (Table 40). 
The levels of S.G.O.T. in hepatic microsomes from rats 
fed a high carbohydrate diet, in the absence of anaes-
thesia, were all within the normal range (less than 
50 I.U.) determined from the mean! three standard 
168 
deviations of values obtained for normal animals 
(Table 38). For all animals, S.G.O.T. levels greater 
than 50 I.U. were considered to be abnormal and 
indicative of hepatic damage. If the values of S.G.O.T. 
were less than 50 I.U., the mean~ standard deviation 
is given; if some values are greater than 50 I.U., the 
two categories have been split and the number greater 
or less than 50 I.U. given. 
The levels of S.G.O.T. in hepatic microsomes from rats 
fed a high carbohydrate diet were within the normal 
range following repeated exposure to halothane, 
enflurane or ether. The S.G.O.T. levels were however, 
significantly raised following repeated chloroform 
anaesthesia of 2 / 7 animals indicating hepatic damage 
(Table 38). S.G.O.T. levels in hepatic microsomes from 
rats fed a normal diet or pretreated with phenobarbitone 
were within the normal range following repeated halo-
thane, enflurane or ether anaesthesia (Tables 39 and 40) 
while exposure to chloroform in rats fed a normal diet 
resulted in raised S.G.O.T. levels in 3/ Brats (Table 39). 
The livers of rats exposed to halothane, enflurane or 
ether appeared histologically normal regardless of 
dietary or phenobarbitone pretreatment (Tables 38, 39 
and 40). Dietary pretreatment appeared not to affect 
the toxicity of chloroform anaesthesia, as animals on 
both high carbohydrate and normal diets anaesthetized 
169 
with chloroform, manifested gross centrilobular necrosis, 
a lesion characteristic of cytochrome P-450 mediated 
hepatic damage (Brown et al., 1974). It was not 
possible to assess the effects of chloroform on animals 
pretreated with phenobarbitone, due to the high 
mortality rate. However, gross hepatic necrosis was 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(b) The effects of anaesthesia under hypoxic conditions 
in vivo. 
It has been reported that exposure of phenobarbitone 
pretreated ani::lals to halothane under conditions of 
hypoxia resulted in gross hepatic centrilobular necrosis 
(Cousir.s et al., 1979; McLain et al., 1979 and Ross et 
al, 1979). The effects of anaesthesia under hypoxic 
conditions on the stearate desaturase enzyme system, 
cytochrome P-450 levels and hepatic histology were 
assessed in the livers from rats fed a high carbohydrate 
or normal diet in the presence and absence of pheno-
barbitone pretreatment. 
The effects of anaesthesia under hypoxic conditions on 
the hepatic microsomal stearate desaturase enzyme system. 
Stearate desaturase activity in hepatic microsomes from 
rats fed a high carbohydrate diet was unaffected by N2o 
or halothane administered under hypoxic conditions (o2 
700 ml/min), when compared to the activity in hepatic 
microsomes from rats fed a high carbohydrate diet, not 
exposed to anaesthesia (Table 41). Stearate desaturase 
activity was markedly decreased following chloroform 
anaesthesia under hypoxic conditions. 
Stearate desaturase activity was decreased in hepatic 
rnicrosomes from rats fed a high carbohydrate diet and 
189 
pretreated with phenobarbitone (Table 41) relative to 
those only fed a high carbohydrate diet. Halothane 
anaesthesia under hypoxic conditions did not further 
reduce the activity of stearate desaturase in hepatic 
microsomes from rats fed a high carbohydrate diet and 
pretreated with phenobarbitone. 
Stearate desaturase activity in hepatic microsomes from 
rats fed a normal diet was measurable, although lower 
than that observed in microsomes from rats fed a high 
carbohydrate diet (Tables 41 and 42). Stearate 
desaturase activity in hepatic microsomes from rats 
fed a normal diet was unaffected by N2o or halothane 
administration under hypoxic conditions, but was 
decreased by chloroform anaesthesia under hypoxic 
conditions (Table 42). Halothane anaesthesia under 
hypoxic conditions did not affect stearate desaturase 
activity in hepatic microsomes from rats fed a normal 
diet and pretreated with phenobarbitone (Table 42). 
The effect of anaesthesia under hypoxic conditions on 
hepatic microsomal cytochrome P-450, S.G.O.T. and 
hepatic histology. 
The levels of hepatic microsomal cytochrome P-450 in 
microsomes from rats fed a high carbohydrate diet were 
unaffected by N2o, halothane or chloro
form anaesthesia 
under hypoxic conditions (Table 43). The levels of 
190 
cytochrome P-450 were elevated by phenobarbitone pre-
treatment, but halothane anaesthesia under hypoxic 
conditions did not affect the raised levels of cyto-
chrome P-450 present in hepatic microsomes from rats 
fed a high carbohydrate diet and pretreated with 
pheno~arbitone (Table 43). 
Similarly, the levels of hepatic microsomal cytochrome 
P-450 in microsomes from rats fed a normal diet, pre-
treated or not with phenobarbitone, were unaffected by 
N2o, halothane or chloroform anaesthesia under hypoxic 
conditions (Table 44). 
The levels of S.G.O.T. were raised, following exposure 
to halothane under hypoxic conditions, in animals fed 
either a normal or high carbohydrate diet, pretreated 
or not with phenobarbitone (Tables 43 and 44 and 
Figures 23 and 24). However, the levels of S.G.O.T. 
in animals on a normal diet, pretreated or not with 
phenobarbitone exposed to halothane and hypoxia, were 
significantly higher than in those animals on a high 
carbohydrate diet, pretreated or not with phenobarbi-
tone exposed to halothane and hypoxia (Tables 43 and 
44) . 
The levels of S.G.O.T. were raised following exposure 
to chloroform and hypoxia in animals fed either a 
normal diet or a high carbohydrate diet (Tables 43 and 
191 
44 and Figures 23 and 24). The levels of S.G.O.T. in 
animals fed a normal diet were raised following 
exposure to enflurane and methoxyflurane under hypoxic 
conditions (Table 44), but exposure to methoxyflurane 
appeared to be less deleterious than exposure to 
enflurane. 
The hepatic histology of animals fed either the normal 
diet or the high carbohydrate diet and exposed to N2o 
or halothane and hypoxia, was normal. When animals 
were fed either the normal diet or the high carbohydrate 
diet, pretreated with phenobarbitone and exposed to 
halothane and hypoxia, the hepatic histology was that of 
congestion and centrilobular necrosis (Tables 43 and 44). 
The hepatic histology of animals fed a normal diet, pre-
treated with phenobarbitone and exposed to enflurane and 
methoxyflurane, was normal. Exposure to chloroform and 
hypoxia resulted in congestion and centrilobular necrosis 
of hepatocytes from animals fed either a normal diet or a 
high carbohydrate diet (Tables 43 and 44). 
The mortality of animals fed a normal diet and exposed 
to halothane and hypoxia, was significantly higher 
than that of animals fed a high carbohydrate diet and 
exposed to halothane and hypoxia (Tables 43 and 44 and 
Figures 23 and 24). The mortality of animals fed a 
normal diet and pretreated with phenobarbitone prior to 
exposure to halothane and hypoxia was not significantly 
192 
different from that of animals fed a high carbohydrate 
diet and pretreated with phenobarbitone prior to 
exposure to halothane and hypoxia (Tables 43 and 44). 
The effect of exposure to halothane under hypoxic 
conditions on hepatic glutathione levels in rats fed a 
normal diet is reported in Table 45 and Figure 25. The 
levels of hepatic glutathione in animals exposed to 
N2o/o2 alone, were unaffected relativ
e to the levels in 
unanaesthetized rats, while the levels of hepatic 
glutathione in animals exposed to halothane and hypoxia 
were significantly decreased after 30 and 45 minutes 
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TABLE 45. THE EFFECT OF HALOTHANE A..~AESTHESIA UNDER 








1 MAC halothane/N 2o;o2 
1 MAC halothane/N 2
o;o
2 
1 MAC halothane/N 2o;o2 
1 MAC halothane/N 2o;o2 
1 MAC halothane/N 2o;o2 













µg Glutathione/100 mg 
wet liver weight 
+ 
133 - 16 
138 + 29 -
123 
+ 39 -
156 + 27 -
+ + 97 - 18' 
110 + gt -




175 - 0 
+ 
160 - 0 
Assays are in duplicate for determinations on each of 3 to 5 
livers of rats fed a normal diet, after a single anaesthetic 
exposure. 
The rats were maintained on a normal diet and induced with 
phenobarbitone as described in Methods. N2o was administered 
at a rate of 4,3 1/min. o2 was adm
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The interaction of xenobiotics with hepatic microsomal 
The interaction of xenobiotics with hepatic microsomal 
cytochrome P-450 has been the subject of extensive inves-
tigations ove~ the past twenty years. The biochemical 
relevance of these investigations is of inestimable 
importance because the metabolism of xenobiotics, particu-
larly by cytochrome P-450, is in general essential in main-
taining the well-being of humans and animals exposed to 
xenobiotics such as medical drugs or environmental pollu-
tants. However, it has recently been demonstrated that 
certain xenobiotics are capable of interacting with other 
hepatic microsomal enzymes, not generally thought to be in-
volved in drug metabolism (Oshino and Sato, 1971). The 
relevance of such an interaction is of interest both bio-
chemically and clinically as the interaction of xenobiotics 
with microsomal enzymes other than cytochrome P-450 could 
affect the extent of their metabolism or the metabolic status 
of the cell, with either beneficial or detrimental conse-
quences to the body. 
The observation that the hepatic microsomal enzyme stearate 
desaturase, which was previously known only to interact with 
its physiological substrate, interacts with Q-cresol and 
halothane (Oshino and Sato, 1971; Berman et al., 1975) 
210 
suggested that other xenobiotics might also interact with 
hepatic microsomal stearate desaturase. This thesis reports 
on an investigation of the possible interaction of approxi-
mately fifty xenobiotics with hepatic microsomal stearate 
desaturase. This study represents the first extensive 
investigation of the interaction of xenobiotics with this 
enzyme. The majority of xenobiotics chosen for this study 
were halogenated hydrocarbons because one of the two xeno-
biotics previously shown to interact with stearate desaturase 
was the halogenated hydrocarbon halothane. However, halo-
genated ethers including the volatile anaesthetic agents 
enflurane (CClFHCF 2ocF 2
H) and methoxyflurane (Ccl 2HcF 2ocH 3), 
were also investigated. Non-halogenated structural analogues 
of some xenobiotics were included in the investigations in an 
attempt to draw some conclusions on the structural features 
of a xenobiotic required to interact with stearate desaturase. 
It was not possible to assess the interaction of xenobiotics 
with stearate desaturase directly viz. via the conversion of 
stearoyl CoA to oleate, because none of the xenobiotics known 
to interact with stearate desaturase affect this process. 
Therefore, assays of the oxidation state of cytochrome Q5 
were employed to indirectly assess the interaction of xeno-
biotics with stearate desaturase. This approach was utilized 
because compounds which interact with stearate desaturase are 
known to enhance the oxidation of hepatic microsomal ferro-
cytochrome b 5 (see Introduction). In these investigations, 
hepatic microsomes from rats fed a high carbohydrate diet to 
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enhance the activity of stearate desaturase were utilized 
and both NADH and NADPH were employed as electron donors 
to stearate desaturase. Furthermore, advantage was taken 
of the observation that cyanide effectively inhibits the 
stearate desaturase enzyme system by binding to the terminal 
oxidase, the c. s. F. (Oshino et al., 1966; Shimakata et al., 
1971). 
The first assay which was utilized to assess the interaction 
of xenobiotics with hepatic microsomal stearate desaturase 
was the redox steady state of microsomal cytochrome hs in 
the presence of NADPH. This assay was chosen because it is 
the most rapid and simple assay which provides a measure of 
the oxidation state of cytochrome hs· This assay does not 
however directly measure the rate of oxidation of ferrocyto-
chrome b 5 , but reflects a composi
te of the rate of reduction 
of ferricytochrome b 5 
by NADPH via NADPH-cytochrome £ (P-450) 
reductase and the rate of oxidation of ferrocytochrome h5 , a 
process which can occur via several pathways (see Figure 7). 
In an attempt to assess the ability of the xenobiotics to 
interact with stearate desaturase,utilizing the NADPH redox 
steady state of microsomal cytochrome h5 , it was observed 
that the majority of xenobiotics shifted the redox steady 
state of microsomal cytochrome b 5 towards
 the ferric form of 
the protein (Table I). This assay provided only a gross 
indication of the ability of a xenobiotic to interact with 
stearate desaturase for several reasons. Firstly, NlillPH is 
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not the preferential electron donor to stearate desaturase 
(but is for cytochrome P-450) and hence electron flow from 
NADPH through cytochrome b 5 
could be due to the interaction 
of xenobiotics with other microsomal proteins such as cyto-
chrome P-450. Secondly, the attempt to assess the role of 
stearate desaturase on the effect of xenobiotics on the 
steady state of cytochrome b 5 in the pr
esence and absence 
of cyanide was unsuccessful because cyanide affected the 
redox steady state of NADPH reduced cytochrome b 5 
in the 
absence of xenobiotics. 
In order to investigate with greater specificity the ability 
of selected xenobiotics to interact with stearate desaturase, 
the effect of those xenobiotics - particularly the halo-
alkanes - which shifted the redox steady state of cytochrome 
hs to 40% or below, on the re-oxidation of NADH reduced hepa-
tic microsomal cytochrome b 5 
was examined. This assay is 
more specific for the interaction of a xenobiotic with 
stearate desaturase than is the NADPH redox steady state assay 
because the assay of the re-oxidation of cytochrome b 5 affor
ds 
a direct measure of the rate of oxidation of cytochroffie b 5 
and is not affected by the rate of reduction of cytochrome hs 
by NADH. A further advantage of this assay is that the re-
ductant NADH is the preferential electron donor for the 
stearate desaturase enzyme system (Jones et al., 1969; Joshi 
et al., 1977). Because the oxidation of cytochrome hs can 
occur via several pathways (see Figure 7), the effects of 
cyanide were utilized to assess the role of stearate desatu-
213 
rase in the enhanced oxidation of microsomal ferrocytochrome 
b 5 . A direct correlation 
between the rate of re-oxidation of 
microsomal ferrocytochrome Q5 and the rate of conversion of 
stearoyl CoA to oleate by stearate desaturase has been demon-
strated by Oshino et al. (1971), confirming that the re-
oxidation of cytochrome QS provides a valid assay for the 
activitv of stearate desaturase. 
The rate of re-oxidation of NADH reduced microsomal ferro-
cytochrome hs was significantly enhanced in the presence of 
the majority of the xenobiotics investigated (Table 2) with 
the exception only of iodoform, l,l,2,2-tetrachloroethane, 
l,2,2-trichloro-l,l,2-trifluoroethane, i.e. thirteen out of 
sixteen xenobiotics enhanced the rate of re-oxidation of 
microsomal ferrocytochrome b 5
. 
In a comparison of the results obtained for the effect of 
xenobiotics on the ~ADPH steady state and on the re-oxidation 
of cytochrome b 5 . it was observed that of the xenobiotics 
which shifted the redox steady state of NADPH reduced cyto-
chrome b 5 towards the ferric form of the protein, 
some, for 
example, iodoform, l,l,2,2-tetrachloroethane and 1,2,2-tri-
chloro-l,l,2-trifluoroethane did not enhance the re-oxidation 
of microsomal ferrocytochrome Qs· Other xenobiotics, at 
comparable concentrations, such as iodomethane, l,l,2-tri-
chloroethane, l-bromo-2-chloroethane and ethyl vinyl ether 
shifted the redox steady state of cytochrome b 5 towards the 
ferric form and enhanced the re-oxidation of cytochrome b 5. 
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Some xenobiotics such as 1,2-dibromo-l,l-dichloroethane, 
1,2,3-trichloropropane, ethyl vinyl ether and l-bromo-2-
chloroethane did not exhibit a cyanide sensitive effect on 
the re-oxidation of cytochrome QS while others such as 
diiodomethane and l,l,2-trichloroethane did (Tables 1 and 2). 
The ability of xenobiotics to enhance the rate of re-oxidation 
of cytochrome b
5 
in a cyanide insensitive manner suggested 
that these xenobiotics (e.g. l,2-dibromo-1,1-dichloroethane, 
1,2,3-trichloropropane, ethyl vinyl ether and l-bromo-2-
chloroethane) might enhance the electron flow through cyto-
chrome hs by interacting with microsomal proteins which are 
not inhibited by 0,5 mM cyanide, such as cytochrome P-450 
(Jefcoate et al., 1969; Correia and Mannering, 1973), N-
hydroxylamine oxidase and the phospholipid desaturase (Pugh 
and Kates, 1977) rather than microsomal stearate desaturase. 
It has been established that 1,2,3-trichloropropane and ethyl 
vinyl ether bind to the substrate binding site of cytochrome 
P-450 and stimulate microsomal NADPH oxidation (Ivanetich 
et al., 1978) suggesting that these xenobiotics are meta-
bolized by the hepatic microsomal cytochrome P-450 enzyme 
system, which is consistent with the above proposal. 
The ability of a xenobiotic to enhance the rate of re-oxida-
tion of cytochrome b 5 in a cyanide sensitive manner suggested 
that the xenobiotic might enhance electron flow through cyto-
chrome hs by interacting with one or more of the terminal 
oxidases which is inhibited by concentrations of cyanide of 
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0,5 mM such as the phospholipid desaturase and the acyl CoA 
65-, t6- and 69-desaturases (see Oshino, 1978). 
Those compounds which shifted the redox steady state of cyto-
chro;ne b_ to 40:~ or below and which increased the rate of re-
-::i 
oxidation of cytochrome Q5 in a cyanide sensit
ive manner were 
bromotrichloromethane, l,2-dibromo-1,2-dichloroethane, chloro-
acetaldehyde and the anaesthetic agents halothane, enflurane 
and methoxyflurane (Berman et al., 1975) (Tables 1 and 2). 
In order to establish whether the enhanced rate of re-oxida-
tion observed in the presence of these xenobiotics was due to 
their interaction with hepatic microsomal stearate desaturase, 
the effect of these xenobiotics on cytochrome hs, the Nl'.DH--
and NADPH-cytochrorne c reductases, cytochrome P-450, N-hy-
droxylamine oxidase, the phospholipid desaturase and the acyl 
CoA 65- and 66-desaturases as well as the C.S.F. of the 
stearate desaturase enzyme system was examined. The possible 
interactions of the halogenated xenobiotics bromotrichlorom-
ethane, l,2-dibrorno-1,2-dichloroethane and chloroacetalde-
hyde with each of the above-mentioned microsomal proteins will 
be discussed first and those of the anaesthetic agents halo-
thane, enflurane and methoxyflurane on these microsomal proteins 
will be discussed subsequently, since more extensive experi-
mentation was undertaken on the interaction of the anaesthetic 
agents with hepatic microsomal proteins. 
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The interaction of bromotrichloromethane, 1,2-dibromo-l,2-
dichloroethane and chloroacetaldehyde with some hepatic 
microsomal proteins. 
The ability of brornotrichloromethane, l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde (as well as the 
anaesthetic agents halothane, enflurane and methoxyflurane) 
to shift the redox steady state of hepatic microsomal 
cytochrome b 5 towards the
 ferric form of the protein 
(Table 1) suggested that these xenobiotics are increasing 
the rate of oxidation and/or decreasing the rate of reduc-
tion of cytochrome 25 . The effect of these xenobiotics on 
the redox steady state of cytochrome b 5 
is apparently due to 
an increased rate of oxidation of cytochrome 25 rather than 
a decreased rate of reduction of the cytochrome since these 
xenobiotics enhance the rate constant for the re-oxidation of 
NADH reduced hepatic microsomal ferrocytochrome 25 , which is 
a measure of the rate of oxidation of this hemoprotein 
(Berman et al., 1975; Oshino et al., 1971), but these xeno-
biotics do not increase the activity of the microsomal NADH-
* or NADPH-cytochrome c reductases (Tables 2, 5 and 10). 
The observed increase in the rate of oxidation of hepatic 
microsomal ferrocytochrome b 5 could therefore be 
due to an 
increased rate of autoxidation of this cytochrome, or due to 
* 
Since electron transfer from ferrocytochrome 25 to ferri-
cytochrome c is rapid, the cytochrome c reductase activities 
provide a measure of the rate of reduction of ferricyto-
chrome b 5 (Strittmatter and Velick, 1956). 
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an increased rate of electron transfer from ferrocytochrome 
hs to one or more of the hepatic microsomal terminal oxidases 
(see above and Figure 7). The autoxidation of ferrocyto-
chrome b 5 refers 
to the direct transfer of electrons from 
ferrocytochrome b 5 to molecular oxyge
n, by the following 
reaction : 
F 2+ b ~~~~ 
3+ b O -. e cytochrome _ 5 + 0 2 4 Fe 
cytochrome _ 5 + 2 
The enhancement of the re-oxidation of NADH reduced hepatic 
microsomal ferrocytochrome hs by bromotrichloromethane, 
l,2-dibromo-1,2-dichloroethane and chloroacetaldehyde 
appeared not to be due to enhanced autoxidation of ferro-
cytochrome b 5 
because the stimulation of the re-oxidation of 
microsomal ferrocytochrome b 5 
by these xenobiotics is cyanide 
sensitive (Table 2) while the autoxidation of purified, 
trypsin-cleaved ferrocytochrome b 5 is insensitiv
e to cyanide 
(Berman et al., 1975). 
Enhanced oxidation of hepatic microsomal ferrocytochrome b 5 
would therefore appear to be a consequence of the stimulation 
by these xenobiotics of electron transfer to one or more of 
the terminal microsomal oxidases (see above). The microsomal 
oxidase cytochrome P~450 is known to bind all three of these 
xenobiotics with the production of a type 1 difference spec-
trum (Ivanetich et al., 1978) (see Results) which is indica-
tive of the binding of a substrate to the substrate-binding 
site of cytochrome P-450. In addition, the K values for the s 
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binding of bromotrichloromethane and l,2-dibromo-1,2-
dichloroethane to cytochrome P-450 were similar to their 
K values for the stimulation of the re-oxidation of micro-eq 
somal cytochrome QS (Table 6 and Figures 8, 9 and 10). 
It would appear however, that the terminal microsomal 
oxidase cytochrome P-450 is not responsible for the stimu-
lation of the re-oxidation of microsomal cytochrome b 5 by 
bromotrichloromethane, but may be at least in part responsible 
for that observed in the presence of 1,2-dibromo-l, 2-dichloro-
ethane and chloroacetaldehyde. The enhanced re-oxidation of 
cytochrome b 5 observed in th
e presence of bromotrichloro-
methane was not decreased by CO and metyrapone (Table 4), 
two inhibitors of cytochrome P-450 which exert their effect 
by binding to the active site of this enzyme (De Bruin, 1976). 
The lack of effect of these inhibitors on the re-oxidation of 
cytochrome b 5 in the p
resence of bromotrichloromethane 
suggested that cytochrome P-450 is not responsible for the 
enhanced re-oxidation observed in the presence of this xeno-
biotic. Furthermore, the re-oxidation of cytochrome b 5 in 
the presence of bromotrichloroethane was inhibited by 0,5 mM 
cyanide at a concentration too low to inhibit cytochrome 
P-450 and decreased by fasting, which did not alter the 
levels of cytochrome P-450 significantly (Table 3). It 
appears therefore that cytochrome P-450 is not involved in 
the enhanced re-oxidation of ferrocytochrome b 5 
observed in 
the presence of bromotrichloromethane. 
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A role for cytochrome P-450 in the stimulation of the re-
oxidation of cytochrome b 5 
by 1,2-dibromo-l,2-dichloro-
ethane and chloroacetaldehyde is supported by the ability 
of CO to significantly inhibit the enhanced re-oxidation 
of cytochrome b 5 
in the presence of these two xenobiotics 
and of metyrapone to inhibit the enhanced re-oxidation of 
cytochrome b~ in the presence of l,2-dibromo-1,2-dichloro-
-J 
ethane (Table 4). Furthermore, fasting, which was without 
effect on the levels of cytochrome P-450, did not affect the 
enhanced re-oxidation of ferrocytochrome b 5 
observed in the 
presence of chloroacetaldehyde (Table 3). 
The effects of the xenobiotics on another microsomal protein, 
N-hydroxylamine oxidase were considered. It appeared that 
N-hydroxylamine oxidase is not involved in the effects of 
bromotrichloromethane, l,2-dibromo-1,2-dichloroethane and 
chloroacetaldehyde on the re--oxidation of cytochrome b 5 
because N-hydroxylamine oxidase is insensitive to cyanide 
and CO (Kadlubar et al., 1973) while the effects of these 
xenobiotics on the re-oxidation of microsomal ferrocytochrome 
b 5 are 
sensitive to cyanide and in the case of l,2-dibromo-
1,2-dichloroethane and chloroacetaldehyde, also to CO 
(Tables 2 and 4). 
Furthermore, the microsomal phospholipid desaturase and the 
microsomal acyl CoA AS- and A6-desaturases would appear to 
play no role in the enhanced oxidation of microsomal ferro-
cytochrome b 5 by the three halo xen
obiotics. The acyl CoA 
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~5-desaturase and the phospholipid desaturase are less 
sensitive to cyanide than is the re-oxidation of cytochrome 
b 5 . T
he activities of the desaturases are inhibited by 1-5 
mM cyanide while the effects of the xenobiotics on the re-
oxidation of cytochrome b 5 
are inhibited by 0,5 mM cyanide. 
Furthermore, the activity of the ~6-desaturase is not en-
hanced by refeeding a high carbohydrate diet (Inkpen et al., 
1969) which enhances the effects of bromotrichloromethane and 
l,2-dibromo-1,2-dichloroethane on microsomal electron trans-
fer (Tables 2 and 3). 
In addition to the microsomal proteins discussed above, the 
microsomal contaminant catalase may also be excluded as a 
mediator of the enhanced oxidation of microsomal ferrocyto-
chrome b 5 in the presence of t
he three halo xenobiotics. 
The K. for cyanide inhibition of catalase (approximately 
1 
8 µM) (Chance, 1952) is ten fold lower than the K. for 
1 
cyanide inhibition of the enhancement of the re-oxidation of 
cytochrome Q5 by the 
three halo xenobiotics (Table 7 and 
Figure 11) which suggests that catalase is not responsible 
for the enhanced re-oxidation of cytochrome b 5 
observed in 
the presence of these xenobiotics. 
In view of the above observations, it appeared that brorno-
trichlorornethane, l,2-dibromo-1,2-dichloroethane and chloro-
acetaldehyde at least in part, stimulate the oxidation of 
hepatic microsomal ferrocytochrome b 5 
by interacting with an 
hepatic microsomal enzyme other than those described above. 
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There are several lines of evidence to suggest that these 
xenobiotics enhance electron flow through cytochrome b 5 by 
interacting with stearate desaturase~ 
The ability of bromotrichloromethane and l,2-dibromo-1,2-
dichloroethane to shift the redox state of cytochrome b 5 
towards the ferric form of the protein and the ability of 
cyanide to inhibit this process, paralleled the dietary 
induction of stearate desaturase (Tables 2 and 3). In rats 
which had been re-fed a high carbohydrate diet to induce 
stearate desaturase, the effect of these xenobiotics on the 
re-oxidation of ferrocytochrome b 5 was enhanced,
 whereas in 
fasted rats which have decreased levels and activity of 
stearate desaturase, the effect of the xenobiotics on the 
re-oxidation of ferrocytochrome b 5 was n
ot observable 
(Oshino and Sato, 1972) (Tables 2 and 3). 
Further evidence that the xenobiotics are interacting with 
stearate desaturase is provided by the K. values for cyanide 
l 
inhibition of the enhancement of the re-oxidation of cytochrome 
b 5 by br
omotrichloromethane and l,2-dibromo-1,2-dichloroethane. 
The K. values for this effect (Table 7 and Figure 11) are in 
l 
good agreement with the K. for cyanide inhibition of stearate 
l 
desaturase (O,l mM) reported by Oshino et al.,(1966), but 
differ from the K. of 2,5 - 8 mM which has been reported for 
l 
cyanide inhibition of cytochrome P-450 (Jefcoate et al., 
1969; Correia and Mannering, 1973). The observed agreement 
in K. values provided further evidence that these two xeno-
1 
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biotics are indeed stimulating microsomal electron transfer 
by interacting with stearate desaturase. 
Although bromotrichloromethane, 1,2-dibromo-l,2-dichloro-
ethane and possibly chloroacetaldehyde appear to bind to 
stearate desaturase (see Results) none of these xenobio-
tics affect the stearate desaturase mediated conversion of 
stearoyl CoA to oleate (Table 5). This observation is 
consistent with reports that all other compounds such as 
phenols and halothane, which appear to stimulate microsomal 
electron transfer by interacting with stearate desaturase, 
also have no effect on the hepatic microsomal metabolism of 
stearoyl CoA (Oshino and Sato, 1970; Berman et al., 1975). 
The lack of effect of these xenobiotics on the conversion 
of stearoyl CoA to oleate could be because the xenobiotics 
do not bind to the active site of stearate desaturase, which 
0 0 
is a cleft 26 A long by 4 A wide (Brett et al., 1971), but 
may bind at a distinct site which differs from the substrate 
binding site. Alternatively, since stearoyl CoA binds 
extremely tightly to the active site of stearate desaturase, 
the xenobiotics may bind at the same site as stearoyl CoA, 
but may not be able to displace stearoyl CoA. In either 
case, the binding of the xenobiotics to stearate desaturase 
might not affect the activity of the enzyme. 
The two alternatives regarding the position on the C.S.F. 
at which these xenobiotics bind may be distinguished by the 
following means : if the two compounds bind at the same site, 
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at an equivalent value of [concentration], each would be 
K 
expected to interfere with the binding of the other. Thus, 
the xenobiotic under these circumstances would be expected 
to decrease the conversion of stearoyl CoA to oleate and 
conversely, stearoyl CoA would be expected to decrease the 
xenobiotic mediated stimulation of microsomal electron 
transfer. 
Therefore, using the following values 
K for stearoyl CoA = 17 µM (Oshino et al., 1966) 
m 
[ Stearoyl CoA J = 40 µM (Oshino et al., 1966) 
K for bromotrichloromethane = 2,2 mM (see Results) eq 
[Bromotrichloromethane] = 3,4 mM (see Results)* 
It can be calculated that: 
[stearoyl CoA] 40 µM 




[Bromotrichloromethane] 3,4 mM 
K 2,2 mM 
eq 
The ratio of these two values is 1,5 : 1. Therefore, under 
the experimental conditions used in this work, approximately a 
* These concentrations of xenobiotics were the highest which 
would not disrupt the microsomal suspension. Therefore, it 
was not possible to conduct experiments using higher con-
centrations of the xenobiotics for less equivocal results. 
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40% decrease in the conversion of stearoyl CoA to oleate 
should be observed in the presence of bromotrichloromethane. 
However, no inhibition was observed (S.D. ~ 2%) (Table 5), 
indicating that bromotrichloromethane binds to a site dis-
tinct from the binding site of stearoyl CoA. 
Similar calculations for l,2-dibromo-1,2-dichloroethane 
using 
K for 1,2-dibromo-l,2-dichloroethane = 0,46 mM (see Results) eq 
and [1, 2-dibromo-l, 2-dichloroethane] = 0, 6 mM (see Results)* 
give a ratio of 1,8 : 1 which suggests that 35% inhibition 
of the conversion of stearoyl CoA to oleate should be ob-
served in the presence of l,2-dibromo-1,2-dichloroethane. 
However, no inhibition was observed (S.D. ! 9%) (Table 5), 
which suggests that l,2-dibromo-1,2-dichloroethane also binds 
to a site on stearate desaturase distinct from that for 
stearoyl CoA. 
Considering all of the above evidence, with regard to the 
interaction of the xenobiotics bromotrichloromethane, l,2-
dibromo-1,2-dichloroethane and chloroacetaldehyde with 
hepatic microsomal proteins, several conclusions regarding 
the ability of these xenobiotics to interact with stearate 
desaturase may be drawn: the abilities of l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde to stimulate the re-
* 
See footnote page 223 
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oxidation of NADH reduced microsomal ferrocytochrome b 5 
appeared to arise as a consequence of enhanced electron 
flow to both cytochrome P-450 and stearate desaturase. 
Bromotrichloromethane on the other hand, appeared to stimulate 
electron flow through cytochrome hs by interacting only with 
stearate desaturase. Although all three of these xenobiotics 
appear to bind to stearate desaturase, none of them affect 
the stearate desaturase mediated conversion of stearoyl CoA to 
oleate, indicating that all three xenobiotics bind to a site on 
the enzyme distinct from the binding site of stearoyl CoA. 
The interaction of halothane, en~lurane and methoxyflurane 
with some hepatic microsomal proteins. 
Similar experiments to those performed on the xenobiotics 
were conducted using the anaesthetic agents halothane, enflu-
rane and methoxyflurane, in order to investigate in detail 
their interaction with some hepatic microsomal proteins. 
The consequences of the interaction of anaesthetic agents 
with microsomal proteins are of importance clinically, 
particularly in the case of halothane which is the most 
corrunonly used of these three anaesthetic agents and which 
has been implicated in the pathogenesis of halothane hepati-
tis (see Introduction). 
The enhanced effects of the anaesthetic agents enflurane and 
methoxyflurane on the re-oxidation of NADH reduced microsomal 
ferrocytochrome b 5 (Table 5) as well as 
their lack of effect 
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on the activity of either the NADH- or the NADPH-cytochrome 
c reductases (Table 10) suggested that these anaesthetic 
agents stimulate microsomal electron transfer by enhancing 
the oxidation of cytochrome Q5 , while not affecting its 
reduction. Enflurane was found to slightly enhance the 
activity of NADH-cytochrome c reductase, which would how-
ever not affect the rate constant for the re-oxidation of 
microsomal ferrocytochrome Qs· 
As stated above, the re-oxidation of hepatic microsomal 
ferrocytochrome b
5
, which is enhanced in the presence of 
halothane, enflurane and methoxyflurane (Berman et al., 1975) 
(Table 2) can proceed via the autoxidation of cytochrome b 5 
or via the transfer of electrons from ferrocytochrome Q5 to 
other microsomal proteins such as cytochrome P-450 or stearate 
desaturase (see Figure 7). In order to assess the effects of 
these anaesthetic agents on the autoxidation of ferrocyto-
chrome b 5 , the purified, trypsin-cleaved cytochrome b 5 was 
used. This heme peptide differs from the intact microsomal 
hemoprotein as follows the hydrophobic tail of this amphi-
pathic molecule, which attaches cytochrome b 5 to the mem-
brane, is lacking, but the hydrophilic region of the mole-
cule, which is responsible for the electron transfer functions 
of cytochrome b
5 
remains intact and active. Trypsin-cleaved 
cytochrome b 5 was chosen as a model system because it does 
not aggregate in water, as does intact cytochrome b 5 which 
has been prepared by detergent solubilization and because the 
structure of the heme crevice and the rate of autoxidation of 
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the hemoprotein are not altered by tryptic digestion of 
cytochrome b 5 (Strittmatter et al., 1972; Berman et al., 
197 5) . 
The pseudo first order rate constant for the autoxidation of 
purified trypsin-cleaved cytochrome Q
5 
(ca. 1,0 x 10 2 sec- 1 ) 
(Table 10) observed in the absence of enflurane and methoxy-
flurane was found to be similar to that reported by Berman 
et al., (1976) and by Strittmatter et al., (1972). This 
value is in good agreement with the reported first order 
rate constant for the re-oxidation of membrane bound hepatic 
microsomal ferrocytochrome br in the absence of substrates 
-::, 
for cytochrome P-450 and stearate desaturase (Boveris et al., 
1972; Berman et al., 1975) (Tables 2 and 10). Furthermore, 
neither enflurane nor methoxyflurane had any significant 
effect on the rate constant for the autoxidation of purified 
ferrocytochrome br (Table 10). In addition, the autoxidation --:, 
of ferrocytochrome Q5 is not cyanide inhibitable (Berman et 
al., 1975), but the effects of enflurane and methoxyflurane 
on hepatic microsomal electron transfer are inhibited by 
0,5 mM cyanide (Table 2). These observations therefore 
indicate that enflurane and methoxyflurane probably do not 
stimulate the autoxidation of ferrocytochrome h 5 , but may 
stimulate electron transfer from ferrocytochrome Q5 to 
another microsomal protein (see pages 214 to 215 and Figure 7). 
From several lines of evidence, it appeared that the terminal 
microsomal oxidase cytochrome P-450 is not involved in the 
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stimulation of the re-oxidation of cytochrome hs observed in 
the presence of enflurane and methoxyflurane. Prior induction 
of cytochrome P-450 by phenobarbitone, which increases the 
levels of this enzyme in hepatic microsomes by 2 - 3 fold 
(Table 11), was without affect on the stimulation of the 
re-oxidation of hepatic microsomal ferrocytochrome hs by 
enflurane and methoxyflurane (Tables 11 and 12). Furthermore, 
metyrapone and CO, which are inhibitors of cytochrome P-450, 
had no effect on the. stimulation of the re-oxidation of NADH 
reduced hepatic microsomal ferrocytochrome b 5 by halothan
e, 
enflurane or methoxyflurane (Berman et al., 1975) (Tables 8 
and 9) which suggests that cytochrome P-450 is not responsible 
for the enhanced re-oxidation observed in the presence of 
these anaesthetic agents. This proposal is supported by the 
K value for the stimulation of the re-oxidation of cytochrome eq 
hs by enflurane which differed significantly from the Ks value 
for the binding of enflurane to cytochrome P-450 (Table 14) 
and further supported by the observation that the Km for 
NADPH oxidation by cytochrome P-450 differed from the K for eq 
the re-oxidation of ferrocytochrome b 5 
in the presence of both 
enflurane and methoxyflurane (Table 14). However, the 
observed Keq for the re-oxidation of ferrocytochrome b 5 in 
the presence of methoxyflurane was identical to the K for s 
its binding to cytochrome P-450. In addition, the K. of 0,1 
1 
m.~ which has been determined for the cyanide inhibition of the 
re-oxidation of ferrocytochrome b 5 in the presence of t
he 
anaesthetic agents (see Results) differs from the Ki values 
of 2, 5 - 10 mM which · have been reported for the cyanide 
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inhibition of cytochrome P-450 (Jefcoate et al., 1969; 
Correia and Mannering, 1973), supporting the hypothesis 
that the observed effects of the anaesthetic agents on the 
re-oxidation of ferrocytochrome QS does not relate to cyto-
chrome P-450. 
Furthermore, it appears that the microsomal ~6-desaturase is 
not involved in the stimulation of microsomal electron trans-
fer by enflurane and methoxyflurane. The activity of the ~6-
desaturase is not increased by re-feeding a high carbohydrate 
diet (Inkpen et ~l., 1969) which enhances the effects of 
enflurane and methoxyflurane on the re-oxidation of ferro-
cytochrome Q5 . Furthermore, 
the 66-desaturase is unaffected 
by fasting (Inkpen et al., 1969) which eliminates the effects 
of enflurane and methoxyflurane on the re-oxidation of ferro-
cytochrome b 5 
(Tables 11 and 12). These results exclude the 
66-desaturase from being involved in the observed enhanced 
re-oxidation of microsomal ferrocytochro~e b 5 . 
It is also 
possible to exclude catalase, a microsomal contaminant, as 
being responsible for mediating the effects of enflurane and 
methoxyflurane on the re-oxidation of NADH reduced microsomal 
ferrocytochrome hs· As stated earlier (see page 220), 
although catalase is cyanide sensitive, the K. for cyanide 1 
inhibition of this enzyme is vastly different from the Ki 
for cyanide inhibition of the enhanced re-oxidation of cyto-
chrome b 5 by enflurane and methoxyfl
urane (ca. 0,1 mM). 
It appears therefore that enflurane and methoxyflurane may 
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stimulate microsomal electron transfer through cytochrome 
b 5 by accelerating the tra
nsfer of electrons to stearate 
desaturase. The magnitudes of the effects of these com-
pounds on microsomal electron transfer parallel the dietary 
induction of stearate desaturase : the re-feeding of a high 
carbohydrate diet, which elevates the levels of stearate 
desaturase, results in the enhancement of electron transfer 
in the presence of these xenobiotics, relative to the rates 
observed in microsomes from rats fed a normal diet. In 
contrast, fasting, which decreases the levels and activity 
of stearate desaturase to negligible proportions, entirely 
eliminates the effects of enflurane and methoxyflurane on 
the re-oxidation of cytochrome QS (Tables 11 and 12). 
Furthermore, the enhanced re-oxidation of cytochrome b 5 
observed in the presence of these anaesthetic agents, is 
inhibited by 0,5 mM cyanide (Table 2) as is stearate desatu-
rase (Oshino et £1., 1966; Oshino et al., 1971). 
values obtained for cyanide inhibition of the stimulation of 
electron transfer by enflurane and methoxyflurane are within 
experimental error of the K. of 0,1 mM reported by Oshino 
l 
et al., (1966) for the cyanide inhibition of the conversion 
of stearoyl CoA to oleate by stearate desaturase. Although 
it appears that enflurane and methoxyflurane affect micro-
somal electron transfer by interacting with stearate desatu-
rase and therefore probably bind to stearate desaturase 
(Table 14), these compounds do not affect the stearate desatu-
rase mediated conversion of stearoyl CoA to oleate (Table 16). 
The latter result is consistent with the ability of the 
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anaesthetic agents to bind to stearate desaturase if one pro-
poses that the anaesthetic agents are not binding at the 
active site of the enzyme. Information on the location on the 
C.S.F. at which the anaesthetic agents bind may be obtained by 
means of the calculation shown above (see page 223) for the 
xenobiotics. 
The K for stearoyl CoA = 17 µM (Oshino et al., 1966) 
m 
[stearoyl CoA] = 40 µM (Oshino et al., 1966) 
K for enflurane = 1,2 mM (see Results) 
eq 
[Enflurane] = 14 mM (see Results)* 
It can be calculated that 
[stearoyl CoA] 40 µM 
= = 2,35 and 
K m 17 µM 
[enf lurane J 14 ITu.1\/l 
= = 11, 7 
K 1,2 mM eq 
The ratio of these two values is 0,2 : 1 which suggests that 
approximately 80% inhibition of the conversion of stearoyl 
+ CoA should be observed. However, no inhibition (S.D. - 30%) 
was observed (Table 16) which indicates that as in the case 
of the xenobiotics, enflurane does not bind to the same site 
·'· 
on stearate desaturase as does stearoyl CoA;. 
Similar calculations for methoxyflurane using K for eq 
methoxyflurane = 0,48 mM (see Results) and [methoxyflurane] = 
* 
t 
See footnote page 223 
This proposal is further supported by the observation that 
stearoyl CoA does not inhibit the production of hydrogen 
peroxide by the anaesthetic agents (Manca, V., Unpublished 
observations). 
* 0,6 mM (see Results) 
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give a ratio of 1,9 : 1 which suggests that approximately 
30% inhibition of the conversion of stearoyl CoA to oleate 
should be observed. However, no inhibition was observed 
(Table 16), but the large standard deviations obtained make 
the case regarding methoxyflurane less clear than that 
of enflurane. However, in line with the results obtained 
for the other xenobiotics, it is possible that methoxyflu-
rane also binds at a site on stearate desaturase distinct 
from that of stearoyl CoA. 
The observation that enflurane and methoxyflurane appear to 
bind to stearate desaturase, but do not affect the enzyme's 
function is consistent with the observation that the halo-
genated alkanes bromotrichloromethane, l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde which also bind to 
stearate desaturase (Table 6 and Figures 9 and 10) do not 
affect the conversion of stearoyl CoA to oleate (Table 5). 
It has furthermore been shown by Berman et al., (1975) and 
Oshino and Sato (1971) that halothane and Q-cresol respec-
tively, interact with stearate desaturase, but do not inhibit 
the activity of stearate desaturase. 
Considering all of the above evidence with regard to the 
interaction of the anaesthetic agents halothane, enflurane 
and methoxyflurane with hepatic microsomal proteins, it 
appears that the ability of the anaesthetic agents to enhance 
the re-oxidation of microsomal ferrocytochrome b 5 results 
* See footnote page 223 
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from enhanced electron flow through cytochrome b 5 to 
stearate desaturase, by virtue of the ability of the anaes-
thetic agents to interact with the C.S.F. of stearate desatu-
rase. It has been previously demonstrated by Berman et al., 
(1975) that halothane enhanced electron flow through micro-
so~al ferrocytochrome b 5 by interacting with ste
arate desatu-
rase. The results reported in this thesis confirm and 
extend this observation and demonstrate that enflurane and 
methoxyflurane also enhance electron flow through microsomal 
ferrocytochroDe hs apparently as a consequence of their inter-
action with stearate desaturase. Although all three of the 
anaesthetic agents appear to bind to stearate desaturase, 
none of them affect the conversion of stearoyl CoA to oleate 
suggesting that they do not bind to the same site on stearate 
desaturase as does stearoyl CoA. 
The metabolism of anaesthetic agents by heoatic microsomal 
stearate desaturase and the uncoupling of the stearate 
desaturase enzyme ~ystem. 
It was attempted to elucidate how the reducing equivalents 
from the enhanced electron flow arising from the interaction 
of the anaesthetic agents with hepatic microsomal stearate 
desaturase are utilized. The question was asked whether 
these reducing equivalents are utilized in the metabolism of 
these anaesthetic agents by stearate desaturase. A second 
question concerned whether or not the anaesthetic agents 
might stimulate the transfer of these reducing equivalents 
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to oxygen viz. essentially by uncoupling the stearate 
desaturase enzyme system. 
A major problem in assessing these alternatives is the 
presence in hepatic microsomes of cytochrome P-450, a 
major drug metabolizing enzyme which has been shown to 
catalyze the first step in the metabolism of halothane 
(Van Dyke, 1966; Karashima et al., 1977), methoxyflurane 
and enflurane (Mazze et al., 1971; Harrison et al., 1976; 
Ivanetich et al., 1979) (see Fj_gures 3, 4, 5 and 6) and 
which is also known to give rise to reduced oxygen species, 
such as hydrogen peroxide and superoxide anion (Hildebrandt 
et al., 1973; Bartoli et al., 1977). Investigation of the 
metabolism of xenobiotics by hepatic microsomal stearate 
desaturase or their stimulation of oxygen reduction by 
stearate desaturase would be hampered therefore by the 
presence of cytochrome P-450. Therefore to investigate 
the fate of the reducing equivalents from the proposed 
interaction of xenobiotics with hepatic microsomal stearate 
desaturase, systems deficient in cytochrome P-450 were 
employed. 
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A two-fold approach was adopted to achieve this goal. 
Firstly, the C.S.F. of stearate desaturase, cytochrome h5 
and NADH-cytochrome hs reductase were isolated from the 
hepatic endoplasmic reticulum by detergent solubilization, 
and the stearate desaturase enzyme system was reconstituted 
in vitro in the absence of cytochrome P-450 activity. The 
second approach was to employ hepatic microsomes obtained 
from animals wi tl:1 elevated levels of stearate desaturase and 
to chemically treat the microsomes in order to greatly reduce 
or entirely eliminate the levels and activity of cytochrome 
P-450. 
The first system used was the reconstituted stearate desatu-
rase enzyme system in vitro. This system was capable of 
supporting the stearate desaturase mediated conversion of 
stearoyl CoA to oleate. The activity of this reconstituted 
system (1,50 and 3,50 nmoles oleate formed/min/mg C.S.F. 
protein) exceeded that achieved by Shimakata et al., (1972), 
when corrected for slightly different experimental conditions, 
by a factor of 3 - 6 fold. Although the stearate desaturase 
enzyme system requires phospholipid, no added exogenous 
phospholipid was required for an active reconstituted enzyme 
system (see Results). Presumably the C.S.F. and reductase 
fractions contain contaminating phospholipid, sufficient to 
satisfy the lipid requirement of the reconstituted desaturase 
system as was reported by Shimakata et al. , ( 197 2) . 
The observation that the anaesthetic agents had no effect on 
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the conversion of stearoyl CoA to oleate in the reconstituted 
system (Table 17) is consistent with their lack of effect on 
this reaction in hepatic microsomes (Table 16). This 
observation, together with the functionality of the re-
constituted enzyme system validated the use of the recon-
stituted system for the investigations of the fate of the 
reducing equivalents from the interaction of the anaesthetic 
agents with stearate desaturase. 
The second experimental approach involved hepatic microsomes 
containing stearate desaturase activity, but devoid of 
cytochrome P-450 content. Such a system had not been pre-
viously described in the literature. Therefore, various 
physical and chemical methods were utilized in an attempt to 
achieve this end. It was anticipated that achieving this 
goal would be difficult due to the complex inter-relation-
ships existing between proteins situated in the endoplasmic 
reticulum, and in fact, several initial attempts to achieve 
this goal were unsuccessful. 
These difficulties are exemplified by the results of the 
investigations of the effect of storing hepatic microsomes 
on the levels of cytochrome P-450 and the activity of stearate 
desaturase. Storage of the hepatic microsomes at 4°c (Table 
18) completely eliminated stearate desaturase activity as 
judged indirectly by the re-oxidation of cytochrome b
5 
while 
cytochrome P-450 levels were reduced to one third of control 
values, indicating that both proteins have been deleteriously 
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affected by the storage treatment, although stearate desatu-
rase to a greater extent than cytochrome P-450. 
Chemical modification of cytochrome P-450 was attempted with 
various chemicals which were chosen on the basis of reports 
that they can decrease the activity of cytochrome P-450 in 
hepatic microsomes (Imai and Sato, 1967; Ichikawa et al., 
1968) although their effects on hepatic microsomal stearate 
desaturase activity were not known. 
Dioxane has been shown to be particularly effective at 
eliminating cytochrome P-450 activity in hepatic microsomes 
(Ichikawa et al_., 1968). Incubation of the hepatic micro-
somes in the presence of dioxane reduced the cytochrome P-450 
content of the hepatic microsomes apparently by degrading the 
heme moeity of the enzyme, as the heme loss to cytochrome 
P-450 loss was in the ratio of 1 : 1 (Table 20) while 
stearate desaturase activity was only slightly reduced 
(Table 19). In an attempt to decrease the cytochrome P-450 
content to negligible levels, an increased concentration of 
dioxane was used. This however also failed to eliminate 
completely cytochrome P-450, as thirty per cent still 
remained, while stearate desaturase activity was drastically 
decreased. 
The demonstration that dioxane affects the heme of cytochrome 
P-450 is contrary to the proposal of Ichikawa et al., (1968) 
that dioxane converts cytochrome P-450 to cytochrome P-420. 
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Iso-butanol (added during the isolation of the hepatic 
microsomes), had similar effects on the proteins of the 
endoplasmic reticulum to dioxane : namely at lower concen-
trations of the chemical, the activity of stearate desatu-
rase was unaffected, while the levels of cytochrome P-450 
were significantly lowered, but not completely eliminated 
(Tables 21 and 22). Increasing the concentration of iso-
butanol lowered the cytochrome P-450 content further, but 
also did not completely eliminate it. In this case 
apparently by converting cytochrome P-450 to cytochrome 
P-420 as previously suggested by Ichikawa et al., (1968). 
The activity of the stearate desaturase enzyme system in 
the presence of 20% v/v iso-butanol was still 50% of that 
seen in untreated microsomes. 
Sodium iodide (when added during the isolation of the hepatic 
microsomes) appeared to be a most successful chemical for 
retaining the stearate desaturase activity while reducing 
cytochrome P-450 levels (Tables 21 and 22). However, it 
was impractical to pursue this observation because sodium 
iodide solubilized the microsomes. 
Of the chemical treatments employed to diminish cytochrome 
P-450 levels without greatly affecting the activity of 
stearate desaturase, iodomethane and potassium thiocyanate 
were the most effective. The levels of cytochrome P-450 
were essentially reduced to zero by iodomethane treatment 
and this was accompanied by decreased activity of the cyto-
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chrome P-450 mediated demethylation of 2-nitroanisole and 
hydroxylation of benzpyrene (Table 24). The decrease in 
cytochrome P-450 levels by this che~ical appeared to be 
due to degradation of the heme moeity of the enzyme because 
the level of the other microsomal he~oprotein - cytochrome 
hs - was not depleted by this chemical and the loss of cyto-
chrome P-450 (0,90 nmoles/mg microso~al protein) was com-
parable to the loss of microsomal he~e (0,72 nmoles/mg 
microsomal protein) (Ivanetich et al., 1978) (Table 24). 
Although stearate desaturase activity, as assessed by the 
re-oxidation of ferrocytochrome Q
5
, appeared to be entirely 
eliminated by iodomethane (Table 23), when stearate desatu-
rase activity was assessed via the conversion of stearoyl 
CoA to oleate, 50% of the activity re::nained when compared 
to control values (Table 23). It is anticipated therefore 
that the re-oxidation of microsomal cytochrome b 5 in the 
presence of iodomethane may not accurately assess the 
activity of the stearate desaturase enzyme system, possibly 
because iodomethane enhances electron flrnv through cytochrome 
b 5 in the absence of added compounc.s (Table 23) (see page 117). 
In any case, the ratio of oleate obtained in the 
oleate + stearate 
iodomethane treated microsomes was far greater than that 
obtained with the reconstituted stearate desaturase system 
(comoare with Table 17). Since the chemically treated micro-
somal system had greater stearate desaturase activity than 
the reconstituted system, it was anticipated that it might be 
preferable to assess the fate of the reducing equivalents from 
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the proposed interaction of the anaesthetic agents with 
stearate desaturase using the chemically treated microsomes 
than using the reconstituted enzyme system. 
An identical pattern to that observed with iodomethane 
treated microsomes emerged for microsomes treated with 
potassium thiocyanate. There was a significant decrease in 
the content and activity of cytochrome P-450 (Table 25) 
which appeared to be due in part to the degradation of the 
heme moiety of the cytochrome : comparison of the loss of 
microsomal heme (0,56 nmoles/mg microsomal protein) to the 
loss of cytochrome P-450 (0,92 nmoles/mg microsomal protein) 
(Table 25) observed in the presence of potassium thiocyanate 
implied that the degradation of cytochrome P-450 in part 
reflects an alteration of the heme moeity of the enzyme. 
This is supported by the observation that as with iodo-
methane treated microsomes, no decrease in cytochrome b 5 was 
detected following potassium thiocyanate treatment. In 
addition, potassium thiocyanate converted cytochrome P-450 
to cytochrome P-420 as was previously reported by Imai and 
Sato (1967). Potassium thiocyanate also lowered stearate 
desaturase activity by approximately 30% (Table 23) as 
assessed by the re-oxidation of hepatic microsomal ferro-
cytochrome hs· When assessed via the conversion of stearoyl 
CoA to oleate, the activity of stearate desaturase was 
lowered by a comparable amount (approximately 20%). The 
activity of stearate desaturase in this microsomal prepara-
tion was more active than that in iodomethane treated micro-
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somes and a further advantage is that microsomal electron 
transfer was not interrupted by potassium thiocyanate as 
is observed in microsomes treated with iodomethane. 
On the basis of the above results of the investigations of 
various chemical treatments of hepatic microsomes, iodo-
methane and potassium thiocyanate treated microsomes were 
chosen to be utilized as a source of stearate desaturase 
activity, but negligible cytochrome P-450 activity. The 
chemically treated microsomes in fact, possessed far greater 
stearate desaturase activity than did the reconstituted 
stearate desaturase enzyme system (Tables 17 and 23). The 
interaction of xenobiotics with cytochrome P-450 in the 
chemically treated microsomes or the reconstituted stearate 
desaturase enzyme system, can be regarded as negligible 
as a consequence of the low cytochrome P-450 content and 
activity of both of these preparations. 
Confirmation that cytochrome P-450 is not operative in the 
metabolism of the anaesthetic agents in the microsomal 
systems described above may be obtained as follows :-
It has been observed by Ivanetich et al., (1979) that 1,0 
nmole cytochrome P-450/mg microsomal protein gave rise to 
0,5 nmoles/fluoride ion produced from methoxyflurane/mg 
microsomal protein/min. The average concentration of cyto-
chrome P-450 present in the hepatic microsomes treated with 
iodomethane or potassium thiocyanate was 0,05 nmoles cyto-
chrome P-450/mg microsomal protein (Tables 24 and 25). 
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Therefore, by analogy 
0,05 nmoles cytochrome P-450/mg 
microsomal protein 
1,0 nmole cytochrome P-450/mg 
microsomal protein 
= 
x nmoles fluoride ion 
produced/mg protein/min 
0,5 nmoles fluoride ion 
produced/mg protein/min 
x = 0,025 nmoles fluoride ion produced/mg microsomal protein/min. 
This value is far below the limit of detection for fluoride 
ion and therefore confirms that the cytochrome P-450 depen-
dent metabolism of enflurane and methoxyflurane will not be 
measured in these hepatic microsomes. 
These systems were therefore chosen as those best suited to 
assess the ability of the stearate desaturase enzyme system 
to metabolize the anaesthetic agents halothane, enflurane 
and methoxyflurane. 
The metabolism of anaesthetic agents by stearate desaturase. 
The enzymatic metabolism of the anaesthetic agents halothane, 
enflurane and methoxyflurane could result in the production 
of volatile metabolites such as haloalcohols or non-volatile 
metabolites such as halo ions (fluoride, chloride or bromide 
or halo carboxylic acids I (see Figures 3, 4, 5 and 6). Using 
the experimental systems described above, the possible produc-
tion of any of these metabolites from the anaesthetic agents 
by stearate desaturase was sought. 
From the results of these investigations, it appeared that 
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the anaesthetic agents halothane, enflurane and methoxy-
flurane are not metabolized by hepatic microsomal stearate 
desaturase. In both experimental systeras, i.e. the recon-
stituted and microsomal systems described above, it was not 
possible to detect measurable amounts of any volatile or 
non-volatile metabolites of halothane, enflurane or methoxy-
flurane. 
No ~easurable levels of fluoride ion or acid-labile fluorine 
compounds were produced in either the reconstituted or micro-
somal systems from any of the anaesthetic agents by stearate 
desaturase (see Results). Although the carbon-fluoride bond 
has an energy of 107 KcaVmole which is greater than the carbon-
bromine, carbon-chlorine or carbon-hydrogen bonds, and 
energetically fluoride ion is the least likely of the halogens 
to be cleaved from any halogenated an2esthetic agents, there 
is virtually no way that enflurane or sethoxyflurane could b~ 
metabolized without the release of fluoride ion (see Figures 
5 and 6) . In fact, halothane, enflura~e and ~ethoxyflura~e 
are all known to be defluorinated in ';ivo, as measured by 
urinary fluoride ion excretion in hu~ans exposed to these 
anaesthetic agents although the rate of defluorination of 
halothane and enflurane is far lower than that of methoxy-
flurane (Rehder et al., 1967; Chase et al., 1971; Cousins 
et al., 1976; Holaday et al., 1970; Fry et al., 1973; 
Greenstein et al., 1975). 
An acid labile fluorinated metabolite is known to be produced 
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from methoxyflurane by cytochrome P-450 in vitro and in vivo 
(Holaday et al., 1970; Ivanetich et al., 1979). This com-
pound is thought to be methoxydifluoroacetic acid (see 
Figure 6) (Mazze et al., 1971) . An analagous compound viz. 
chlorofluoroacetic acid may also be produced from enflurane 
(see Figure 5) (Cousins and Mazze, 1974). However, in 
general, no acid-labile fluorine compounds are produced from 
the interaction of halothane, enflurane or methoxyflurane 
with stearate desaturase and therefore specifically methoxy-
difluoroacetic acid and difluorornethoxy difluoroacetic acid are 
not produced by this interaction. 
No measurable levels of bromide could be detected on incu-
bating halothane with either the reconstituted or microsomal 
systems (see Results) which indicated that stearate desatu-
rase does not remove bromide ions from halothane. Bromide 
ions are, however, known in vivo metabolites of halothane 
from the cytochrome P-450 enzyme system (Stier et al., 1964). 
Van Dyke and Chenoweth (1965) have shown that the carbon-
bromide bond of the halothane molecule is broken enzymatically 
and the debromination and dechlorination of halothane gives 
rise to the major oxidative metabolite, trifluoroacetic acid 
in vivo (Van Dyke and Chenoweth, 1965; Rehder et al., 1967). 
No volatile products of halothane were measurable following 
its interaction with stearate desaturase in either the recon-
stituted or microsomal systems. Among the volatile compounds 
assessed were several recently identified metabolites of 
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halothane from the action of cytochrome P-450 in vivo. 
These metabolites include 2-chloro-1,1-difluoroethylene 
and 2-chloro-l,l,l-trifluoroethane and 1,1-difluoro-2-
brorno-2-chloroethylene and haloalcohols (such as the pro-
posed metabolite 2, 2, 2-trif luoroethanol) (Maiorino et al., 
1979; Mukai et: al., 1977 and Sharp et al., 1979) (Figure 4). 
No volatile metabolites appeared to be produced from enflu-
rane or methoxyflurane by the action of stearate desaturase, 
using either the reconstituted or microsomal enzymes. In 
contrast to halothane, there are no known cytochrome P-450 
mediated volatile metabolites of either enflurane or methoxy-
flurane although several of the proposed intermediates in 
the metabolic pathways for enflurane and methoxyflurane are 
haloalcohols which would be volatile. Examples are 2-chloro-
l,l,2-trifluoroethanol from enflurane and 2,2-dichloro-1,1-
difluoroethanol from methoxyflurane (see Figures 5 and 6). 
Neither of these intermediates have been identified as yet, 
and no unknown peaks were seen on gas liquid chromatography 
columns specific for haloalcohols (see Results). 
The production of non-volatile metabolites of halothane, such 
as trifluoroacetic acid which is known to be produced by the 
cytochrome P-450 mediated metabolism of halothane in vivo 
(Cohen et al., 1975), was assessed. As may be seen in Table 
27, no non-volatile metabolites of halothane could be detected 
using 14c-halothane and the microsomal systems. There is 
therefore no support that stearate desaturase can chemically 
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transform halothane into non-volatile, polar metabolites 
such as the carboxylic acid, trifluoroacetic acid. 
Further support for the proposal that the anaesthetic agents 
are not metabolized by stearate desaturase can be obtained 
by a comparison of the rate of re-oxidation of microsomal 
ferrocytochrome Q5 and the c
alculated maximum rate of meta-
bolite production from halothane, enflurane and methoxyflurane 
in both the reconstituted stearate desaturase enzyme system 
and the microsomal systems treated with iodomethane or 
potassium thiocyanate. 
The rate of re-oxidation of cytochrome b 5 
may be represented 
as follows 
V cytochrome b,.. 
re-oxidat.io;:J 
since the re-oxidation of cytochrome b 5 i
s a pseudo first-
constant for 
order reaction. The rate " re-oxidation of cytochrome Q5 
(kobs) in the absence of added substrates for cytochrome 
P-450 and stearate desaturase in hepatic microsomes or for 
autoxidation of purified cytochrome b 5 is a
pproximately 
1 x 10- 2 sec- 1 (Table 2) (Berman et al., 1975; 1976) and in 
the presence of halothane, enflurane or methoxyflurane, the 
rate constant for the re-oxidation of cytochrome b 5 is 
approximately 3 x 10- 2 sec- 1 (Table 2). The rate of re-
oxidation of cytochrome Q5 due to




to stearate desaturase is therefore 
approximately 3 x 10- 2 sec- 1 minus 1 x 10- 2 sec- 1 , or 
2 x 10- 2 sec- 1 in hepatic microsow.es from rats fed a high 
carbohydrate diet. The concentration of cytochrome b
5 
in 






= 2 X 10- 2 
sec 
J O, 4 nmoles lj 
L mg protein 
= 8 x 10- 3 nmoles/mg microsomal 
protein/sec 
= 0,48 nmoles/mg microsomal 
protein/min. 
Based on the assumption that the rate of electron transfer 
from cytochrome b 5 is approximately equal to the rate of 
electron transfer to stearate desaturase and fu=ther assuming 
that the rate of electron transfer to stearate desaturase is 
equivalent to the rate of metabolite production from the 
anaesthetic agents, the rate of re-oxidation of cytochrome hs 
can be described as follows : 
vcytochrome b 5 re-oxidation~ vmetabolite production, 
if 
the electron transfer through cytochrome b
5 
involves a free 
radical. However, if the metabolism of the anaesthetic 
agents requires an electron pair, then 
2V = V cytochrome b 5 re-oxidation~ metabolite production. 
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The maximum rate of metabolite production from the rate 
of halo ion production may be assessed as follows : 
vmetabolite 
production 
= VF_ d t· ~ 10 µM/40 min, and pro uc ion . 
V = V . < 10 µM/ 4 0 :min metabolite Br- production~ 
production 
(the lower limit of detection of these assays for fluoride 
and bromide ion was 10 µM). v is linear over 40 min. 
metabolite 
production 
Therefore, for fluoride ion production from halothane, 
enflurane and methoxyflurane, the maximum amount of meta-
bolite expected to be produced is 
~ 10 nmoles/1,5 mg protein/40 min or 
~ 0,17 nmoles/mg protein/min 
For bromide ion production from halothane, the maximum rate 
of metabolism would be : 
~ 10 nmoles/1, 5 mg protein/ 40 min or 
~ 0,17 nmoles/mg protein/min. 
The maximum possible rates obtained for the metabolism of 
the anaesthetic agents (0,17 nmoles/mg/min) are approximately 
3 fold lower than the rate for metabolite production calcu-
lated on the basis of the extent of electron transfer, 
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(0,48 nmoles/mg/min) supporting the proposal described 
above that the stearate desaturase enzyme system does not 
appreciably metabolize the anaesthetic agents. 
In conclusion therefore, there is no evidence for the release 
of halogen ions or for the production of volatile or non-
volatile metabolites from the interaction of halothane, 
enflurane or raethoxyflurane with stearate desaturase, in 
either the reconstituted stearate desaturase enzyme system 
or in hepatic microsomes treated with chemicals to decrease 
cytochrorri<2 P--450 content and activity in vitro. The lack of 
production of metabolites from these compounds together with 
the enhanced electron flow through cytochrome b 5 observed in 
the presence of these xenobiotics (Table 2) and their apparent 
ability to bind to stearate desaturase (Tables l, 2, 13 and 
14) suggests that the anaesthetic agents may stimulate the 
transfer of electrons from NADE via stearate desaturase to 
oxygen, i.e. these xenobiotics ~ight uncouple the stearate 
desaturase enzyme system in hepatic microsomes. It is there-
fore anticipated that bromotrichloronethane, l,2-dibromo-1,2-
dichloroethane and chloroacetaldehyde, which enhance electron 
transfer via stearate desaturase nav also have similar effects. 
I -
The uncouDling of the stearate desaturase enzyme system by 
anaesthetic agents. 
Uncoupling refers to the enhanced flow of electrons through 
an enzyme system to oxygen, without the metabolism of the 
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compound stimulating electron flow. An alternative definition 
of uncoupling is a situation in which mono-oxygenases display 
oxidase activity, rather than oxygenase activity (White, 
Stevens and Kamin, 1970; Ullrich and Diehl, 1971). Compounds 
which cause uncoupling appear to stimulate oxygen uptake due 
to the formation of an enzyme-substrate complex, but these 
compounds are unable to incorporate the active oxygen atom, 
as a consequence of their cheDical structure (Staudt et al., 
1974). Up to the present time, cytochrome P-450 has been the 
only microsomal enzyme shown to be uncoupled. The classic 
uncoupler of cytochrome P-450 is perfluorohexane which forms 
an enzyme-substrate complex with cytochrome P-450 : No meta-
bolites are formed from perfluorohexane although two moles of 
NADPH are oxidized per mole of oxygen utilized (Ullrich and 
Diehl, 1971; Staudt et al., 1974). In general, in the 
presence of uncouplers, electrons from NADPH are utilized in 
the reduction of oxygen to hydrogen peroxide. Partial uncoup-
ling of cytochrome P-450 occurs in the presence of n-hexane, 
aminopyrene and several other compounds (Hildebrandt et al., 
1973; Staudt et al., 1974). It was anticipated that some 
xenobiotics might fully or partially uncouple the stearate 
desaturase enzyme system just as perfluorohexane and n-hexane 
uncouple the cytochrome P-450 enzyme system because some xeno-
biotics and anaesthetic agents stimulate electron flow, 
apparently without being metabolized. 
Therefore, the ability of selected xenobiotics and anaesthetic 
agents to stimulate electron transfer through cytochrome QS 
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and stearate desaturase (Table 2) to oxygen was assessed. 
The reduction of oxygen can result in the production of 
"activated" oxygen species such as hydrogen peroxide,or 
superoxide anion. A further "activated" oxygen species, 
viz. singlet oxygen,can be formed non-enzymatically from 
superoxide. 
There is precedent for the production of both hydrogen per-
oxide and superoxide in hepatic microsomes for example, the 
autoxidation of hepatic microscmal cytochrome hs generates 
superoxide anion (Berman et al., 1976) as does cytochrome 
P-450 hydroxylation reactions (Strobel and Coon, 1971) while 
the partial or full uncoupling of mixed function oxidation 
reactions in hepatic microsomes gives rise to hydrogen 
peroxide (Estabrook et al., 1968; Hildebrandt et al., 1973; 
Bartoli et al., 1977). 
Singlet oxygen ( 1o2 ) differs from hydrogen peroxide and super-
oxide in that the oxygen molecule is in an excited electronic 
state rather than in a reduced state of molecular oxygen 
(Politzer et al., 1971). Singlet oxygen (
1o
2
) differs from 
ground state molecular oxygen ( 3o2 ) in the distribution of 
the two highest-energy electrons in the pi molecular orbitals. 
The "activated" oxygen species described above which may be 
produced in hepatic microsomes are interconvertible due to 
the action of enzymes such as superoxide dismutase and cata-
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1 lase and via the non-enzymic production of o2 . For example, 
superoxide (o
2
~) can dismute enzymatically via superoxide 
dismutase as follows 
Superoxide can also dismutate non-enzymically with the pro-
duction of singlet oxygen as follows : 
H2o2 produced from these or other reactions may be degraded 
by the action of catalase to produce two molecules of water 
and a molecule of oxygen: 
Because of these interconversions, it was attempted to measure 
as many of the active oxygen species as possible. It was 
however not possible to assay the production of singlet oxygen 
in hepatic microsomes in the presence of the anaesthetic agents. 
Various chemical trapping agents such as 1,3-diphenylisobenzo-
furan and 2,5-diphenylfuran have been employed to monitor the 
formation of singlet oxygen (Piatt and O'Brien, 1979). These 
experiemnts have been conducted in closed, clearly defined 
systems. It is not possible to employ these trapping agents 
in microsomal systems as their sensitivity to autoxidation by 
ground state singlet oxygen in the presence of free radical 
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initiators renders them unsuitable in a system as complex 
as the microsomes (see Fee and Valentine, 1977). 
Superoxide anion was not produced in hepatic microsomes from 
rats fed a high carbohydrate diet in the presence of the 
anaesthetic agents (Table 32). 
Under certain experimental conditions, hydrogen peroxide was 
produced in hepatic microsomes in the absence and presence 
of the xenobiotics. The production of hydrogen peroxide in 
hepatic microsomes in the absence of xenobiotics, but in the 
presence of NADH is in the order of 
microsomes treated with iodomethane > 
microsomes treated with potassium thiocyanate> 
untreated microsomes. 
This same order of reactivity is observed in the re-oxidation 
of cytochrome Q5 in the absence of the xenobiotics, suggesting 
that the enhanced electron flow seen in the microsomes treated 
with these chemicals in the absence of added xenobiotics 
results from the transfer of electrons from NADH via cyto-
chrome Q5 to oxygen to produce hydrogen peroxide. If 
electrons from NADE are passed through cytochrome b 5 directly 
or indirectly to oxygen to form hydrogen peroxide, it would 
be expected that two molecules of cytochrome b 5 would have to 
be re-oxidized to produce one molecule of hydrogen peroxide. 
As expected, twice the rate of cytochrome Q5 re-oxidation was 
approximately equivalent to the rate of production of hydrogen 
peroxide for untreated,iodomethane or potassium thiocyanate 





































































































































































































































































































































































































































































































Therefore, reducing equivalents from cytochrome h5 appear 
to be transferred to oxygen to give rise to hydrogen peroxide 
in the absence of xenobiotics. This process may reflect a 
direct transfer of electrons from cytochrome h 5 to oxygen 
via an autoxidation reaction, or may involve the transfer 
of electrons fro~ cytochrom€ h5 to oxygen via a terminal 
oxidase. 
Since the rate of re-oxidation of cytochrome h5 in untreated 
microsomes in the absence of added xenobiotics is approxi-
mately equal to the rate of autoxidation of purified, ferro-
cytochrome h5 (see Berman et al., 1975; 1976 and references 
therein), it appears that the re-oxidation of cytochrome h5 
in these microsomes reflects an autoxidation reaction. 
Therefore, it appears that the autoxidation of cytochrome b 5 
in these microsomes gives rise to hydrogen peroxide. Since 
the autoxidation of purified cytochrome b 5 
has been reported 
to produce superoxide (Berman et al., 1976) it is possible 
that superoxide is an intermediate in the production of 
hydrogen peroxide, from the autoxidation of cytochrome b 5 in 
these microsomes. 
In the case of microsomes treated with iodomethane and 
potassium thiocyanate, the hydrogen peroxide produced could 
represent the enhanced autoxidation of cytochrome b 5 or a 
stimulation of the transfer of electrons from cytochrome hs 
to oxygen via one or more terminal oxidases. At present, 
these possiblities have not been distinguished. 
256 
In the presence of the halogenated xenobiotics bromotrichloro-
methane and chloroacetaldehyde, the production of hydrogen 
peroxide was increased while the production of hydrogen 
peroxide in the presence of l,2-dibromo-1,2-dichloroethane 
was not elevated in hepatic microsomes from rats fed a high 
carbohydrate diet and treated with iodomethane (Table 28). 
The anaesthetic agents halothane, enflurane and methoxyflurane 
significantly increased the production of hydrogen peroxide in 
microsomes from rats fed a high carbohydrate diet, pretreated 
or not with iodornethane or potassium thiocyanate (Tables 29, 
30 and 31). These increases in hydrogen peroxide production 
were significantly higher than those observed in the presence 
of NADH alone or the anaesthetic agents alone. The lack of 
metabolites of the anaesthetic agents produced, together with 
the elevated levels of hydrogen peroxide observed in the 
presence of the anaesthetic agents suggests that the anaes-
thetic agents stimulate electron transfer to oxygen. This 
may reflect a non-enzymatic process such as autoxidation of 
cytochrome hs or the uncoupling of one or more microsomal 
terminal oxidases. 
Autoxidation can be eliminated as being responsible for the 
production of hydrogen peroxide inasmuch as the enhanced 
electron flow through cytochrome b 5 is cyanide inhibitable 
whereas the autoxidation of cytochrome b 5 is not affected by 
cyanide (Berman et al., 1975; 1976). 
It would appear that a non-enzymic process such as that 
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proposed by Holtzman (1980) for nitrobenzofuran is not 
II II 
operative in the production of activated oxygen species in 
hepatic rnicrosomes in the presence of the anaesthetic agents. 
Holtzman (1980) has suggested that certain compounds such as 
5-nitrofuran may be reduced by NADPH-cytochrome P-450 
reductase and then react non-enzymatically with oxygen to 








This produces a cyclic effect, with the concomitant produc-
tion of superoxide and hydrogen peroxide. However, this 
mechanism is probably not operative in the case of the anaes-
thetic agents as the anaesthetic agents are not able to 
provide stable free radical intermediates in the same way 
that, for instance, 5-nitrofuran can. 
A role for cytochrome P-450 in the production of hydrogen 
peroxide in the presence of the anaesthetic agents can be 
eliminated because the hydrogen peroxide production is not 
diminished in the hepatic microsomes which have no residual 
cytochrome P-450 levels or activity (Tables 30 and 31). 
That cytochrome P-450 is not involved in the hydrogen 
peroxide production by the anaesthetic agents is supported 
by the observation that CO: o2 (80 : 20 v/v) does not 
diminish hydrogen peroxide production in hepatic microsomes 
from rats fed a high carbohydrate diet (Manca, V., Unpublished 
observations). 
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It appears therefore that the hydrogen peroxide produced in 
the presence of the anaesthetic agents could result from 
interaction of anaesthetic agents with stearate desaturase. 
This proposal arises from the observation that the enhanced 
electron flow through cytochrome b 5 observed in the presence 
of the anaesthetic agents is cyanide sensitive and presumably 
these electrons give rise to the production of hydrogen 
peroxide. It was however not possible to monitor the effects 
of cyanide on the production of hydrogen peroxide by hepatic 
microsomes in the presence of the xenobiotics because cyanide 
interferes with the hydrogen peroxide assay that was used and 
with every other known assay for this active oxygen species 
(Orrenius, 1980). The definitive experiment in establishing 
this hypothesis would be to assess the production of hydrogen 
peroxide in the reconstituted stearate desaturase enzyme 
system. 
Although hydrogen peroxide has been proposed to be produced 
during cytochrome P-450 catalyzed reactions (Hildebrandt 
et al., 1973), hydrogen peroxide has not been proposed to 
be produced during stearate desaturase mediated reactions. 
The observation that the presence of stearoyl CoA does not 
lead to an increase in hydrogen peroxide production (Manca, 
V., Unpublished observations) supports this proposal and 
suggests that the hydrogen peroxide observed on interaction 
of the anaesthetic agents with stearate desaturase is 
produced during uncoupling of stearate desaturase by the 
anaesthetic agents. 
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The amounts of hydrogen peroxide produced in hepatic micro-
somes in the presence of the anaesthetic agents plus NADH is 
approximately 2,5 ~M/per min (Tables 29, 30 and 31 and 
Figures 20, 21 and 22). These amounts correspond to approxi-
mately 1,7 nmoles hydrogen peroxide produced/mg microsomal 
protein. ~nen corrected for hydrogen peroxide production in 
the presence of NADH alone, this figure becomes 0,6 nmoles 
hydrogen percxide produced/mg protein/min. This latter 
figure is 3 - 13 fold lower than the range of 2 - 10 nmoles 
hydrogen peroxide/mg protein/min produced in phenobarbitone 
treated microsomes by partial uncouplers of cytochrome P-450 
such as aminopyrene, aniline and hexobarbital (Hildebrandt 
et al., 1973). One would therefore expect much higher values 
of hydrogen peroxide production in the presence of a full 
uncoupler of cytochrome P-450 such as perfluorohexane. 
The "activated" oxygen species, hydrogen peroxide, which is 
produced in hepatic microsomes as a consequence of the 
uncoupling of stearate desaturase by the anaesthetic agents 
(Tables 29, 30 and 31) may have a deleterious effect on the 
cell. However, enzymes such as superoxide dismutase and 
catalase are known to play a role in protecting the cell 
against the deleterious effects of active oxygen species, 
which include toxic effects on proteins, lipid peroxidation 
in membranes, peroxidation of unsaturated fatty acids and 
damage to DNA (Fong et al., 1973; Lavelle et al., 1973; 
Kellogg and Fridovich, 1975; King ~t al., 1975; Van Herrunen 
and Meuling, 1975). 
260 
The hydrogen peroxide produced during the uncoupling of 
stearate desaturase by the anaesthetic agents might play 
a role in the metabolism of xenobiotics by cytochrome P-450. 
It has been shown that cytochrome P-450 can utilize hydrogen 
peroxide as an "artificial electron donor" to support the 
metabolism of xenobiotics e.g. aminopyrene and trichloro-
ethylene (Hildebrandt et al., 1973; Costa et al., 1979) and 
endogenous substrates (Hrycay et al., 1976). 
In conclusion therefore, the anaesthetic agents halothane, 
enflurane and methoxyflurane appear to uncouple the stearate 
desaturase enzyme system. The results presented above are 
the first report in the literature of the possible un-
coupling of stearate desaturase and provide the first 
suggestion of the uncoupling of any microsomal enzyme system 
other than cytochrome P-450. 
Observations on the structural characteristics of xenobiotics 
interacting with hepatic microsomal stear~te desaturase. 
The observation that bromotrichloromethane, l,2-dibromo-
l,2-dichloroethane, chloroacetaldehyde, halothane, enflurane 
and methoxyflurane enhance microsomal electron flow through 
cytochrome QS by interacting with stearate desaturase, 
suggested that other xenobiotics may also do so. In 
particular diiodomethane and 1,1,2-trichloroethane might 
be anticipated to do so as these xenobiotics stimulate the 
cyanide inhibitable re-oxidation of cytochrome Q5 (Ta
ble 2). 
It is anticipated that other xenobiotics, particularly halo-
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alkanes or halogenated aliphatic ethers, having multiple 
halo substituents (e.g. carbontetrachloride, tetrabromo-
methane, 1,2-dichloroethane) which have been shown to shift 
the redox state of cytochrome b 5 towards the ferric form 
(Table 1) might also stimulate microsomal electron transfer 
via cytochrome b 5 by interacting with stearate desaturase. 
The results of the investigations of the abilities of xeno-
biotics to enhance the re-oxidation of cytochrome b 5 do not 
however allow a complete elucidation of the structural 
characteristics of a xenobiotic which may be required for its 
interaction with stearate desaturase. Some general conclu-
sions, as regards these structural characteristics may however 
be drawn. All the xenobiotics which interact with stearate 
desaturase (bromotrichloromethane, l,2-dibromo-1,2-dichloro-
ethane, chloroacetaldehyde, halothane, enflurane and methoxy-
flurane) are halogenated, but all halogenated compounds do 
not interact (see Tables 1 and 2). There appears to be no 
correlation between the number and type of the halogen sub-
stituents of a compou~d required for interaction with stearate 
desaturase inasmuch as xenobiotics containing multiple bromine 
or chlorine atoms such as bromotrichloromethane and 1,2-
dibromo-l,2-dichloroethane interact with stearate desaturase 
while l,l,2,2-tetrachloroethane, 1-bromo-2-chloroethane do 
not (Table 2). In general however, compounds containing 
bromine or chlorine atoms such as those mentioned above, 
appear to be more reactive with stearate desaturase than 
compounds containing iodine atoms, such as diiodomethane and 
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iodoform. Xenobiotics containing fluorine atoms as the sole 
halogen substituent such as 1-fluorobutane and perfluoro-
hexane do not appear to interact with stearate desaturase 
{Table 1) while compounds containing fluorine atoms plus 
other types of halogen atoms such as halothane and enflurane 
do {Tables 1 and 2). Of the six xenobiotics which interact 
with stearate desaturase, five contain multiple halogen 
substituents and only chloroacetaldehyde contains only one 
type of halogen. It appears therefore that multiple halo 
substituents may be favourable for the interaction of a xeno-
biotic with stearate desaturase. 
The effects of anaesthetic agents in vivo 
It was attempted to investigate whether the interaction of 
the anaesthetic agents, in particular, halothane, with 
stearate desaturase affected the activity of stearate desatu-
rase in vivo. In addition, it was attempted to determine 
whether the potential hepatotoxicity of the anaesthetic agents 
could be connected with their ability to interact with 
stearate desaturase. 
It general, it was observed that anaesthesia of rats with 
halothane, enflurane, ether or chloroform did not markedly 
affect the activity of stearate desaturase in vivo {Tables ---
35, 36 and 37) which was consistent with the lack of effect 
of halothane and enflurane on the conversion of stearoyl CoA 
to oleate in vitro {Table 16). 
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With regard to the hepatotoxic potential of the anaesthetic 
agents, halothane, enflurane and ether produced no evidence 
of hepatotoxicity in animals on a normal diet (Table 39). 
No significant changes in S.G.O.T. levels or in hepatic 
histology were observed following halothane, enflurane or 
ether anaesthesia of rats pretreated to enhance or reduce 
the activity of stearate desaturase (Tables 38, 39 and 40). 
These results suggest that these anaesthetic agents do not 
produce hepatic damage in vivo regardless of the activity 
of stearate desaturase. Only chloroform anaesthesia elevated 
S.G.O.T. levels and produced centrilobular necrosis (Tables 
38 and 39). This is consistent with the known ability of 
chloroform to produce centrilobular necrosis of the liver, 
a cytochrome P-450 mediated effect (Brown et al., 1974). 
The lack of effect of stearate desaturase activity on chloro-
apparent 
form toxicity is consistent with theAinability of chloroform 
to interact with stearate desaturase (Table 1). 
Although repeated halothane anaesthesia did not produce 
evidence of hepatic damage in the investigations described 
in this thesis (see Tables 38, 39 and 40), halothane has been 
reported to produce a dose-related reproducible hepatotoxicity 
(Hughes and Lang, 1972; Stevens et al., 1975). The observa-
tion that repeated enflurane anaesthesia does not produce 
evidence of hepatic damage regardless of the activity of 
stearate desaturase in the animals thus exposed (Tables 38, 
39 and 40) agrees with the implication that enflurane is not an 
hepatotoxin ("Ethrane", 1972; Harrison et al., 1976). There 
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have however, been some reports that enflurane can cause 
cell degeneration and necrosis (Van der Reis et al., 1974; 
Stevens et al., 1977) although the extent of damage is 
always mild and far less than that produced by halothane 
(Stevens et al., 1977). Enflurane has been shown not to 
increase S.G.O.T. levels (Stacey et al., 1978; Thompson and 
Friday, 1978) which is in agreement with the normal range of 
S.G.O.T. levels observed after enflurane anaesthesia (Tables 
38, 39 and 40). The observation that ether produced no 
hepatotoxicity (Tables 38, 39 and 40) is also in agreement 
with the lack of hepatotoxicity of this anaesthetic agent 
(Fairlie et al., 1951). --
In order to investigate the possible protective effect of the 
interaction of halothane with stearate desaturase, it was 
essential to produce a reliable experimental model of cyto-
chrome P-450 mediated hepatic necrosis, such as is produced 
by halothane in the rare disorder known as halothane 
hepatitis (see Introduction). 
Recently, it has been established that halothane can be meta-
bolized by cytochrome P-450 via a reductive pathway under 
hypoxic conditions, as opposed to the more general oxidative 
pathways (Sharp et al., 1979) (see Figures 3 and 4) and that 
such reductive biotransformation causes reproducible hepatic 
necrosis. The nature of the observed hepatotoxicity is that 
of centrilobular necrosis (Brown and Sipes, 1977; Nastaincyk 
et al., 1978; Cousins et al., 1979). Further evidence for 
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the hepatotoxicity of halothane under hypoxic conditions is 
provided by the observation that hepatic glutathione levels 
are decreased during such anaesthesia (Table 45 and Figure 25). 
It was observed that anaesthesia with halothane under hypoxic 
conditions following phenobarbitone pretreatment as described 
by Brown and Sipes (1977), Nastaincyk (1978) and Cousins et 
al., (1979) caused congestion and centrilobular necrosis of 
the hepatocytes in animals fed a normal diet (Table 44). It 
was however, not possible to employ this model to study the 
effect of stearate desaturase activity on halothane induced 
hepatotoxicity because phenobarbitone decreased the activity 
of stearate desaturase to such an extent that no difference 
in this activity could be seen in rats fed a normal or a high 
carbohydrate diet (Tables 41 and 42). 
Another model, consisting of halothane anaesthesia under 
hypoxic conditions in the absence of phenobarbitone pretreat-
ment, was therefore employed to study the possible protective 
effect of the interaction of halothane with stearate desatu-
rase. The S.G.O.T. levels were lower and the mortality 
significantly decreased in animals on the high carbohydrate 
diet anaesthetized with halothane under hypoxic conditions in 
the absence of phenobarbitone compared to these parameters in 
animals on the normal diet anaesthetized in the same way 
(Tables 43 and 44 and Figure 23). This result suggests that 
elevated levels of stearate desaturase may protect against 
the hepatotoxic potential of halothane. 
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In contrast to halothane, anaesthesia with enflurane and 
methoxyflurane under hypoxic conditions, does not give rise 
to hepatotoxicity (Table 44). This is consistent with the 
lack of evidence for the reductive metabolism of enflurane 
and methoxyflurane by hepatic cytochrome P-450 although there 
is much evidence for the oxidative metabolism of these anaes-
thetic agents. 
As opposed to halothane, enflurane and methoxyflurane which 
interact with stearate desaturase (Tables l, 2, 13 and 14), 
chloroform does not interact with this enzyme (Table 1). As 
expected, the induction of stearate desaturase was without 
effect on the chloroform mediated mortality and hepatic 
necrosis observed in animals exposed to chloroform under 
hypoxic conditions (Tables 43 and 44 and Figure 23). These 
observations further suggest that the ability of a xenobiotic 
to interact with stearate desaturase might have a protective 




The xenobiotics bromotrichloromethane, l,2-dibromo-1,2-di-
chloroethane and chloroacetaldehyde and the anaesthetic agents 
halothane, enflurane and methoxyflurane enhance hepatic micro-
somal electron transfer through cytochrome b 5 in a cyanide 
sensitive manner, apparently as a consequence of their interaction 
with stearate desaturase. In addition to the xenobiotics mentioned 
above, it is anticipated that other halogenated compounds having 
multiple halo substituents (e.g. diiodomethane, 1,1,2-trichloro-
ethane, carbontetrachloride, tetrabromomethane, 1,2-dichloro-
ethane, 1,2-dibromo-l,l-dichloroethane) which shift the redox 
state of cytochrome ~ 5 towards the ferric form and/ or stim-
ulate the cyanide inhibitable re-oxidation of cytochrome £5 , 
might also interact with stearate desaturase. Although the 
anaesthetic agents halothane, enflurane and methoxyflurane and 
the xenobiotics bromotrichloromethane and l,2-dibromo-1,2-di-
chloroethane appear to bind to stearate desaturase, it is 
anticipated that they do not bind to the same site on the enzyme 
as does stearoyl CoA, as the xenobiotics do not affect the 
stearate desaturase mediated conversion of stearoyl CoA to 
oleate. Although the anaesthetic agents appear to bind to 
stearate desaturase, they are apparently not metabolized by this 
enzyme system. This lack of metabolism of the anaesthetic 
agents, together with their ability to stimulate the production 
of hydrogen peroxide in hepatic microsomes free of cytochrome 
P-450, suggested that the anaesthetic agents may uncouple the 
stearate desaturase enzyme system. From in vivo studies, there 
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was no evidence that the enhanced production of hydrogen per-
oxide gave rise to hepatotoxic effects. 
The hepatotoxicity of halothane under hypoxic conditions could 
be decreased by feeding rats a high carbohydrate diet, which 
elevates the levels and activity of hepatic microsomal stearate 
desaturase, suggesting that stearate desaturase might protect 
against the potential hepatotoxicity of halothane. 
It has been demonstrated that xenobiotics and anaesthetic 
agents can interact with other hepatic microsomal enzymes not 
generally thought to be involved in xenobiotic metabolism. This 
interaction should be considered in work on drug metabolism 
employing hepatic microsomes. Microsomes should therefore not 
only be considered as a source of cytochrome P-450 but also as 
a medium where xenobiotics may interact with a variety of 
other microsomal proteins. 
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